Section 73

EurekaMag PDF full texts Chapter 72,182


Yan, W.; Yun, Y.; Ku, T.; Li, G.; Sang, N. 2016: NO2 inhalation promotes Alzheimer's disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication. Scientific Reports 6: 22429
Deng, H.; Yu, B.; Yu, Y.; Tian, G.; Yang, L. 2020: NO66 overexpression rescues ethanol-induced cell apoptosis in human AC16 cardiomyocytes by suppressing PTEN and activating the PI3K/Akt signaling. Acta Biochimica et Biophysica Sinica 52(10): 1093-1101
Liu, L.; Stamler, J.S. 1999: NO: an inhibitor of cell death. Cell Death and Differentiation 6(10): 937-942
Dalton, R.; Witze, A.; Lubchenco, J. 2009: NOAA chief ready to tackle climate. Nature 458(7237): 396
Di Cesare, M.; Jarvis, J.D.; Scarlatescu, O.; Leng, X.; Zaidel, E.J.; Burrone, E.; Eiselé, J.-L.; Prabhakaran, D.; Sliwa, K. 2020: NOACs Added to WHO's Essential Medicines List: Recommendations for Future Policy Actions. Global Heart 15(1): 67
Roth, B.L.; Marshall, F.H. 2012: NOBEL 2012 Chemistry: Studies of a ubiquitous receptor family. Nature 492(7427): 57
Chen, Y.; Goeree, J. 2012: NOBEL 2012 Economics: Stable allocations and market design. Nature 492(7427): 54-55
Hinds, E.; Blatt, R. 2012: NOBEL 2012 Physics: Manipulating individual quantum systems. Nature 492(7427): 55
Rossant, J.; Mummery, C. 2012: NOBEL 2012 Physiology or medicine: Mature cells can be rejuvenated. Nature 492(7427): 56
Bebiş, H.; Moorhead, S.; Gençbaş, D.; Özdemir, S.; Seven, M. 2019: NOC/NIC Linkages to NANDA-i for Continence Care of Elderly people with Urinary Incontinence in Nursing Homes: a Systematic Review. Florence Nightingale Hemsirelik Dergisi 27(3): 284-303
Zeidler, M.; Kummer, K.K.; Schöpf, C.L.; Kalpachidou, T.; Kern, G.; Cader, M.Z.; Kress, M. 2021: NOCICEPTRA: Gene and microRNA Signatures and their Trajectories Characterizing Human iPSC-Derived Nociceptor Maturation. Advanced Science 8(21): E2102354
Aldrich, V.R.; Hernandez-Rovira, B.B.; Chandwani, A.; Abdulreda, M.H. 2020: NOD Mice-Good Model for T1D but not Without Limitations. Cell Transplantation 29: 963689720939127
Philpott, D.J.; Sorbara, M.T.; Robertson, S.J.; Croitoru, K.; Girardin, S.E. 2014: NOD proteins: regulators of inflammation in health and disease. Nature Reviews. Immunology 14(1): 9-23
Fan, Z.; Pan, J.; Wang, H.; Zhang, Y. 2021: NOD-like receptor X1, tumor necrosis factor receptor-associated factor 6 and NF-κB are associated with clinicopathological characteristics in gastric cancer. Experimental and Therapeutic Medicine 21(3): 208
Mai, Y.; Peng, S.; Li, H.; Gao, Y.; Lai, Z. 2021: NOD-like receptor signaling pathway activation: a potential mechanism underlying negative effects of benzo(α)pyrene on zebrafish. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 240: 108935
Wang, H.; Lin, X.; Pu, X. 2020: NOD-like receptors mediate inflammatory lung injury during plateau hypoxia exposure. Journal of Physiological Anthropology 39(1): 32
Wong, C.Kwok.; Hu, S.; Leung, K.Ming-Lam.; Dong, J.; He, L.; Chu, Y.Jun.; Chu, I.Miu-Ting.; Qiu, H-Na.; Liu, K.Yan-Ping.; Lam, C.Wai-Kei. 2013: NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma. Cellular and Molecular Immunology 10(4): 317-329
Nicolini, F.E.; Cashman, J.D.; Hogge, D.E.; Humphries, R.K.; Eaves, C.J. 2004: NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia 18(2): 341-347
de Wynter, E.A.; Heyworth, C.M.; Mukaida, N.; Matsushima, K.; Testa, N.G. 2001: NOD/SCID repopulating cells but not LTC-IC are enriched in human CD34+ cells expressing the CCR1 chemokine receptor. Leukemia 15(7): 1092-1101
Jia, F.; Deng, F.; Xu, P.; Li, S.; Wang, X.; Hu, P.; Ren, H.; Tong, S.; Yin, W. 2021: NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced Fatal Hepatitis Through the Upregulation of A20 Expression in Hepatocytes. Frontiers in Immunology 12: 603192
Trindade, B.C.; Chen, G.Y. 2020: NOD1 and NOD2 in inflammatory and infectious diseases. Immunological Reviews 297(1): 139-161
Keestra-Gounder, A.Marijke.; Byndloss, M.X.; Seyffert, Núbia.; Young, B.M.; Chávez-Arroyo, A.; Tsai, A.Y.; Cevallos, S.A.; Winter, M.G.; Pham, O.H.; Tiffany, C.R.; de Jong, M.F.; Kerrinnes, T.; Ravindran, R.; Luciw, P.A.; McSorley, S.J.; Bäumler, A.J.; Tsolis, Rée.M. 2016: NOD1 and NOD2 signalling links ER stress with inflammation. Nature 532(7599): 394-397
Hu, Y.Wei.; Wu, X.Man.; Ren, S.Si.; Cao, L.; Nie, P.; Chang, M.Xian. 2017: NOD1 deficiency impairs CD44a/Lck as well as PI3K/Akt pathway. Scientific Reports 7(1): 2979
González-Ramos, S.; Paz-García, M.; Fernández-García, V.; Portune, K.J.; Acosta-Medina, E.F.; Sanz, Y.; Castrillo, A.; Martín-Sanz, P.; Obregon, M.Jesus.; Boscá, L. 2020: NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet. Scientific Reports 10(1): 12317
Fernández-García, V.; González-Ramos, S.; Martín-Sanz, P.; García-Del Portillo, F.; Laparra, J.é M.és.; Boscá, L. 2021: NOD1 in the interplay between microbiota and gastrointestinal immune adaptations. Pharmacological Research 171: 105775
Neuper, T.; Ellwanger, K.; Schwarz, H.; Kufer, T.A.; Duschl, A.; Horejs-Hoeck, J. 2017: NOD1 modulates IL-10 signalling in human dendritic cells. Scientific Reports 7(1): 1005
Gonzalez-Hormazabal, P.; Pelaez, D.; Musleh, M.; Bustamante, M.; Stambuk, J.; Pisano, R.; Valladares, H.; Lanzarini, E.; Chiong, H.; Suazo, J.; Quiñones, L.A.; Varela, N.M.; Castro, V.G.; Jara, L.; Berger, Z. 2021: NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori. Biological Research 54(1): 13
Tukhvatulin, A.I.; Dzharullaeva, A.S.; Erokhova, A.S.; Scheblyakov, D.V.; Naroditsky, B.S.; Gintsburg, A.L.; Logunov, D.Y. 2020: NOD1/2 and the C-Type Lectin Receptors Dectin-1 and Mincle Synergistically Enhance Proinflammatory Reactions Both in Vitro and in Vivo. Journal of Inflammation Research 13: 357-368
Wang, M.; Ye, X.; Hu, J.; Zhao, Q.; Lv, B.; Ma, W.; Wang, W.; Yin, H.; Hao, Q.; Zhou, C.; Zhang, T.; Wu, W.; Wang, Y.; Zhou, M.; Zhang, C.-H.; Cui, G. 2020: NOD1/RIP2 signalling enhances the microglia-driven inflammatory response and undergoes crosstalk with inflammatory cytokines to exacerbate brain damage following intracerebral haemorrhage in mice. Journal of Neuroinflammation 17(1): 364
Carlos, D.; Pérez, M.M.; Leite, J.A.; Rocha, F.A.; Martins, L.M.S.; Pereira, C.A.; Fraga-Silva, T.F.C.; Pucci, T.ís.A.; Ramos, S.G.; Câmara, N.O.S.; Bonato, V.ân.L.D.; Tostes, R.C.; Silva, J.ão.S. 2020: NOD2 Deficiency Promotes Intestinal CD4+ T Lymphocyte Imbalance, Metainflammation, and Aggravates Type 2 Diabetes in Murine Model. Frontiers in Immunology 11: 1265
Jiao, D.; Wong, C-Kwok.; Qiu, H-Na.; Dong, J.; Cai, Z.; Chu, M.; Hon, K-Lun.; Tsang, M.Sin-Man.; Lam, C.Wai-Kei. 2016: NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation. Cellular and Molecular Immunology 13(4): 535-550
Rochereau, N.; Roblin, X.; Michaud, E.; Gayet, Rémi.; Chanut, B.; Jospin, F.; Corthésy, B.; Paul, Séphane. 2021: NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn's disease. Nature Communications 12(1): 261
Takada, R.; Watanabe, T.; Hara, A.; Sekai, I.; Kurimoto, M.; Otsuka, Y.; Masuta, Y.; Yoshikawa, T.; Kamata, K.; Minaga, K.; Kudo, M. 2021: NOD2 deficiency protects mice from the development of adoptive transfer colitis through the induction of regulatory T cells expressing forkhead box P3. Biochemical and Biophysical Research Communications 568: 55-61
Ajendra, J.; Specht, S.; Ziewer, S.; Schiefer, A.; Pfarr, K.; Parčina, M.; Kufer, T.A.; Hoerauf, A.; Hübner, M.P. 2016: NOD2 dependent neutrophil recruitment is required for early protective immune responses against infectious Litomosoides sigmodontis L3 larvae. Scientific Reports 6: 39648
Watanabe, T.; Asano, N.; Meng, G.; Yamashita, K.; Arai, Y.; Sakurai, T.; Kudo, M.; Fuss, I.J.; Kitani, A.; Shimosegawa, T.; Chiba, T.; Strober, W. 2014: NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6. Mucosal Immunology 7(6): 1312-1325
Ningappa, M.; Higgs, B.W.; Weeks, D.E.; Ashokkumar, C.; Duerr, R.H.; Sun, Q.; Soltys, K.A.; Bond, G.J.; Abu-Elmagd, K.; Mazariegos, G.V.; Alissa, F.; Rivera, M.; Rudolph, J.; Squires, R.; Hakonarson, H.; Sindhi, R. 2011: NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome. American Journal of Gastroenterology 106(1): 157-165
Jüngst, C.; Stadlbauer, V.; Reichert, M.C.; Zimmer, V.; Weber, S.N.; Ofner-Ziegenfuß, L.; Voigtländer, T.; Spindelböck, W.; Fickert, P.; Kirchner, G.I.; Lammert, F.; Lankisch, T.O.; Krawczyk, M. 2017: NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients. Scientific Reports 7(1): 7026
Cavallari, J.F.; Pokrajac, N.T.; Zlitni, S.; Foley, K.P.; Henriksbo, B.D.; Schertzer, J.D. 2020: NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice. American Journal of Physiology. Endocrinology and Metabolism 319(2): E305-E314
Ma, X.; Qiu, Y.; Sun, Y.; Zhu, L.; Zhao, Y.; Li, T.; Lin, Y.; Ma, D.; Qin, Z.; Sun, C.; Han, L. 2020: NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway. Cell Death and Disease 11(3): 174
Watanabe, T.; Kitani, A.; Murray, P.J.; Strober, W. 2004: NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 5(8): 800-808
van der Velden, W.J.F.M.; Blijlevens, N.M.A.; Maas, F.M.H.M.; Schaap, N.P.M.; Jansen, J.H.; van der Reijden, B.A.; Feuth, T.; Dolstra, H.; Donnelly, J.P. 2009: NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. Bone Marrow Transplantation 44(4): 243-248
Du, P.; Fan, B.; Han, H.; Zhen, J.; Shang, J.; Wang, X.; Li, X.; Shi, W.; Tang, W.; Bao, C.; Wang, Z.; Zhang, Y.; Zhang, B.; Wei, X.; Yi, F. 2013: NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney International 84(2): 265-276
Pereira, N.d.S.; Queiroga, T.B.D.; da Silva, D.D.; Nascimento, M.S.L.; Andrade, C.éb.M.d.; Souto, J.T.d.; Ricci, M.F.; Arantes, R.M.E.; Zamboni, D.S.õe.; Chiari, E.; Câmara, A.ôn.C.áu.J.ác.d.; Galvão, L.úc.M.d.C.; Guedes, P.M.M. 2020: NOD2 receptor is crucial for protecting against the digestive form of Chagas disease. Plos Neglected Tropical Diseases 14(9): E0008667
Strober, W.; Watanabe, T. 2011: NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunology 4(5): 484-495
Wannigama, D.L.; Jacquet, A. 2020: NOD2-dependent BCG-induced trained immunity: a way to regulate innate responses to SARS-CoV2?. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 101: 52-55
Chen, X.; Zhou, Z.; Zhang, Y.; Cheng, X.; Guo, X.; Yang, X. 2018: NOD2/CARD15 gene polymorphisms and sarcoidosis susceptibility: review and meta-analysis. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 35(2): 115-122
Abdelnaby, H.; Ndiaye, N.C.; D'Amico, F.; Fouad, A.M.; Hassan, S.; Elshafey, A.; Al Hashash, W.; Faisal, M.; Alshamali, Y.; Al-Taweel, T.; Peyrin-Biroulet, L. 2021: NOD2/CARD15 polymorphisms (P268S, IVS8+158, G908R, L1007fs, R702W) among Kuwaiti patients with Crohn's disease: a case-control study. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 27(4): 249-256
Arnott, I.D.R.; Nimmo, E.R.; Drummond, H.E.; Fennell, J.; Smith, B.R.K.; MacKinlay, E.; Morecroft, J.; Anderson, N.; Kelleher, D.; O'Sullivan, M.; McManus, R.; Satsangi, J. 2004: NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes and Immunity 5(5): 417-425
Khan, A.; Singh, V.K.; Mishra, A.; Soudani, E.; Bakhru, P.; Singh, C.R.; Zhang, D.; Canaday, D.H.; Sheri, A.; Padmanabhan, S.; Challa, S.; Iyer, R.P.; Jagannath, C. 2020: NOD2/RIG-i Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice. Frontiers in Immunology 11: 592333
Body-Malapel, M.; Dharancy, Sébastien.; Berrebi, D.; Louvet, A.; Hugot, J-Pierre.; Philpott, D.J.; Giovannini, M.; Chareyre, F.; Pages, G.; Gantier, E.; Girardin, S.E.; Garcia, Iène.; Hudault, S.; Conti, Féna.; Sansonetti, P.J.; Chamaillard, M.; Desreumaux, P.; Dubuquoy, L.; Mathurin, P. 2008: NOD2: a potential target for regulating liver injury. Laboratory Investigation; a Journal of Technical Methods and Pathology 88(3): 318-327
Narwani, T.Jairaj.; Srinivasan, N.; Chakraborti, S. 2021: NOD: a web server to predict New use of Old Drugs to facilitate drug repurposing. Scientific Reports 11(1): 13540
Yechikov, S.; Kao, H.K.J.; Chang, C.-W.; Pretto, D.; Zhang, X.-D.; Sun, Y.-H.; Smithers, R.; Sirish, P.; Nolta, J.A.; Chan, J.W.; Chiamvimonvat, N.; Lieu, D.K. 2020: NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells. Stem Cell Research 49: 102043
Kamiya, K.; Hori, M.; Aoki, S. 2020: NODdi in clinical research. Journal of Neuroscience Methods 346: 108908
Jain, D.; Arora, S.; Virk, R.S.; Gupta, M.; Arora, K. 2020: NODIC technique - (Nasal oxygenation during infraglottic coblation) to increase the safe apnoea time. Indian Journal of Anaesthesia 64(8): 717-719
Sathiavageesan, S.; Natarajan, L. 2021: Nodular skin eruption following centipede bite in a transplant patient. Transplant Infectious Disease: An Official Journal of the Transplantation Society 23(4): E13648
Tadagavadi, R.K.; Reeves, W.Brian. 2015: NODding off in acute kidney injury with progranulin?. Kidney International 87(5): 873-875
Inohara, N.; Nuñez, G. 2003: NODs: intracellular proteins involved in inflammation and apoptosis. Nature Reviews. Immunology 3(5): 371-382
Huo, X.; Wu, S.; Zhu, Z.; Liu, F.; Fu, Y.; Cai, H.; Sun, X.; Gu, P.; Xie, D.; Tan, L.; Sun, C. 2017: NOG1 increases grain production in rice. Nature Communications 8(1): 1497
Rämö, O.; Kumar, D.; Gucciardo, E.; Joensuu, M.; Saarekas, M.; Vihinen, H.; Belevich, I.; Smolander, O-Pekka.; Qian, K.; Auvinen, P.; Jokitalo, E. 2016: NOGO-A/RTN4A and NOGO-B/RTN4B are simultaneously expressed in epithelial, fibroblast and neuronal cells and maintain ER morphology. Scientific Reports 6: 35969
Chen, Y.; Chi, Y.; Fan, J.; Ma, C.; Yan, Y. 2020: Noisy Matrix Completion: Understanding Statistical Guarantees for Convex Relaxation via Nonconvex Optimization. Siam Journal on Optimization: a Publication of the Society for Industrial and Applied Mathematics 30(4): 3098-3121
Wang, Y.; Liu, S.; Jiang, G.; Zhai, W.; Yang, L.; Li, M.; Chang, Z.; Zhu, B. 2020: NOK associates with c-Src and promotes c-Src-induced STAT3 activation and cell proliferation. Cellular Signalling 75: 109762
Yu, G.; Xie, Z.; Zhang, J.; Lei, S.; Lin, W.; Xu, B.; Huang, B. 2021: NOL-mediated functional stay-green traits in perennial ryegrass (Lolium perenne L.) involving multifaceted molecular factors and metabolic pathways regulating leaf senescence. Plant Journal: for Cell and Molecular Biology 106(5): 1219-1232
Sheikholeslami, S.; Azizi, F.; Ghasemi, A.; Alibakhshi, A.; Parsa, H.; Tavangar, S.M.; Shivaee, S.; Zarif Yeganeh, M.; Hedayati, M.; Teimoori-Toolabi, L. 2020: NOL4 is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting its Role as a Tumor Suppressor Gene. International Journal of Endocrinology and Metabolism 18(4): E108510
Lin, F.; Zhou, J.; Li, X.; Wang, X. 2021: NOL4L, a novel nuclear protein, promotes cell proliferation and metastasis by enhancing the PI3K/AKT pathway in ovarian cancer. Biochemical and Biophysical Research Communications 559: 121-128
Li, Y.; Zhong, C.; Wang, J.; Chen, F.; Shen, W.; Li, B.; Zheng, N.; Lu, Y.; Katanaev, V.L.; Jia, L. 2021: NOL7 facilitates melanoma progression and metastasis. Signal Transduction and Targeted Therapy 6(1): 352
Hasina, R.; Pontier, A.L.; Fekete, M.J.; Martin, L.E.; Qi, X.M.; Brigaudeau, C.; Pramanik, R.; Cline, E.I.; Coignet, L.J.; Lingen, M.W. 2006: NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype. Oncogene 25(4): 588-598
Schuster, S.; Rivalan, M.; Strauss, U.; Stoenica, L.; Trimbuch, T.; Rademacher, N.; Parthasarathy, S.; Lajkó, D.; Rosenmund, C.; Shoichet, S.A.; Winter, Y.; Tarabykin, V.; Rosário, M. 2015: NOMA-GAP/ARHGAP33 regulates synapse development and autistic-like behavior in the mouse. Molecular Psychiatry 20(9): 1120-1131
Requena, F.; Asenjo, H.G.; Barturen, G.; Martorell-Marugán, J.; Carmona-Sáez, P.; Landeira, D. 2019: NOMePlot: analysis of DNA methylation and nucleosome occupancy at the single molecule. Scientific Reports 9(1): 8140
Cassinotti, A.; Corona, A.; Duca, P.; Nebuloni, M.; Maconi, G.; Fociani, P.; Ardizzone, S. 2021: Noninvasive Monitoring After Azathioprine Withdrawal in Patients with Inflammatory Bowel Disease in Deep Remission. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 19(11): 2293-2301.E1
Carmel, P.W.; Starr, A. 1964: Non-Acoustic Factors Influencing Activity of Middle Ear Muscles in Waking Cats. Nature 202: 195-196
Koval, T.V.; Chopey, I.V.; Hechko, M.M.; Kurakh, A.V. 2021: Non-Alcoholic Fatty Liver Disease in the Context of Altered Gut Microbiota. Wiadomosci Lekarskie 74(4): 1007-1010
Ahmad, H.M.N.; Si, B.; Dutta, G.; Csoros, J.R.; Seitz, W.R.; Song, E. 2019: Non-Enzymatic Electrochemical Detection of Glutamate using Templated Polymer-Based Target Receptors. International Solid-State Sensors Actuators and Microsystems Conference: Proceedings . International Conference on Solid-State Sensors Actuators and Microsystems 2019: 613-616
Alivisatos, S.G.; Ungar, F.; Abraham, G. 1964: Non-Enzymatic Interactions of Reduced Coenzyme I with Inorganic Phosphate and Certain other Anions. Nature 203: 973-975
Hardinge, M.G.; Crooks, H. 1963: Non-Flesh Dietaries. Journal of the American Dietetic Association 43: 550-558
Hardinge, M.G.; Crooks, H. 1964: Non-Flesh Dietaries. Journal of the American Dietetic Association 45: 537-542
Dumortier, J.ér.ôm.; Besch, C.; Moga, L.; Coilly, A.; Conti, F.; Corpechot, C.; Del Bello, A.; Faitot, F.ço.; Francoz, C.; Hilleret, M.-N.ël.; Houssel-Debry, P.; Jezequel, C.; Lavayssière, L.; Neau-Cransac, M.; Erard-Poinsot, D.; de Lédinghen, V.; Bourlière, M.; Bureau, C.; Ganne-Carrié, N. 2022: Non-invasive diagnosis and follow-up in liver transplantation. Clinics and Research in Hepatology and Gastroenterology 46(1): 101774
Lemoinne, S.; Heurgue, A.; Bouzbib, C.; Hanslik, B.; Gournay, J.ér.ôm.; Nguyen-Khac, E.; Bureau, C.; de Lédinghen, V.; Ganne-Carrié, N.; Bourlière, M. 2022: Non-invasive diagnosis and follow-up of autoimmune hepatitis. Clinics and Research in Hepatology and Gastroenterology 46(1): 101772
Nault, J.-C.; Blanc, J.-F.éd.ér.; Moga, L.; Calderaro, J.; Dao, T.ôn.; Guiu, B.; Hocquelet, A.; Paradis, V.ér.; Salamé, E.; de Lédinghen, V.; Bourlière, M.; Bureau, C.; Ganne-Carrié, N. 2022: Non-invasive diagnosis and follow-up of benign liver tumours. Clinics and Research in Hepatology and Gastroenterology 46(1): 101765
Leroy, V.; Chevaliez, S.ép.; Decraecker, M.; Roulot, D.; Nana, J.; Asselah, T.; Causse, X.; Durantel, D.; Thibaut, V.; Ganne-Carrié, N.; Bureau, C.; de Lédinghen, V.; Bourlière, M. 2022: Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus. Clinics and Research in Hepatology and Gastroenterology 46(8): 101773
Tran, A.; Shili-Masmoudi, S.; Moga, L.; Chevaliez, S.ép.; Luciani, A.; Ruiz, I.; Ganne-Carrié, N.; Bureau, C.; Bourlière, M.; de Lédinghen, V. 2022: Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus. Clinics and Research in Hepatology and Gastroenterology 46(1): 101771
De Lédinghen, V. 2022: Non-invasive diagnosis and follow-up of chronic liver disease. Clinics and Research in Hepatology and Gastroenterology 46(1): 101763
Bardou-Jacquet, E.; Hamdi-Roze, H.; Paisant, A.; Decraecker, M.; Bourlière, M.; Ganne-Carrié, N.; de Lédinghen, V.; Bureau, C. 2022: Non-invasive diagnosis and follow-up of hyperferritinaemia. Clinics and Research in Hepatology and Gastroenterology 46(1): 101762
Boursier, J.ér.ôm.; Guillaume, M.; Bouzbib, C.; Lannes, A.; Pais, R.; Smatti, S.; Cariou, B.; Bureau, C.; Ganne-Carrié, N.; Bourlière, M.; de Lédinghen, V. 2022: Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease. Clinics and Research in Hepatology and Gastroenterology 46(1): 101769
Thabut, D.; Weil, D.; Bouzbib, C.; Rudler, M.; Cassinotto, C.; Castéra, L.; Serste, T.; Oberti, F.éd.ér.; Ganne-Carrié, N.; de Lédinghen, V.; Bourlière, M.; Bureau, C. 2022: Non-invasive diagnosis and follow-up of portal hypertension. Clinics and Research in Hepatology and Gastroenterology 46(8): 101767
Corpechot, C.; Heurgue, A.; Tanne, F.; Potier, P.; Hanslik, B.; Decraecker, M.; de Lédinghen, V.; Ganne-Carrié, N.; Bureau, C.; Bourlière, M. 2022: Non-invasive diagnosis and follow-up of primary biliary cholangitis. Clinics and Research in Hepatology and Gastroenterology 46(1): 101770
Nahon, P.; Aubé, C.; Moga, L.; Chalaye, J.; Guiu, B.; Luciani, A.; Rode, A.ès.; Ronot, M.; Seror, O.; Soussan, M.; Sutter, O.; Bourlière, M.; Bureau, C.; de Lédinghen, V.; Ganne-Carrié, N. 2022: Non-invasive diagnosis and follow-up of primary malignant liver tumours. Clinics and Research in Hepatology and Gastroenterology 46(1): 101766
Chazouillères, O.; Potier, P.; Bouzbib, C.; Hanslik, B.; Heurgue, A.; NGuyen-Khac, E.; Gournay, J.ér.ôm.; Tanne, F.; Bureau, C.; Bourlière, M.; Ganne-Carrié, N.; de Lédinghen, V. 2022: Non-invasive diagnosis and follow-up of primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 46(1): 101775
Sobesky, R.; Guillaud, O.; Bouzbib, C.; Sogni, P.; Poujois, A.él.; Woimant, F.; Duclos-Vallée, J.C.; Bourlière, M.; de Lédinghen, V.; Ganne-Carrié, N.; Bureau, C. 2022: Non-invasive diagnosis and follow-up of rare genetic liver diseases. Clinics and Research in Hepatology and Gastroenterology 46(1): 101768
Rautou, P.-E.; Elkrief, L.; Decraecker, M.; Ollivier-Hourmand, I.; Plessier, A.él.; Ronot, M.; Vilgrain, V.ér.; Bourlière, M.; Ganne-Carrié, N.; de Lédinghen, V.; Bureau, C. 2022: Non-invasive diagnosis and follow-up of vascular liver diseases. Clinics and Research in Hepatology and Gastroenterology 46(1): 101764
Preciado-Puga, M.C.; Ruiz-Noa, Y.; Garcia-Ramirez, J.R.; Jordan-Perez, B.; Garnelo-Cabañas, S.; Lazo de la Vega-Monroy, M.L.; Gutierrez-Aguirre, K.I.; Ibarra-Reynoso, L.R. 2021: Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures. Annals of Hepatology 22: 100335
Basile, A.; Navarra, S. 1963: Non-Neonatal Intestinal Occlusions. Minerva Medica 54: 3220-3222
Basile, A.; Navarra, S. 1963: Non-Neonatal Intestinal Occlusions. Minerva Chirurgica 18: 978-980
Semikov, V.; Aleksandrov, Y.; Shulutko, A.; Mansurova, T.; Gogokhia, T.; Gorbacheva, A. 2021: Non-Surgical Aspects of Thyroid Surgery. Georgian Medical News 312: 14-22
Chernylovskyi, V.A.; Krakhotkin, D.V.; Chaikovskyi, V.P. 2021: Non-Surgical Treatment of Peyronie's Disease: a Comprehensive Review. Wiadomosci Lekarskie 74(3 Cz 1: 539-545
Branch, A. 1927: Non-Tuberculous Pulmonary Diseases. Canadian Medical Association Journal 17(7): 836-837
Sheinfeld, W.I.; Rubinow, M. 1964: Noncaseating Epithelioid Granuloma of the Appendix (Localized Sarcoid Disease)?. Journal of the International College of Surgeons 42: 1-4
Chabot, J. 1964: Noncomatose Terminal Form of Untreated Myxedema. Study of 8 Cases. Annales d'Endocrinologie 25: 59-64
Kim, J.H.; Kim, M.J.; Lee, J.H.; Yoon, J.W.; Shin, C.S. 2020: Nonfunctioning Adrenal Incidentalomas Are not Clinically Silent: a Longitudinal Cohort Study. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020
Gonçalves, A.R.; Ambrogini, O.; Forones, N.M. 2021: Noninvasive Breath tests for Diagnosis of Sibo and Lactose Intolerance in Patients on Chemotherapy Treatment for Colorectal and Gastric Câncer. Arquivos de Gastroenterologia 58(1): 26-31
Jeffrey, A.; Evans, T.S.; Molter, C.; Howard, L.L.; Ling, P.; Goldstein, T.; Gilardi, K. 2020: Noninvasive Sampling for Detection of Elephant Endotheliotropic Herpesvirus and Genomic DNA in Asian (Elephas Maximus) and African (Loxodonta Africana) Elephants. Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 51(2): 433-437
Lopez-Gomez, M.; Llop, E.; Puente, A.; Hernández Conde, M.; Ruiz, P.; Alvárez, S.; Martínez, J.L.; Abad, J.; Fernández, N.; Perelló, C.; Fernández-Carrillo, C.; Ferre, C.; Trapero, M.; Fraga, E.; Crespo, J.; Calleja Panero, J.L. 2021: Non-malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors. Hepatology Research: the Official Journal of the Japan Society of Hepatology 51(10): 1064-1072
Xie, R.; Chen, X.; Cheng, L.; Huang, M.; Zhou, Q.; Zhang, J.; Chen, Y.; Peng, S.; Chen, Z.; Dong, W.; Huang, J.; Lin, T. 2021: NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(1): 291-307
Liang, S.; Takahashi, H.; Hirose, T.; Kuramitsu, Y.; Hatakeyama, S.; Yoshiyama, H.; Wang, R.; Hamada, J.-I.; Iizasa, H. 2020: NONO Is a Negative Regulator of SOX2 Promoter. Cancer Genomics and Proteomics 17(4): 359-367
Fan, X.-J.; Wang, Y.-L.; Zhao, W.-W.; Bai, S.-M.; Ma, Y.; Yin, X.-K.; Feng, L.-L.; Feng, W.-X.; Wang, Y.-N.; Liu, Q.; Hung, M.-C.; Wan, X.-B. 2021: NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activation. American Journal of Cancer Research 11(6): 2838-2852
Ding, H.; Liu, J.; Wang, C.; Su, Y. 2020: NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA. Cancer Cell International 20: 425
Alfano, L.; Costa, C.; Caporaso, A.; Altieri, A.; Indovina, P.; Macaluso, M.; Giordano, A.; Pentimalli, F. 2016: NONO regulates the intra-S-phase checkpoint in response to UV radiation. Oncogene 35(5): 567-576
Donovan, K.M.; Hudgens, M.G.; Gilbert, P.B. 2019: Nonparametric Inference for Immune Response Thresholds of Risk in Vaccine Studies. Annals of Applied Statistics 13(2): 1147-1165
Glacet-Bernard, A.ès.; Miere, A.; Houmane, B.; Tilleul, J.; Souied, E. 2021: Nonperfusion Assessment in Retinal Vein Occlusion: Comparison between Ultra-Widefield Fluorescein Angiography and Widefield Optical Coherence Tomography Angiography. Retina 41(6): 1202-1209
Venher, I.; Kostiv, S.; Kolotylo, O.; Herasymiuk, N.; Nechytailo, O. 2021: Nonspecific Dysplasia of the Connective Tissue - a Factor in Venous Thromboembolic Complications of Hip Joints' Endoprosthetics. Georgian Medical News 314: 21-25
Amreich, I. 1965: Nonspecific Intestinal Diseases and their Treatment. Wiener Medizinische Wochenschrift 115: 97
Zhuang, H.; Wang, H-Lei.; Zhang, T.; Zeng, X-Qin.; Chen, H.; Wang, Z-Wei.; Zhang, J.; Zheng, H.; Tang, J.; Ling, Y-Hua.; Yang, Z-Lin.; He, G-Hua.; Li, Y-Feng. 2020: NONSTOP GLUMES1 Encodes a C2H2 Zinc Finger Protein That Regulates Spikelet Development in Rice[OPEN. Plant Cell 32(2): 392-413
Stan, M.N.; Castro, M.R. 2020: Nonsurgical Treatment of Thyroid Cysts - "seal them Up". Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 26(5): 573-575
Zhu, X.; Jia, W.; Yan, Y.; Huang, Y.; Wang, B. 2021: NOP14 regulates the growth, migration, and invasion of colorectal cancer cells by modulating the NRIP1/GSK-3β/β-catenin signaling pathway. European Journal of Histochemistry: Ejh 65(3)
Ma, X.; Huang, J.; Yang, L.; Yang, Y.; Li, W.; Xue, L. 2012: NOPO modulates Egr-induced JNK-independent cell death in Drosophila. Cell Research 22(2): 425-431
Nguyen, L.; Chopra, S.; Laskar, D.B.; Rao, J.; Lieu, D.; Chung, F.; Kim, E.D.; de Peralta-Venturina, M.; Bose, S.; Balzer, B. 2020: NOR-1 distinguishes acinic cell carcinoma from its mimics on fine-needle aspiration biopsy specimens. Human Pathology 102: 1-6
Jin, Y.-T.; Yu-Fong Chang, J.; Sun, A.; Chiang, C.-P. 2021: NOR-1 immunostain is a good method to confirm the diagnosis of an oral acinic cell carcinoma. Journal of Dental Sciences 16(3): 1030-1032
Alonso, J.; Galán, Mía.; Martí-Pàmies, I.; Romero, Jé.María.; Camacho, M.; Rodríguez, C.; Martínez-González, Jé. 2016: NOR-1/NR4A3 regulates the cellular inhibitor of apoptosis 2 (cIAP2) in vascular cells: role in the survival response to hypoxic stress. Scientific Reports 6: 34056
Anca, D.; Pua, B.; Fogarty Mack, P. 2021: NORA: Considerations during COVID 19 Pandemic-The new York Experience. Perioperative Care and Operating Room Management 22: 100148
Liu, Y.; Zhu, Y.; Liu, S.; Liu, J.; Li, X. 2021: NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD/miR-125a-3p/Fyn. Inflammation Research: Official Journal of the European Histamine Research Society . 70(10-12): 1113-1127
Han, T.; Wu, Y.; Hu, X.; Chen, Y.; Jia, W.; He, Q.; Bian, Y.; Wang, M.; Guo, X.; Kang, J.; Wan, X. 2020: NORAD orchestrates endometrial cancer progression by sequestering FUBP1 nuclear localization to promote cell apoptosis. Cell Death and Disease 11(6): 473
Han, Y.; Tian, H.; Gao, X. 2020: NORAD regulates proliferation and apoptosis in cardiomyocytes under high-glucose treatment through miRNA-150-5p/ZEB1 axis. European Review for Medical and Pharmacological Sciences 24(21): 11259-11265
Soghli, N.; Yousefi, T.; Abolghasemi, M.; Qujeq, D. 2021: NORAD, a critical long non-coding RNA in human cancers. Life Sciences 264: 118665
Brouquet, A.; Bachet, J.-B.; Huguet, F.; Karoui, M.; Artru, P.; Sabbagh, C.; Lefèvre, J.ér.ém.H.; Vernerey, D.; Mariette, C.; Vicaut, E.; Benoist, S. 2020: NORAD01-GRECCAR16 multicenter phase IIi non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial). Bmc Cancer 20(1): 485
Ko, K-Phil.; Jeong, S-In.; Lim, J-Sun.; Lee, K-Woo.; Lee, M-Goo.; Chi, S-Gil. 2020: NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX. Oncogene 39(34): 5675-5689
Hesson, L.; Dallol, A.; Minna, J.D.; Maher, E.R.; Latif, F. 2003: NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene 22(6): 947-954
Schwarz, P.M.; Freisleben, B. 2021: NOREC4DNA: using near-optimal rateless erasure codes for DNA storage. Bmc Bioinformatics 22(1): 406
Du, X.; Liu, L.; Li, Q.; Zhang, L.; Pan, Z.; Li, Q. 2020: NORFA, long intergenic noncoding RNA, maintains sow fertility by inhibiting granulosa cell death. Communications Biology 3(1): 131
Yao, W.; Pan, Z.; Du, X.; Zhang, J.; Liu, H.; Li, Q. 2021: NORHA, a novel follicular atresia-related lncRNA, promotes porcine granulosa cell apoptosis via the miR-183-96-182 cluster and FoxO1 axis. Journal of Animal Science and Biotechnology 12(1): 103
Shang, Z.; Dang, Y.; Wang, Y.; Zheng, G. 2021: NORM survey within the second census on pollution sources in China. Journal of Environmental Radioactivity 237: 106714
Soneye, M.A.; Adekanmi, A.J. 2018: Normal Femoral Artery Intima-Media Thickness among Healthy Nigerian Adults; Relationship with Age, Gender and Body Mass Index. Journal of the West African College of Surgeons 8(4): 67-93
Domingues, G.R.; Michelsohn, N.H.; Viebig, R.G.; Chinzon, D.éc.; Nasi, A.; Andrade, C.G.; Lemme, E.M.; AbrahÃo Junior, L.J.ão.; Bravim, M.G.; Nobre-E-Souza, M.Ân.; Carvalho, N.S.; Carvalho, P.J.P.C.; Rodrigues, T.ás.N.; Moraes Filho, J.P.P. 2020: Normal Values of Esophageal High-Resolution Manometry: a Brazilian Multicenter Study. Arquivos de Gastroenterologia 57(2): 209-215
Bukia, N.; Butskhrikidze, M.; Machavariani, L.; Svanidze, M.; Jojua, N. 2021: Normalizing Effect of Electromagnetic Stimulation on Blood Quantitative Indices in Depressed Rats on the Background of Oxytocin. Georgian Medical News 2021(312): 100-104
El-Sehemy, A.; Wallace, V.A. 2020: NORRIN plays a context-dependent role in glioblastoma stem cells. Molecular and Cellular Oncology 7(4): 1758540
Sadaf, S.; Nagarkoti, S.; Awasthi, D.; Singh, A.K.; Srivastava, R.N.; Kumar, S.; Barthwal, M.K.; Dikshit, M. 2021: NNOS induction and NOSIP interaction impact granulopoiesis and neutrophil differentiation by modulating nitric oxide generation. Biochimica et Biophysica Acta. Molecular Cell Research 1868(7): 119018
Grünewald, T.; Beal, M.F. 1999: NOS knockouts and neuroprotection. Nature Medicine 5(12): 1354-1355
Tyganov, S.A.; Mochalova, E.P.; Melnikov, I.Y.; Vikhlyantsev, I.M.; Ulanova, A.D.; Sharlo, K.A.; Mirzoev, T.M.; Shenkman, B.S. 2021: NOS-dependent effects of plantar mechanical stimulation on mechanical characteristics and cytoskeletal proteins in rat soleus muscle during hindlimb suspension. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(10): e21905
Zhu, L.; Li, L.; Zhang, Q.; Yang, X.; Zou, Z.; Hao, B.; Marincola, F.M.; Liu, Z.; Zhong, Z.; Wang, M.; Li, X.; Wang, Q.; Li, K.; Gao, W.; Yao, K.; Liu, Q. 2017: NOS1 S -nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells. Cell Death Discovery 3: 17011
Gengenbacher, M.; Duque-Correa, M.A.; Kaiser, P.; Schuerer, S.; Lazar, D.; Zedler, U.; Reece, S.T.; Nayyar, A.; Cole, S.T.; Makarov, V.; Barry Iii, C.E.; Dartois, Véronique.; Kaufmann, S.H.E. 2017: NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans. Scientific Reports 7(1): 8853
Hare, J.M.; Stamler, J.S. 1999: NOS: modulator, not mediator of cardiac performance. Nature Medicine 5(3): 273-274
Oltmanns, S.; Abben, F.S.; Ender, A.; Aimon, S.; Kovacs, R.; Sigrist, S.J.; Storace, D.A.; Geiger, J.ör.R.P.; Raccuglia, D. 2020: NOSA, an Analytical Toolbox for Multicellular Optical Electrophysiology. Frontiers in Neuroscience 14: 712
Cheriguene, A.; Kabache, T.; Kerrache, C.A.; Calafate, C.T.; Cano, J.C. 2022: NOTA: a novel online teaching and assessment scheme using Blockchain for emergency cases. Education and Information Technologies 27(1): 115-132
Wang, Y.; Fang, Y.; Lu, P.; Wu, B.; Zhou, B. 2021: NOTCH Signaling in Aortic Valve Development and Calcific Aortic Valve Disease. Frontiers in Cardiovascular Medicine 8: 682298
Alanazi, I.O.; Shaik, J.P.; Parine, N.R.; Al Naeem, A.; Azzam, N.A.; Almadi, M.A.; Aljebreen, A.M.; Alharbi, O.; Alanazi, M.S.; Khan, Z. 2021: NOTCH Single Nucleotide Polymorphisms in the Predisposition of Breast and Colorectal Cancers in Saudi Patients. Pathology Oncology Research: Por 27: 616204
Ng, J.; Sutherland, K.D. 2020: NOTCH your Usual Suspect: MYC Charged with Controlling Neuroendocrine Cell-Fate in Small Cell Lung Cancer. Cancer Cell 38(1): 17-20
Pappas, K.; Martin, T.C.; Wolfe, A.L.; Nguyen, C.B.; Su, T.; Jin, J.; Hibshoosh, H.; Parsons, R. 2021: NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer. Communications Biology 4(1): 312
Li, Y.; Li, Y.; Chen, X. 2021: NOTCH and Esophageal Squamous Cell Carcinoma. Advances in Experimental Medicine and Biology 1287: 59-68
Hedera, P. 2020: NOTCHing toward better understanding of CADASIL. Neurology 95(13): 565-566
Real, P.J.; Ferrando, A.A. 2009: NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. Leukemia 23(8): 1374-1377
Ferrando, A. 2010: NOTCH mutations as prognostic markers in T-ALL. Leukemia 24(12): 2003-2004
Alderuccio, J.Pablo.; Lossos, I.S. 2021: NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy. Leukemia and Lymphoma 2021: 1-12
Uenishi, G.I.; Jung, H.Sun.; Kumar, A.; Park, M.Ae.; Hadland, B.K.; McLeod, E.; Raymond, M.; Moskvin, O.; Zimmerman, C.E.; Theisen, D.J.; Swanson, S.; J Tamplin, O.; Zon, L.I.; Thomson, J.A.; Bernstein, I.D.; Slukvin, I.I. 2018: NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells. Nature Communications 9(1): 1828
Aggarwal, V.; Tuli, H.S.; Varol, M.; Tuorkey, M.; Sak, K.; Parashar, N.C.; Barwal, T.S.; Sharma, U.; Iqubal, A.; Parashar, G.; Jain, A. 2021: NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target. Critical Reviews in Oncology/Hematology 164: 103403
Perez-Fidalgo, J.A.; Ortega, B.; Simon, S.; Samartzis, E.P.; Boussios, S. 2020: NOTCH signalling in ovarian cancer angiogenesis. Annals of Translational Medicine 8(24): 1705
Luiken, S.; Fraas, A.; Bieg, M.; Sugiyanto, R.; Goeppert, B.; Singer, S.; Ploeger, C.; Warsow, G.; Marquardt, J.U.; Sticht, C.; De La Torre, C.; Pusch, S.; Mehrabi, A.; Gretz, N.; Schlesner, M.; Eils, R.; Schirmacher, P.; Longerich, T.; Roessler, S. 2020: NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis. Oncogene 39(15): 3128-3144
Aref, S.; Rizk, R.; El Agder, M.; Fakhry, W.; El Zafarany, M.; Sabry, M. 2020: NOTCH-1 Gene Mutations Influence Survival in Acute Myeloid Leukemia Patients. Asian Pacific Journal of Cancer Prevention: Apjcp 21(7): 1987-1992
Volk, A. 2021: NOTCH-ing up nucleotide metabolism in T-cell acute lymphoblastic leukemia. Communications Biology 4(1): 809
Parry, A.J.; Hoare, M.; Bihary, Dóra.; Hänsel-Hertsch, R.; Smith, S.; Tomimatsu, K.; Mannion, E.; Smith, A.; D'Santos, P.; Russell, I.Alasdair.; Balasubramanian, S.; Kimura, H.; Samarajiwa, S.A.; Narita, M. 2018: NOTCH-mediated non-cell autonomous regulation of chromatin structure during senescence. Nature Communications 9(1): 1840
Baldoni, S.; Del Papa, B.; De Falco, F.; Dorillo, E.; Sorrentino, C.; Rompietti, C.; Adamo, F.M.; Nogarotto, M.; Cecchini, D.; Mondani, E.; Silva Barcelos, E.C.; Moretti, L.; Mameli, M.G.; Fabi, B.; Sorcini, D.; Stella, A.; Giancola, R.; Guardalupi, F.; Ulbar, F.; Plebani, S.; Guarente, V.; Rosati, E.; Di Nicola, M.; Marchioni, M.; Di Ianni, M.; Sportoletti, P. 2021: NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is not Correlated to the NOTCH1 and IGHV Mutational Status. Frontiers in Oncology 11: 668573
Miao, K.; Lei, J.Haipeng.; Valecha, M.Vishnu.; Zhang, A.; Xu, J.; Wang, L.; Lyu, X.; Chen, S.; Miao, Z.; Zhang, X.; Su, S.Man.; Shao, F.; Rajendran, B.Kumar.; Bao, J.; Zeng, J.; Sun, H.; Chen, P.; Tan, K.; Chen, Q.; Wong, K.Ho.; Xu, X.; Deng, C-Xia. 2020: NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation. Nature Communications 11(1): 3256
Licciardello, M.P.; Müllner, M.K.; Dürnberger, G.; Kerzendorfer, C.; Boidol, B.; Trefzer, C.; Sdelci, S.; Berg, T.; Penz, T.; Schuster, M.; Bock, C.; Kralovics, R.; Superti-Furga, G.; Colinge, J.; Nijman, S.M.; Kubicek, S. 2015: NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation. Oncogene 34(29): 3780-3790
Castro, R.C.; Zambuzi, F.A.; Fontanari, C.; de Morais, F.R.; Bollela, V.R.; Kunkel, S.L.; Schaller, M.A.; Frantz, F.G. 2020: NOTCH1 and DLL4 are involved in the human tuberculosis progression and immune response activation. Tuberculosis 124: 101980
Clappier, E.; Collette, S.; Grardel, N.; Girard, S.; Suarez, L.; Brunie, G.; Kaltenbach, S.; Yakouben, K.; Mazingue, F.; Robert, A.; Boutard, P.; Plantaz, D.; Rohrlich, P.; van Vlierberghe, P.; Preudhomme, C.; Otten, J.; Speleman, F.; Dastugue, N.; Suciu, S.; Benoit, Y.; Bertrand, Y.; Cavé, H. 2010: NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 24(12): 2023-2031
Mansouri, L.; Cahill, N.; Gunnarsson, R.; Smedby, K.E.; Tjönnfjord, E.; Hjalgrim, H.; Juliusson, G.; Geisler, C.; Rosenquist, R. 2013: NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia 27(2): 512-514
Zuurbier, L.; Homminga, I.; Calvert, V.; te Winkel, M.L.; Buijs-Gladdines, J.G.C.A.M.; Kooi, C.; Smits, W.K.; Sonneveld, E.; Veerman, A.J.P.; Kamps, W.A.; Horstmann, M.; Petricoin, E.F.; Pieters, R.; Meijerink, J.P.P. 2010: NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia 24(12): 2014-2022
Katarkar, A.; Bottoni, G.; Clocchiatti, A.; Goruppi, S.; Bordignon, P.; Lazzaroni, F.; Gregnanin, I.; Ostano, P.; Neel, V.; Dotto, G.Paolo. 2020: NOTCH1 gene amplification promotes expansion of Cancer Associated Fibroblast populations in human skin. Nature Communications 11(1): 5126
Mack, J.J.; Mosqueiro, T.S.; Archer, B.J.; Jones, W.M.; Sunshine, H.; Faas, G.C.; Briot, A.; Aragón, R.L.; Su, T.; Romay, M.C.; McDonald, A.I.; Kuo, C-Hsiang.; Lizama, C.O.; Lane, T.F.; Zovein, A.C.; Fang, Y.; Tarling, E.J.; de Aguiar Vallim, T.Q.; Navab, M.; Fogelman, A.M.; Bouchard, L.S.; Iruela-Arispe, M.Luisa. 2017: NOTCH1 is a mechanosensor in adult arteries. Nature Communications 8(1): 1620
Ribeiro da Silva, A.; Neri, E.A.; Turaça, L.Thiago.; Dariolli, R.; Fonseca-Alaniz, M.H.; Santos-Miranda, A.; Roman-Campos, D.; Venturini, G.; Krieger, J.E. 2020: NOTCH1 is critical for fibroblast-mediated induction of cardiomyocyte specialization into ventricular conduction system-like cells in vitro. Scientific Reports 10(1): 16163
Hoare, M.; Ito, Y.; Kang, T-Won.; Weekes, M.P.; Matheson, N.J.; Patten, D.A.; Shetty, S.; Parry, A.J.; Menon, S.; Salama, R.; Antrobus, R.; Tomimatsu, K.; Howat, W.; Lehner, P.J.; Zender, L.; Narita, M. 2016: NOTCH1 mediates a switch between two distinct secretomes during senescence. Nature Cell Biology 18(9): 979-992
Benedetti, D.; Tissino, E.; Pozzo, F.; Bittolo, T.; Caldana, C.; Perini, C.; Martorelli, D.; Bravin, V.; D'Agaro, T.; Rossi, F.M.; Bomben, R.; Santinelli, E.; Zaja, F.; Pozzato, G.; Chiarenza, A.; Di Raimondo, F.; Del Poeta, G.; Rossi, D.; Gaidano, G.; Dal Bo, M.; Gattei, V.; Zucchetto, A. 2018: NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways. Leukemia 32(3): 654-662
Wu-Chou, Y-Huei.; Hsieh, C-Hsun.; Liao, C-Ta.; Lin, Y-Ting.; Fan, W-Lang.; Yang, C-Han. 2021: NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma. Pathology Research and Practice 223: 153474
Pozzo, F.; Bittolo, T.; Arruga, F.; Bulian, P.; Macor, P.; Tissino, E.; Gizdic, B.; Rossi, F.M.; Bomben, R.; Zucchetto, A.; Benedetti, D.; Degan, M.; D'Arena, G.; Chiarenza, A.; Zaja, F.; Pozzato, G.; Rossi, D.; Gaidano, G.; Del Poeta, G.; Deaglio, S.; Gattei, V.; Dal Bo, M. 2016: NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation. Leukemia 30(1): 182-189
Villamor, N.; Conde, L.; Martínez-Trillos, A.; Cazorla, M.; Navarro, A.; Beà, S.; López, C.; Colomer, D.; Pinyol, M.; Aymerich, M.; Rozman, M.; Abrisqueta, P.; Baumann, T.; Delgado, J.; Giné, E.; González-Díaz, M.; Hernández, J.M.; Colado, E.; Payer, A.R.; Rayon, C.; Navarro, B.; José Terol, M.; Bosch, F.; Quesada, V.; Puente, X.S.; López-Otín, C.; Jares, P.; Pereira, A.; Campo, E.; López-Guillermo, A. 2013: NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia 27(5): 1100-1106
South, A.P.; Purdie, K.J.; Watt, S.A.; Haldenby, S.; den Breems, N.; Dimon, M.; Arron, S.T.; Kluk, M.J.; Aster, J.C.; McHugh, A.; Xue, D.J.; Dayal, J.Hs.; Robinson, K.S.; Rizvi, S.Hasan.; Proby, C.M.; Harwood, C.A.; Leigh, I.M. 2014: NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis. Journal of Investigative Dermatology 134(10): 2630-2638
Giambra, V.; Jenkins, C.R.; Wang, H.; Lam, S.H.; Shevchuk, O.O.; Nemirovsky, O.; Wai, C.; Gusscott, S.; Chiang, M.Y.; Aster, J.C.; Humphries, R.Keith.; Eaves, C.; Weng, A.P. 2012: NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species. Nature Medicine 18(11): 1693-1698
van der Fits, L.; Qin, Y.; Out-Luiting, J.J.; Vermeer, K.G.; Whittaker, S.; van Es, J.H.; Tensen, C.P.; Vermeer, M.H. 2012: NOTCH1 signaling as a therapeutic target in Sézary syndrome. Journal of Investigative Dermatology 132(12): 2810-2817
Wang, Y-Ping.; Liu, I-Ju.; Chen, K-Chi.; Wu, H-Chung. 2021: NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck. Oncogenesis 10(8): 59
Chen, J.; Jette, C.; Kanki, J.P.; Aster, J.C.; Look, A.T.; Griffin, J.D. 2007: NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 21(3): 462-471
Pozzo, F.; Bittolo, T.; Vendramini, E.; Bomben, R.; Bulian, P.; Rossi, F.M.; Zucchetto, A.; Tissino, E.; Degan, M.; D'Arena, G.; Di Raimondo, F.; Zaja, F.; Pozzato, G.; Rossi, D.; Gaidano, G.; Del Poeta, G.; Gattei, V.; Dal Bo, M. 2017: NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components. Leukemia 31(11): 2407-2415
Michelini, S.; Ricci, M.; Serrani, R.; Barati, S.; Kenanoglu, S.; Veselenyiova, D.; Kurti, D.; Baglivo, M.; Basha, S.H.; Priya, S.; Dautaj, A.; Dundar, M.; Krajcovic, J.; Bertelli, M. 2021: NOTCH1: Review of its role in lymphatic development and study of seven families with rare pathogenic variants. Molecular Genetics and Genomic Medicine 9(1): E1529
Manokawinchoke, J.; Sumrejkanchanakij, P.; Boonprakong, L.; Pavasant, P.; Egusa, H.; Osathanon, T. 2020: NOTCH2 participates in Jagged1-induced osteogenic differentiation in human periodontal ligament cells. Scientific Reports 10(1): 13329
Jedlickova, I.; Pristoupilova, A.; Hulkova, H.; Vrbacka, A.; Stranecky, V.; Hruba, E.; Jesina, P.; Honzik, T.; Hrdlicka, I.; Fremuth, J.; Pivovarcikova, K.; Bitar, I.; Matej, R.; Kmoch, S.; Sikora, J. 2020: NOTCH2NLC CGG Repeats Are not Expanded and Skin Biopsy Was Negative in an Infantile Patient with Neuronal Intranuclear Inclusion Disease. Journal of Neuropathology and Experimental Neurology 79(10): 1065-1071
Ng, A.S.L.; Lim, W.K.; Xu, Z.; Ong, H.L.; Tan, Y.J.; Sim, W.Y.; Ng, E.Y.L.; Teo, J.X.; Foo, J.N.; Lim, T.C.C.; Yu, W.-Y.; Chan, L.-L.; Lee, H.-Y.; Chen, Z.; Lim, E.-W.; Ting, S.K.S.; Prakash, K.M.; Tan, L.C.S.; Yi, Z.; Tan, E.-K. 2020: NOTCH2NLC GGC Repeat Expansions Are Associated with Sporadic Essential Tremor: Variable Disease Expressivity on Long-Term Follow-up. Annals of Neurology 88(3): 614-618
Ng, A.S.L.; Xu, Z.; Chen, Z.; Tan, Y.J.; Lim, W.K.; Ting, S.K.S.; Yu, W.Y.; Cheng, Q.H.; Foo, J.N.; Tan, E.K.; Lim, T.C.C. 2020: NOTCH2NLC-linked neuronal intranuclear inclusion body disease and fragile X-associated tremor/ataxia syndrome. Brain: a Journal of Neurology 143(8): E69
Cao, L.; Yan, Y.; Zhao, G. 2021: NOTCH2NLC-related repeat expansion disorders: an expanding group of neurodegenerative disorders. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 42(10): 4055-4062
Hu, Y.; Sun, Q.; Zhou, Y.; Yi, F.; Tang, H.; Yao, L.; Tian, Y.; Xie, N.; Luo, M.; Wang, Z.; Liao, X.; Xu, H.; Zhou, L. 2021: NOTCH3 Variants and Genotype-Phenotype Features in Chinese CADASIL Patients. Frontiers in Genetics 12: 705284
Diluvio, G.; Del Gaudio, F.; Giuli, M.Valeria.; Franciosa, G.; Giuliani, E.; Palermo, R.; Besharat, Z.Mersini.; Pignataro, M.Gemma.; Vacca, A.; d'Amati, G.; Maroder, M.; Talora, C.; Capalbo, C.; Bellavia, D.; Checquolo, S. 2018: NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. Oncogenesis 7(5): 42
Cui, Y.; Li, Q.; Li, W.; Wang, Y.; Lv, F.; Shi, X.; Tang, Z.; Shen, Z.; Hou, Y.; Zhang, H.; Mao, B.; Liu, T. 2020: NOTCH3 is a Prognostic Factor and Is Correlated with Immune Tolerance in Gastric Cancer. Frontiers in Oncology 10: 574937
López-López, S.; Monsalve, E.María.; Romero de Ávila, Mía.José.; González-Gómez, J.; Hernández de León, N.; Ruiz-Marcos, F.; Baladrón, V.; Nueda, Mía.Luisa.; García-León, Mía.Jesús.; Screpanti, I.; Felli, Mía.Pía.; Laborda, J.; García-Ramírez, Jé.Javier.; Díaz-Guerra, Mía.José.M. 2020: NOTCH3 signaling is essential for NF-κB activation in TLR-activated macrophages. Scientific Reports 10(1): 14839
Geles, K.G.; Gao, Y.; Giannakou, A.; Sridharan, L.; Yamin, T.-T.; Zhang, J.; Karim, R.; Bard, J.; Piche-Nicholas, N.; Charati, M.; Maderna, A.; Lucas, J.; Golas, J.; Guffroy, M.; Pirie-Shepherd, S.; Roy, M.; Qian, J.; Franks, T.; Zhong, W.; O'Donnell, C.J.; Tchistiakova, L.; Gerber, H.-P.; Sapra, P. 2021: NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells. Cell Reports. Medicine 2(5): 100279
Brommage, R.; Liu, J.; Vogel, P.; Mseeh, F.; Thompson, A.Y.; Potter, D.G.; Shadoan, M.K.; Hansen, G.M.; Jeter-Jones, S.; Cui, J.; Bright, D.; Bardenhagen, J.P.; Doree, D.D.; Movérare-Skrtic, S.; Nilsson, K.H.; Henning, P.; Lerner, U.H.; Ohlsson, C.; Sands, A.T.; Tarver, J.E.; Powell, D.R.; Zambrowicz, B.; Liu, Q. 2019: NOTUM inhibition increases endocortical bone formation and bone strength. Bone Research 7: 2
Guo, F.; Seldin, M.; Péterfy, Mós.; Charugundla, S.; Zhou, Z.; Lee, S.D.; Mouton, A.; Rajbhandari, P.; Zhang, W.; Pellegrini, M.; Tontonoz, P.; Lusis, A.J.; Shih, D.M. 2021: NOTUM promotes thermogenic capacity and protects against diet-induced obesity in male mice. Scientific Reports 11(1): 16409
Sayed, M.E.; Yuan, L.; Robin, J.D.; Tedone, E.; Batten, K.; Dahlson, N.; Wright, W.E.; Shay, J.W.; Ludlow, A.T. 2019: NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells. Oncogene 38(16): 2937-2952
Kim, E.Kyung.; Cho, Y.Ah.; Seo, M-Kyoung.; Ryu, H.; Cho, B.Chul.; Koh, Y.Woo.; Yoon, S.Och. 2019: NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma. Scientific Reports 9(1): 11231
Ludlow, A.T.; Wong, M.Sze.; Robin, J.D.; Batten, K.; Yuan, L.; Lai, T-Po.; Dahlson, N.; Zhang, L.; Mender, I.; Tedone, E.; Sayed, M.E.; Wright, W.E.; Shay, J.W. 2018: NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer. Nature Communications 9(1): 3112
Sohrabi, M.; Hakimi, A. 2020: Novel 'photoneutron Volume Dose Equivalent' Hypothesis and Methodology for Second Primary Cancer Risk Estimation in High-Energy X-Ray Medical Accelerators. Radiation Protection Dosimetry 188(4): 432-443
Kojima, T.; Aihara, H.; Kodashima, Y.; Makishima, H.; Nakiri, S.; Takada, S.; Shimada, H.; Ukai, M.; Ozga, C.; Holzapfel, X.; Schmidt, P.; Küstner-Wetekam, C.; Otto, H.; Bloβ, D.; Knie, A.; Ehresmann, A.; Yokoya, A.; Fujii, K.; Fukuda, Y.; Saitoh, Y. 2019: Novel Analytical Study for Reaction Intermediates in the Primary Radiation Interaction of Dna Using a Synchrotron Radiation-Induced Luminescence Spectroscopy. Radiation Protection Dosimetry 183(1-2): 32-35
Spaide, R.F.; Ledesma-Gil, G. 2020: Novel Method for Image Averaging of Optical Coherence Tomography Angiography Images. Retina 40(11): 2099-2105
Berselli, A.; Ramos, M.J.; Menziani, M.C. 2021: Novel Pet-Degrading Enzymes: Structure-Function from a Computational Perspective. Chembiochem: a European Journal of Chemical Biology 22(12): 2032-2050
Giner, J.é-L.; Faraldos, J.A.; Boyer, G.L. 2003: Novel Sterols of the Toxic Dinoflagellate Karenia Brevis (Dinophyceae): a Defensive Function for Unusual Marine Sterols?1. Journal of Phycology 39(2): 315-319
Igawa, K. 2021: Novel Therapeutics for Atopic Dermatitis∼biologics∼. Arerugi 70(8): 913-917
Qaiser, D.; Sood, A.; Mishra, D.; Kharbanda, O.P.; Srivastava, A.; Gupta, S.Datta.; Pandey, R.M.; Yadav, R.; Bhatt, K.; Kumawat, R. 2020: Novel use of Fluorescein Dye in Detection of Oral Dysplasia and Oral Cancer. Photodiagnosis and Photodynamic Therapy 31: 101824
Fredette, M.E.; Lombardi, K.C.; Duker, A.L.; Buck, C.O.; Phornphutkul, C.; Bober, M.B.; Quintos, J.B. 2020: Novel Xrcc4 Mutations in an Infant with Microcephalic Primordial Dwarfism, Dilated Cardiomyopathy, Subclinical Hypothyroidism, and Early Death: Expanding the Phenotype of Xrcc4 Mutations. Aace Clinical Case Reports 6(1): E1-E4
Sepúlveda-Loyola, W.; de Castro, L.A.új.; Matsumoto, A.K.; Camillo, C.A.; Barbosa, D.éc.S.; Galvan, C.C.R.; Probst, V.S. 2021: NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD. Heart and Lung: the Journal of Critical Care 50(1): 184-191
Lambeth, J.David. 2004: NOX enzymes and the biology of reactive oxygen. Nature Reviews. Immunology 4(3): 181-189
Pache, J-Claude.; Carnesecchi, S.; Deffert, C.; Donati, Y.; Herrmann, Fçois.R.; Barazzone-Argiroffo, C.; Krause, K-Heinz. 2011: NOX-4 is expressed in thickened pulmonary arteries in idiopathic pulmonary fibrosis. Nature Medicine 17(1): 31
Damiano, S.; Sozio, C.; La Rosa, G.; Santillo, M. 2020: NOX-Dependent Signaling Dysregulation in Severe COVID-19: Clues to Effective Treatments. Frontiers in Cellular and Infection Microbiology 10: 608435
Al-Eisa, A.; Dhaunsi, G.S. 2017: NOX-mediated impairment of PDGF-induced DNA synthesis in peripheral blood lymphocytes of children with idiopathic nephrotic syndrome. Pediatric Research 82(4): 629-633
Li, H.; He, Y.; Zhang, C.; Ba, T.; Guo, Z.; Zhuo, Y.; He, L.; Dai, H. 2020: NOX1 down-regulation attenuated the autophagy and oxidative damage in pig intestinal epithelial cell following transcriptome analysis of transport stress. Gene 763: 145071
Vandierendonck, A.; Degroote, H.; Vanderborght, B.; Verhelst, X.; Geerts, A.; Devisscher, L.; Van Vlierberghe, H. 2021: NOX1 inhibition attenuates the development of a pro-tumorigenic environment in experimental hepatocellular carcinoma. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 40
Schwerd, T.; Bryant, R.V.; Pandey, S.; Capitani, M.; Meran, L.; Cazier, J-B.; Jung, J.; Mondal, K.; Parkes, M.; Mathew, C.G.; Fiedler, K.; McCarthy, D.J.; Sullivan, P.B.; Rodrigues, A.; Travis, S.P.L.; Moore, C.; Sambrook, J.; Ouwehand, W.H.; Roberts, D.J.; Danesh, J.; Russell, R.K.; Wilson, D.C.; Kelsen, J.R.; Cornall, R.; Denson, L.A.; Kugathasan, S.; Knaus, U.G.; Serra, E.G.; Anderson, C.A.; Duerr, R.H.; McGovern, D.Pb.; Cho, J.; Powrie, F.; Li, V.Sw.; Muise, A.M.; Uhlig, H.H.; Donnelly, P.; Bell, J.; Bentley, D.; McVean, G.; Ratcliffe, P.; Taylor, J.; Wilkie, A.O.M.; Donnelly, P.; Broxholme, J.; Buck, D.; Cazier, J-B.; Cornall, R.; Gregory, L.; Knight, J.; Lunter, G.; McVean, G.; Taylor, J.; Tomlinson, I.; Wilkie, A.O.M.; Buck, D.; Alla 2018: NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunology 11(2): 562-574
Van der Post, S.; Birchenough, G.M.H.; Held, J.M. 2021: NOX1-dependent redox signaling potentiates colonic stem cell proliferation to adapt to the intestinal microbiota by linking EGFR and TLR activation. Cell Reports 35(1): 108949
Makhezer, N.; Ben Khemis, M.; Liu, D.; Khichane, Y.; Marzaioli, V.; Tlili, A.; Mojallali, M.; Pintard, C.; Letteron, P.; Hurtado-Nedelec, M.; El-Benna, J.; Marie, J-Claude.; Sannier, Aélie.; Pelletier, A-Laure.; Dang, P.My-Chan. 2019: NOX1-derived ROS drive the expression of Lipocalin-2 in colonic epithelial cells in inflammatory conditions. Mucosal Immunology 12(1): 117-131
Sela, M.; Tirza, G.; Ravid, O.; Volovitz, I.; Solodeev, I.; Friedman, O.; Zipori, D.; Gur, E.; Krelin, Y.; Shani, N. 2015: NOX1-induced accumulation of reactive oxygen species in abdominal fat-derived mesenchymal stromal cells impinges on long-term proliferation. Cell Death and Disease 6: E1728
Zhang, X.; Ibi, M.; Haga, R.; Iwata, K.; Matsumoto, M.; Asaoka, N.; Liu, J.; Katsuyama, M.; Yabe-Nishimura, C. 2021: NOX1/NADPH oxidase affects the development of autism-like behaviors in a maternal immune activation model. Biochemical and Biophysical Research Communications 534: 59-66
Matsumoto, M.; Liu, J.; Iwata, K.; Ibi, M.; Asaoka, N.; Zhang, X.; Katsuyama, M.; Matsuda, M.; Nabe, T.; Schröder, K.; Yabe-Nishimura, C. 2021: NOX1/NADPH oxidase is involved in the LPS-induced exacerbation of collagen-induced arthritis. Journal of Pharmacological Sciences 146(2): 88-97
Asaoka, N.; Ibi, M.; Hatakama, H.; Nagaoka, K.; Iwata, K.; Matsumoto, M.; Katsuyama, M.; Kaneko, S.; Yabe-Nishimura, C. 2021: NOX1/NADPH oxidase promotes synaptic facilitation induced by repeated D 2 receptor stimulation; involvement in behavioral repetition. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 2021
Moazzen, H.; Wu, Y.; Engineer, A.; Lu, X.; Aulakh, S.; Feng, Q. 2020: NOX2 Is Critical to Endocardial to Mesenchymal Transition and Heart Development. Oxidative Medicine and Cellular Longevity 2020: 1679045
Brandt, M.; Garlapati, V.; Oelze, M.; Sotiriou, E.; Knorr, M.; Kröller-Schön, S.; Kossmann, S.; Schönfelder, T.; Morawietz, H.; Schulz, E.; Schultheiss, H-Peter.; Daiber, A.; Münzel, T.; Wenzel, P. 2016: NOX2 amplifies acetaldehyde-mediated cardiomyocyte mitochondrial dysfunction in alcoholic cardiomyopathy. Scientific Reports 6: 32554
Husain, M.; Becker, E.J.; Bone, N.B.; Schmitt, A.; Pittet, J.-F.; Zmijewski, J.W. 2020: NOX2 decoy peptides disrupt trauma-mediated neutrophil immunosuppression and protect against lethal peritonitis. Redox Biology 36: 101651
Aydin, E.; Hallner, A.; Grauers Wiktorin, H.; Staffas, A.; Hellstrand, K.; Martner, A. 2019: NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease. Oncogene 38(9): 1534-1543
Padilha, E.C.; Shah, P.; Rai, G.; Xu, X. 2021: NOX2 inhibitor GSK2795039 metabolite identification towards drug optimization. Journal of Pharmaceutical and Biomedical Analysis 201: 114102
Liao, Y.-C.; Wu, S.-Y.; Huang, Y.-F.; Lo, P.-C.; Chan, T.-Y.; Chen, C.-A.; Wu, C.-H.; Hsu, C.-C.; Yen, C.-L.; Chen, P.-C.; Shieh, C.-C. 2021: NOX2-Deficient Neutrophils Facilitate Joint Inflammation Through Higher Pro-Inflammatory and Weakened Immune Checkpoint Activities. Frontiers in Immunology 12: 743030
Grauers Wiktorin, H.; Aydin, E.; Hellstrand, K.; Martner, A. 2020: NOX2-Derived Reactive Oxygen Species in Cancer. Oxidative Medicine and Cellular Longevity 2020: 7095902
Wu, Q.; Allouch, A.; Paoletti, A.; Leteur, C.; Mirjolet, C.; Martins, I.; Voisin, L.; Law, Fédéric.; Dakhli, H.; Mintet, E.; Thoreau, M.; Muradova, Z.; Gauthier, Mélanie.; Caron, O.; Milliat, F.; Ojcius, D.M.; Rosselli, F.; Solary, E.; Modjtahedi, N.; Deutsch, E.; Perfettini, J-Luc. 2017: NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy. Cell Death and Differentiation 24(9): 1632-1644
Sasaki, Y.; Dehnad, A.; Fish, S.; Sato, A.; Jiang, J.; Tian, J.; Schröder, K.; Brandes, R.; Török, N.J. 2017: NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease. Scientific Reports 7: 46144
Park, M.W.; Cha, H.W.; Kim, J.; Kim, J.H.; Yang, H.; Yoon, S.; Boonpraman, N.; Yi, S.S.; Yoo, I.D.; Moon, J.-S. 2021: NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases. Redox Biology 41: 101947
Larson-Casey, J.L.; Gu, L.; Kang, J.; Dhyani, A.; Carter, A.B. 2021: NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression. Journal of Biological Chemistry 297(1): 100810
Tobar, N.; Guerrero, J.; Smith, P.C.; Martínez, J. 2010: NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration. British Journal of Cancer 103(7): 1040-1047
Moon, J-Seok.; Nakahira, K.; Chung, K-Pin.; DeNicola, G.M.; Koo, M.Jakun.; Pabón, M.A.; Rooney, K.T.; Yoon, J-Heon.; Ryter, S.W.; Stout-Delgado, H.; Choi, A.M.K. 2016: NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nature Medicine 22(9): 1002-1012
Pavlov, T.S.; Palygin, O.; Isaeva, E.; Levchenko, V.; Khedr, S.; Blass, G.; Ilatovskaya, D.V.; Cowley, A.W.; Staruschenko, A. 2020: NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 34(10): 13396-13408
Jayavelu, A.K.; Müller, J.P.; Bauer, R.; Böhmer, S-A.; Lässig, J.; Cerny-Reiterer, S.; Sperr, W.R.; Valent, P.; Maurer, B.; Moriggl, R.; Schröder, K.; Shah, A.M.; Fischer, M.; Scholl, S.; Barth, J.; Oellerich, T.; Berg, T.; Serve, H.; Frey, S.; Fischer, T.; Heidel, F.H.; Böhmer, F-D. 2016: NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells. Leukemia 30(2): 473-483
Kumar, V.; Kurth, T.; Zheleznova, N.N.; Yang, C.; Cowley, A.W. 2020: NOX4/H2O2/mTORC1 Pathway in Salt-Induced Hypertension and Kidney Injury. Hypertension 76(1): 133-143
Wu, C.-Z.; Li, X.; Hong, L.; Han, Z.-N.; Liu, Y.; Wei, C.-X.; Cui, X. 2021: NOX4/Src regulates ANP secretion through activating ERK1/2 and Akt/GATA4 signaling in beating rat hypoxic atria. Korean Journal of Physiology and Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology 25(2): 159-166
Wang, J.; Xiao, J.; Meng, X.; Chu, X.; Zhuansun, D.D.; Xiong, B.; Feng, J. 2021: NOX5 is expressed aberrantly but not a critical pathogenetic gene in Hirschsprung disease. Bmc Pediatrics 21(1): 153
Chen, J.; Wang, Y.; Zhang, W.; Zhao, D.; Zhang, L.; Zhang, J.; Fan, J.; Zhan, Q. 2021: NOX5 mediates the crosstalk between tumor cells and cancer-associated fibroblasts via regulating cytokine network. Clinical and translational medicine 11(8): e472
Elbatreek, M.H.; Sadegh, S.; Anastasi, E.; Guney, E.; Nogales, C.; Kacprowski, T.; Hassan, A.A.; Teubner, A.; Huang, P.-H.; Hsu, C.-Y.; Schiffers, P.M.H.; Janssen, G.M.; Kleikers, P.W.M.; Wipat, A.; Baumbach, J.; De Mey, J.G.R.; Schmidt, H.H.H.W. 2020: NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype. Plos Biology 18(11): E3000885
Kiknavelidze, K.; Shavdia, M.; Chikhladze, N.; Abshilava, L.; Messina, M.; Mautner, G.; Kelly, G. 2021: NOX66 as Monotherapy, and in Combination with Carboplatin, in Patients with Refractory Solid Tumors: Phase Ia/b Study. Current Therapeutic Research 94: 100631
Ehrhardt, H.; Höfig, I.; Wachter, F.; Obexer, P.; Fulda, S.; Terziyska, N.; Jeremias, I. 2012: NOXA as critical mediator for drug combinations in polychemotherapy. Cell Death and Disease 3: E327
Craxton, A.; Butterworth, M.; Harper, N.; Fairall, L.; Schwabe, J.; Ciechanover, A.; Cohen, G.M. 2012: NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1. Cell Death and Differentiation 19(9): 1424-1434
Moeller, S.; Pisharady, P.K.; Ramanna, S.; Lenglet, C.; Wu, X.; Dowdle, L.; Yacoub, E.; Uğurbil, K.; Akçakaya, M. 2021: NOise reduction with DIstribution Corrected (NORDIC) PCA in dMRi with complex-valued parameter-free locally low-rank processing. Neuroimage 226: 117539
Van der Meij, A.; van Walderveen, M.A.A.; Kruyt, N.D.; van Zwet, E.W.; Liebler, E.J.; Ferrari, M.D.; Wermer, M.J.H. 2020: NOn-invasive Vagus nerve stimulation in acute Ischemic Stroke (NOVIS): a study protocol for a randomized clinical trial. Trials 21(1): 878
Rani, S.; Kumar, M.; Singh, Y.; Tomar, M.; Sharma, A.; Gupta, V.; Singh, V.N. 2021: NO₂ Gas Sensor Based on SnSe/SnSe₂p-n Hetrojunction. Journal of Nanoscience and Nanotechnology 21(9): 4779-4785
Galvis, A.E.; Fisher, H.E.; Camerini, D. 2017: NP-40 Fractionation and Nucleic Acid Extraction in Mammalian Cells. Bio-Protocol 7(20):E2584
Lu, C.-C.; Yen, R.-F.; Peng, K.-Y.; Huang, J.-Y.; Wu, K.-D.; Chueh, J.S.; Lin, W.-Y. 2021: NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict KCNJ5 Mutation in Primary Aldosteronism Patients. Frontiers in Endocrinology 12: 644927
Jilishitz, I.; Quiñones, J.L.; Patel, P.; Chen, G.; Pasetsky, J.; VanInwegen, A.; Schoninger, S.; Jogalekar, M.P.; Tsiperson, V.; Yan, L.; Wu, Y.; Gottesman, S.R.S.; Somma, J.; Blain, S.W. 2021: NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells. Molecular Cancer Research: Mcr 19(11): 1929-1945
Zhu, Y.; Wang, G.Z.; Cingöz, O.; Goff, S.P. 2018: NP220 mediates silencing of unintegrated retroviral DNA. Nature 564(7735): 278-282
Yuan, P.; Li, J.; Zhou, F.; Huang, Q.; Zhang, J.; Guo, X.; Lyu, Z.; Zhang, H.; Xing, J. 2017: NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A. Cell Death and Disease 8(3): E2704
Zhang, T.; Ji, D.; Sun, J.; Song, J.; Nie, L.; Sun, N. 2021: NPAS4 suppresses propofol-induced neurotoxicity by inhibiting autophagy in hippocampal neuronal cells. Archives of Biochemistry and Biophysics 711: 109018
Weng, W.; Nagai, H.; Hamidi, S.; Sheng, G. 2020: NPAS4L is involved in avian hemangioblast specification. Haematologica 105(11): 2647-2650
Xu, T.; Chen, W.; Zhou, J.; Dai, J.; Li, Y.; Zhao, Y. 2020: NPBS database: a chemical data resource with relational data between natural products and biological sources. Database: the Journal of Biological Databases and Curation 2020
Kelsey, R. 2018: NPC mutations cause SRNS. Nature Reviews. Nephrology 14(12): 720
Lee, A.W.M.; Ngan, R.K.C.; Ng, W.-T.; Tung, S.Y.; Cheng, A.A.C.; Kwong, D.L.W.; Lu, T.-X.; Chan, A.T.C.; Sze, H.C.K.; Yiu, H.H.Y.; Wong, F.C.S.; Yuen, K.-T.; Chappell, R.; Choi, H.C.W. 2020: NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma. Cancer 126(16): 3674-3688
Yin, Z.; Klionsky, D.J. 2020: NPC-phagy: selective autophagy of the nuclear pore complexes. Autophagy 16(10): 1735-1736
Höglinger, D.; Burgoyne, T.; Sanchez-Heras, E.; Hartwig, P.; Colaco, A.; Newton, J.; Futter, C.E.; Spiegel, S.; Platt, F.M.; Eden, E.R. 2019: NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress. Nature Communications 10(1): 4276
Kutchukian, C.; Vivas, O.; Casas, M.; Jones, J.G.; Tiscione, S.A.; Simó, S.; Ory, D.S.; Dixon, R.E.; Dickson, E.J. 2021: NPC1 regulates the distribution of phosphatidylinositol 4-kinases at Golgi and lysosomal membranes. EMBO Journal 40(13): E105990
Encarnação, M.; Coutinho, M.F.; Cho, S.M.; Cardoso, M.T.; Ribeiro, I.; Chaves, P.; Santos, J.I.ês.; Quelhas, D.; Lacerda, L.úc.; Leão Teles, E.; Futerman, A.H.; Vilarinho, L.; Alves, S. 2020: NPC1 silent variant induces skipping of exon 11 (p.V562V) and unfolded protein response was found in a specific Niemann-Pick type C patient. Molecular Genetics and Genomic Medicine 8(11): E1451
Srivastava, R.Ajit.K.; Cefalu, A.B.; Srivastava, N.S.; Averna, M. 2020: NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists. Molecular and Cellular Biochemistry 473(1-2): 247-262
Wei, D.; Shen, S.; Lin, K.; Lu, F.; Zheng, P.; Wu, S.; Kang, D. 2021: NPC2 as a Prognostic Biomarker for Glioblastoma Based on Integrated Bioinformatics Analysis and Cytological Experiments. Frontiers in Genetics 12: 611442
Chae, Y.S.; Kim, H. 2021: NPC2 expression in thyroid tumors and its possible diagnostic utility. International Journal of Clinical and Experimental Pathology 14(1): 126-132
Zirpoli, H.; Sosunov, S.A.; Niatsetskaya, Z.V.; Mayurasakorn, K.; Manual Kollareth, D.J.; Serhan, C.N.; Ten, V.S.; Deckelbaum, R.J. 2021: NPD1 rapidly targets mitochondria-mediated apoptosis after acute injection protecting brain against ischemic injury. Experimental Neurology 335: 113495
Calandria, J.M.; Asatryan, A.; Balaszczuk, V.; Knott, E.J.; Jun, B.K.; Mukherjee, P.K.; Belayev, L.; Bazan, N.G. 2015: NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival. Cell Death and Differentiation 22(8): 1363-1377
Sansal, I.; Dupont, E.; Toru, D.; Evrard, C.; Rouget, P. 2000: NPDC-1, a regulator of neural cell proliferation and differentiation, interacts with E2F-1, reduces its binding to DNA and modulates its transcriptional activity. Oncogene 19(43): 5000-5009
Kim, K.Seop.; Kim, M.Ae.; Park, K.; Sohn, Y.Chang. 2021: NPF activates a specific NPF receptor and regulates food intake in Pacific abalone Haliotis discus hannai. Scientific Reports 11(1): 20912
Snetkov, X.; Weisswange, I.; Pfanzelter, J.; Humphries, A.C.; Way, M. 2016: NPF motifs in the vaccinia virus protein A36 recruit intersectin-1 to promote Cdc42:N-WASP-mediated viral release from infected cells. Nature Microbiology 1(10): 16141
Chao, Z.-F.; Wang, Y.-L.; Chen, Y.-Y.; Zhang, C.-Y.; Wang, P.-Y.; Song, T.; Liu, C.-B.; Lv, Q.-Y.; Han, M.-L.; Wang, S.-S.; Yan, J.; Lei, M.-G.; Chao, D.-Y. 2021: NPF transporters in synaptic-like vesicles control delivery of iron and copper to seeds. Science Advances 7(36): Eabh 2450
Zhao, B.; Zhang, Z.; Jiang, M.; Hu, S.; Luo, Y.; Wang, L. 2020: NPF:network propagation for protein function prediction. Bmc Bioinformatics 21(1): 355
Zhu, H.; Peng, B.; Klausen, C.; Yi, Y.; Li, Y.; Xiong, S.; von Dadelszen, P.; Leung, P.C.K. 2020: NPFF increases fusogenic proteins syncytin 1 and syncytin 2 via GCM1 in first trimester primary human cytotrophoblast cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 34(7): 9419-9432
Leeman, K.T.; Dobson, L.; Towne, M.; Dukhovny, D.; Joshi, M.; Stoler, J.; Agrawal, P.B. 2014: NPHP3 mutations are associated with neonatal onset multiorgan polycystic disease in two siblings. Journal of Perinatology: Official Journal of the California Perinatal Association 34(5): 410-411
Boute, N.; Gribouval, O.; Roselli, S.; Benessy, F.; Lee, H.; Fuchshuber, A.; Dahan, K.; Gubler, M.C.; Niaudet, P.; Antignac, C. 2000: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nature Genetics 24(4): 349-354
Frisira, E.; Rashid, F.; Varma, S.Nath.; Badodi, S.; Benjamin-Ombo, V.Ayodele.; Michod, D.; Niklison-Chirou, M.Victoria. 2019: NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma. Cell Death and Disease 10(11): 785
Pomari, E.; Basso, G.; Bresolin, S.; Pillon, M.; Carraro, E.; d'Amore, E.S.; Viola, G.; Frasson, C.; Basso, K.; Bonvini, P.; Mussolin, L. 2017: NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma. Leukemia 31(2): 498-501
Bone, K.M.; Wang, P.; Wu, F.; Wu, C.; Li, L.; Bacani, J.T.; Andrew, S.E.; Lai, R. 2015: NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair. Blood Cancer Journal 5: E311
McDonnell, S.R.P.; Hwang, S.R.; Basrur, V.; Conlon, K.P.; Fermin, D.; Wey, E.; Murga-Zamalloa, C.; Zeng, Z.; Zu, Y.; Elenitoba-Johnson, K.S.J.; Lim, M.S. 2012: NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis. Oncogene 31(32): 3733-3740
Lee, W-H.; Salek-Ardakani, S.; Pandolfi, P.P.; Brady, H.J.M.; de Boer, J.; Williams, O. 2012: NPM-MLF1 synergizes with Npm haploinsufficiency to enhance myeloid progenitor activity. Leukemia 26(5): 1110-1112
Yamamoto, I.; Azuma, Y.; Kushimura, Y.; Yoshida, H.; Mizuta, I.; Mizuno, T.; Ueyama, M.; Nagai, Y.; Tokuda, T.; Yamaguchi, M. 2018: NPM-hMLF1 fusion protein suppresses defects of a Drosophila FTLD model expressing the human FUS gene. Scientific Reports 8(1): 11291
Hernández, F.; López, O.; Estivill, C.; Baiget, M.; Pujol, R.M.; Bordes, R.; Nomdedéu, J.F. 1999: NPM/ALK rearrangements in indolent cutaneous lesions. Leukemia 13(8): 1291-1292
Patel, S.S.; Kluk, M.J.; Weinberg, O.K. 2020: NPM1 Biology in Myeloid Neoplasia. Current Hematologic Malignancy Reports 15(4): 350-359
Liu, X.-S.; Zhou, L.-M.; Yuan, L.-L.; Gao, Y.; Kui, X.-Y.; Liu, X.-Y.; Pei, Z.-J. 2021: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated with m6A Modification and Glycolysis. Frontiers in Immunology 12: 724741
Naseem, S.; Binota, J.; Varma, N.; Virk, H.; Varma, S.; Malhotra, P. 2021: NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia. International Journal of Hematology-Oncology and Stem Cell Research 15(1): 15-26
Zhou, F.; Müller-Tidow, C. 2019: NPM1 functions in epitranscriptomics. Nature Genetics 51(10): 1436-1437
Holmberg Olausson, K.; Elsir, T.; Moazemi Goudarzi, K.; Nistér, M.; Lindström, M.S. 2015: NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape. Scientific Reports 5: 16495
Andersen, M.T.; Andersen, M.K.; Christiansen, D.H.; Pedersen-Bjergaard, J. 2008: NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features. Leukemia 22(5): 951-955
Watkins, D.B.; Hughes, T.P.; White, D.L.; D'Andrea, R.J. 2013: NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis. Leukemia 27(2): 489-490
Qin, G.; Wang, X.; Ye, S.; Li, Y.; Chen, M.; Wang, S.; Qin, T.; Zhang, C.; Li, Y.; Long, Q.; Hu, H.; Shi, D.; Li, J.; Zhang, K.; Zhai, Q.; Tang, Y.; Kang, T.; Lan, P.; Xie, F.; Lu, J.; Deng, W. 2020: NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer. Nature Communications 11(1): 1669
Raman, H.S.; Shanmugam, V.; Li, J.; Steensma, D.P.; Kim, A.S.; Luskin, M.R. 2021: NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation. Leukemia and Lymphoma 2021: 1-5
Pasqualucci, L.; Li, S.; Meloni, G.; Schnittger, S.; Gattenlohner, S.; Liso, A.; Di Ianni, M.; Martelli, M.P.; Pescarmona, E.; Foa, R.; Haferlach, T.; Skoda, R.C.; Falini, B. 2008: NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?. Leukemia 22(7): 1459-1463
Falini, B.; Brunetti, L.; Sportoletti, P.; Martelli, M.P. 2020: NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood 136(15): 1707-1721
Sun, C.; Gao, Y.; Yang, L.; Shao, H.; Li, J.; Gao, X.; Ma, L.; Lin, M.; Sui, J. 2018: NPM1A in Plasma is a Potential Prognostic Biomarker in Acute Myeloid Leukemia. Open Life Sciences 13: 236-241
Wang, A.J.; Han, Y.; Jia, N.; Chen, P.; Minden, M.D. 2020: NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemia. Leukemia 34(5): 1278-1290
Mallardo, M.; Caronno, A.; Pruneri, G.; Raviele, P.R.; Viale, A.; Pelicci, P.G.; Colombo, E. 2013: NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model. Leukemia 27(11): 2248-2251
Saeed, F.; Liu, T.-Y.; Chung, W.; Rich, H. 2021: NPO at Midnight: Reassessing Unnecessary Pre-Endoscopy Fasting. Rhode Island Medical Journal 104(8): 35-38
Carlezon, W.A.; Abi-Dargham, A. 2017: NPP: Our Designs for the Future. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 42(7): 1371-1372
Fujita, H.; Suzuki, K. 2020: NPPV Treatment for Neuromuscular Diseases during the COVID-19 Pandemic. Brain and Nerve 72(10): 1085-1089
Yu, Y.; Zhi, L.; Wu, Q.; Jing, L.; Wang, D. 2018: NPR-9 regulates the innate immune response in Caenorhabditis elegans by antagonizing the activity of AIB interneurons. Cellular and Molecular Immunology 15(1): 27-37
Abdelalim, E.M.; Tooyama, I. 2011: NPR-A regulates self-renewal and pluripotency of embryonic stem cells. Cell Death and Disease 2: E127
Mhamdi, A. 2019: NPR1 Has Everything under Control. Plant Physiology 181(1): 6-7
Olate, E.; Jiménez-Gómez, Jé.M.; Holuigue, L.; Salinas, J. 2018: NPR1 mediates a novel regulatory pathway in cold acclimation by interacting with HSFA1 factors. Nature Plants 4(10): 811-823
Fu, Z.Qing.; Yan, S.; Saleh, A.; Wang, W.; Ruble, J.; Oka, N.; Mohan, R.; Spoel, S.H.; Tada, Y.; Zheng, N.; Dong, X. 2012: NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants. Nature 486(7402): 228-232
Li, S.; Guo, R.; Peng, Z.; Quan, B.; Hu, Y.; Wang, Y.; Wang, Y. 2021: NPR3, transcriptionally regulated by POU2F1, inhibits osteosarcoma cell growth through blocking the PI3K/AKT pathway. Cellular Signalling 86: 110074
Zhao, X.; Jiang, L.; Hu, D.; Tang, Y.; Zhao, G.; Du, X.; Luo, S.; Tang, W. 2021: NPRL2 reduces the niraparib sensitivity of castration-resistant prostate cancer via interacting with UBE2M and enhancing neddylation. Experimental Cell Research 403(2): 112614
Lapointe, J-Y.; Tessier, J.; Paquette, Y.; Wallendorff, B.; Coady, M.J.; Pichette, V.; Bonnardeaux, A. 2006: NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney International 69(12): 2261-2267
Khan, A.; Johnson, R.; Wittmer, C.; Maile, M.; Tatsukawa, K.; Wong, J.L.; Gill, M.B.; Stocking, E.M.; Natala, S.R.; Paulino, A.D.; Bowden-Verhoek, J.K.; Wrasidlo, W.; Masliah, E.; Bonhaus, D.W.; Price, D.L. 2021: NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson's disease. Brain: a Journal of Neurology 144(12): 3692-3709
Chang, S.; Bok, P.; Tsai, C-Yen.; Sun, C-Pu.; Liu, H.; Deussing, J.M.; Huang, G-Jen. 2018: NPTX2 is a key component in the regulation of anxiety. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 43(9): 1943-1953
Xu, C.; Tian, G.; Jiang, C.; Xue, H.; Kuerbanjiang, M.; Sun, L.; Gu, L.; Zhou, H.; Liu, Y.; Zhang, Z.; Xu, Q. 2019: NPTX2 promotes colorectal cancer growth and liver metastasis by the activation of the canonical Wnt/β-catenin pathway via FZD6. Cell Death and Disease 10(3): 217
Matsumine, H.; Giatsidis, G.; Fujimaki, H.; Yoshimoto, N.; Makino, Y.; Hosoi, S.; Takagi, M.; Shimizu, M.; Takeuchi, M. 2021: NPWTi allows safe delayed free flap repair of Gustilo IIIb injuries: a prospective case series. Regenerative Therapy 18: 82-87
Comeras, L.B.; Hörmer, N.; Mohan Bethuraj, P.; Tasan, R.O. 2021: NPY Released from GABA Neurons of the Dentate Gyrus Specially Reduces Contextual Fear Without Affecting Cued or Trace Fear. Frontiers in Synaptic Neuroscience 13: 635726
Molosh, A.I.; Sajdyk, T.J.; Truitt, W.A.; Zhu, W.; Oxford, G.S.; Shekhar, A. 2013: NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 38(7): 1352-1364
Cattaneo, S.; Verlengia, G.; Marino, P.; Simonato, M.; Bettegazzi, B. 2020: NPY and Gene Therapy for Epilepsy: How, When,... and y. Frontiers in Molecular Neuroscience 13: 608001
Engström Ruud, L.; Pereira, M.M.A.; de Solis, A.J.; Fenselau, H.; Brüning, J.C. 2020: NPY mediates the rapid feeding and glucose metabolism regulatory functions of AgRP neurons. Nature Communications 11(1): 442
Pronchuk, N.; Colmers, W.F. 2004: NPY presynaptic actions are reduced in the hypothalamic mpPVN of obese (fa/fa), but not lean, Zucker rats in vitro. British Journal of Pharmacology 141(6): 1032-1036
Félétou, M.; Nicolas, J.P.; Rodriguez, M.; Beauverger, P.; Galizzi, J.P.; Boutin, J.A.; Duhault, J. 1999: NPY receptor subtype in the rabbit isolated ileum. British Journal of Pharmacology 127(3): 795-801
Pleil, K.E.; Rinker, J.A.; Lowery-Gionta, E.G.; Mazzone, C.M.; McCall, N.M.; Kendra, A.M.; Olson, D.P.; Lowell, B.B.; Grant, K.A.; Thiele, T.E.; Kash, T.L. 2015: NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nature Neuroscience 18(4): 545-552
Chen, F.; Zhou, Y.; Yang, K.; Shen, M.; Wang, Y. 2020: NPY stimulates cholesterol synthesis acutely by activating the SREBP2-HMGCR pathway through the Y1 and Y5 receptors in murine hepatocytes. Life Sciences 262: 118478
Saffari, R.; Teng, Z.; Zhang, M.; Kravchenko, M.; Hohoff, C.; Ambrée, O.; Zhang, W. 2016: NPY+-, but not PV+- GABAergic neurons mediated long-range inhibition from infra- to prelimbic cortex. Translational Psychiatry 6: E736
Vázquez-León, P.; Ramírez-San Juan, E.; Marichal-Cancino, B.A.; Campos-Rodríguez, C.; Chávez-Reyes, J.ús.; Miranda-Páez, A. 2020: NPY-Y1 receptors in dorsal periaqueductal gray modulate anxiety, alcohol intake, and relapse in Wistar rats. Pharmacology Biochemistry and Behavior 199: 173071
Bertocchi, I.; Mele, P.; Ferrero, G.; Oberto, A.; Carulli, D.; Eva, C. 2021: NPY-Y1 receptor signaling controls spatial learning and perineuronal net expression. Neuropharmacology 184: 108425
Fadda, M.; De Fruyt, N.; Borghgraef, C.; Watteyne, J.; Peymen, K.; Vandewyer, E.; Naranjo Galindo, F.J.; Kieswetter, A.; Mirabeau, O.; Chew, Y.L.; Beets, I.; Schoofs, L. 2020: NPY/NPF-Related Neuropeptide FLP-34 Signals from Serotonergic Neurons to Modulate Aversive Olfactory Learning in Caenorhabditis elegans. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 40(31): 6018-6034
Erondu, N.; Addy, C.; Lu, K.; Mallick, M.; Musser, B.; Gantz, I.; Proietto, J.; Astrup, A.; Toubro, Søren.; Rissannen, A.M.; Tonstad, S.; Haynes, W.G.; Gottesdiener, K.M.; Kaufman, K.D.; Amatruda, J.M.; Heymsfield, S.B. 2007: NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine. Obesity 15(8): 2027-2042
Huang, T.; Chen, P.; Liu, B.; Li, X.; Lv, X.; Hu, K. 2020: NPid: an Automatic Approach to Rapid Identification of Known Natural Products in the Crude Extract of Crabapple Based on 2D 1H-13C Heteronuclear Correlation Spectra of the Extract Mixture. Analytical Chemistry 92(16): 10996-11006
Gifford, L. 2011: NPs + FPs: finding ways to work together. Journal of Family Practice 60(2): 65
Tsvetkov, P.; Adler, J.; Strobelt, R.; Adamovich, Y.; Asher, G.; Reuven, N.; Shaul, Y. 2021: NQO1 Binds and Supports SIRT1 Function. Frontiers in Pharmacology 12: 671929
Hirose, Y.; Sakata, J.; Kobayashi, T.; Miura, K.; Yuza, K.; Nakano, M.; Ichikawa, H.; Nagahashi, M.; Shimada, Y.; Kameyama, H.; Wakai, T. 2021: NQO1 as a Marker of Chemosensitivity and Prognosis for Colorectal Liver Metastasis. Anticancer Research 41(3): 1563-1570
Oh, E-Taex.; Kim, J-Whan.; Kim, J.Mee.; Kim, S.Jung.; Lee, J-Seon.; Hong, S-Sun.; Goodwin, J.; Ruthenborg, R.J.; Jung, M.Gu.; Lee, H-June.; Lee, C-Ho.; Park, E.Sung.; Kim, C.; Park, H.Joo. 2016: NQO1 inhibits proteasome-mediated degradation of HIF-1α. Nature Communications 7: 13593
Guo, G.; Gao, Z.; Tong, M.; Zhan, D.; Wang, G.; Wang, Y.; Qin, J. 2020: NQO1 is a determinant for cellular sensitivity to anti-tumor agent Napabucasin. American Journal of Cancer Research 10(5): 1442-1454
Di Francesco, A.; Choi, Y.; Bernier, M.; Zhang, Y.; Diaz-Ruiz, A.; Aon, M.A.; Kalafut, K.; Ehrlich, M.R.; Murt, K.; Ali, A.; Pearson, K.J.; Levan, S.; Preston, J.D.; Martin-Montalvo, A.; Martindale, J.L.; Abdelmohsen, K.; Michel, C.R.; Willmes, D.M.; Henke, C.; Navas, P.; Villalba, J.Manuel.; Siegel, D.; Gorospe, M.; Fritz, K.; Biswal, S.; Ross, D.; de Cabo, R. 2020: NQO1 protects obese mice through improvements in glucose and lipid metabolism. Npj Aging and Mechanisms of Disease 6(1): 13
Li, X.; Liu, Z.; Zhang, A.; Han, C.; Shen, A.; Jiang, L.; Boothman, D.A.; Qiao, J.; Wang, Y.; Huang, X.; Fu, Y-Xin. 2019: NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance. Nature Communications 10(1): 3251
Zhang, C.; Qu, Y.; Ma, X.; Li, M.; Li, S.; Li, Y.; Wu, L. 2020: NQO1-selective activated prodrugs of combretastatin A-4: Synthesis and biological evaluation. Bioorganic Chemistry 103: 104200
Masna, N.Vikram.Raj.; Huan, J.; Mandal, S.; Bhunia, S. 2021: NQR sensitive embedded signatures for authenticating additively manufactured objects. Scientific Reports 11(1): 12207
Yin, L.; Li, W.; Wang, G.; Shi, H.; Wang, K.; Yang, H.; Peng, B. 2019: NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling. Journal of Experimental and Clinical Cancer Research: Cr 38(1): 343
Liu, H.; Zhu, Y.; Gao, Y.; Qi, D.; Zhao, L.; Zhao, L.; Liu, C.; Tao, T.; Zhou, C.; Sun, X.; Guo, F.; Xiao, J. 2020: NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis. Cell Death and Disease 11(2): 129
Wang, H.; Fu, Y. 2021: NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway. Bmc Cancer 21(1): 871
Grimaudo, S.; Dongiovanni, P.; Pihlajamäki, J.; Eslam, M.; Yki-Järvinen, H.; Pipitone, R.M.; Baselli, G.; Cammà, C.; Di Marco, V.; Enea, M.; Longo, M.; Pennisi, G.; Prati, D.; Zito, R.; Fracanzani, A.L.; Craxì, A.; George, J.; Romeo, S.; Valenti, L.; Petta, S. 2021: NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease. Liver International: Official Journal of the International Association for the Study of the Liver 41(11): 2712-2719
Himes, R.W.; Mojarrad, M.; Eslahi, A.; Finegold, M.J.; Maroofian, R.; Moore, D.D. 2020: NR1H4-related Progressive Familial Intrahepatic Cholestasis 5: Further Evidence for Rapidly Progressive Liver Failure. Journal of Pediatric Gastroenterology and Nutrition 70(6): E111-E113
Yang, M.; Qiu, Y.; Jin, Y.; Liu, W.; Wang, Q.; Yi, H.; Tang, S. 2020: NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: a systematic review and meta-analysis. Pharmacology Research and Perspectives 8(6): E00696
Nakazawa, T.; Komai, S.; Watabe, A.M.; Kiyama, Y.; Fukaya, M.; Arima-Yoshida, F.; Horai, R.; Sudo, K.; Ebine, K.; Delawary, M.; Goto, J.; Umemori, H.; Tezuka, T.; Iwakura, Y.; Watanabe, M.; Yamamoto, T.; Manabe, T. 2006: NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. EMBO Journal 25(12): 2867-2877
Baron, A.; Montagne, A.; Cassé, F.; Launay, S.; Maubert, E.; Ali, C.; Vivien, D. 2010: NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity. Cell Death and Differentiation 17(5): 860-871
Bertacchi, M.; Romano, A.Lisa.; Loubat, Aès.; Tran Mau-Them, F.; Willems, M.; Faivre, L.; Khau van Kien, P.; Perrin, L.; Devillard, Fçoise.; Sorlin, A.; Kuentz, P.; Philippe, C.; Garde, A.; Neri, F.; Di Giaimo, R.; Oliviero, S.; Cappello, S.; D'Incerti, L.; Frassoni, C.; Studer, Mèle. 2020: NR2F1 regulates regional progenitor dynamics in the mouse neocortex and cortical gyrification in BBSOAS patients. EMBO Journal 39(13): E104163
Li, X.; Li, Y.; Bai, S.; Zhang, J.; Liu, Z.; Yang, J. 2021: NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular Carcinoma. Cancer Management and Research 13: 427-437
Xia, B.; Hou, L.; Kang, H.; Chang, W.; Liu, Y.; Zhang, Y.; Ding, Y. 2020: NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells. Bmc Cancer 20(1): 626
Larsen, R.S.; Corlew, R.J.; Henson, M.A.; Roberts, A.C.; Mishina, M.; Watanabe, M.; Lipton, S.A.; Nakanishi, N.; Pérez-Otaño, I.; Weinberg, R.J.; Philpot, B.D. 2011: NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity. Nature Neuroscience 14(3): 338-344
Efstathopoulos, P.; Andersson, F.; Melas, P.A.; Yang, L.L.; Villaescusa, J.Carlos.; Rȕegg, Jëlle.; Ekström, T.J.; Forsell, Y.; Galanti, M.Rosaria.; Lavebratt, C. 2018: NR3C1 hypermethylation in depressed and bullied adolescents. Translational Psychiatry 8(1): 121
Lu, J.; Hu, F.; Zhou, Y. 2021: NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma. Biomed Research International 2021: 9025481
Tan, C.; Hiwa, R.; Mueller, J.L.; Vykunta, V.; Hibiya, K.; Noviski, M.; Huizar, J.; Brooks, J.F.; Garcia, J.; Heyn, C.; Li, Z.; Marson, A.; Zikherman, J. 2020: NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting. Nature Immunology 21(10): 1267-1279
Pei, L.; Waki, H.; Vaitheesvaran, B.; Wilpitz, D.C.; Kurland, I.J.; Tontonoz, P. 2006: NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nature Medicine 12(9): 1048-1055
Chen, J.; López-Moyado, I.F.; Seo, H.; Lio, C-Wang.J.; Hempleman, L.J.; Sekiya, T.; Yoshimura, A.; Scott-Browne, J.P.; Rao, A. 2019: NR4A transcription factors limit CAR T cell function in solid tumours. Nature 567(7749): 530-534
Zhi, D.; Wu, W.; Xiao, B.; Qi, S.; Jiang, R.; Yang, X.; Yang, J.; Xiao, W.; Liu, C.; Long, H.; Calhoun, V.D.; Long, L.; Sui, J. 2020: NR4A1 Methylation Associated Multimodal Neuroimaging Patterns Impaired in Temporal Lobe Epilepsy. Frontiers in Neuroscience 14: 727
Pu, Z-Qing.; Yu, T-Fu.; Liu, D.; Jin, C-Wen.; Sadiq, E.; Qiao, X.; Li, X.; Chen, Y.; Zhang, J.; Tian, M.; Li, S.; Zhao, R-Xing.; Wang, X-Dong. 2021: NR4A1 enhances MKP7 expression to diminish JNK activation induced by ROS or ER-stress in pancreatic β cells for surviving. Cell Death Discovery 7(1): 133
Li, Y.; Wang, F.; Lu, L.; Zhu, F.; Huang, S.; Nomie, K.; Zhang, L.; Yang, D.T.; Huang, W.; Kahl, B.S.; Safe, S.; Wang, M.; Rui, L. 2017: NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells. Blood Cancer Journal 7(12): 632
Guo, H.; Golczer, G.; Wittner, B.S.; Langenbucher, A.; Zachariah, M.; Dubash, T.D.; Hong, X.; Comaills, V.; Burr, R.; Ebright, R.Y.; Horwitz, E.; Vuille, J.A.; Hajizadeh, S.; Wiley, D.F.; Reeves, B.A.; Zhang, J.-M.; Niederhoffer, K.L.; Lu, C.; Wesley, B.; Ho, U.; Nieman, L.T.; Toner, M.; Vasudevan, S.; Zou, L.; Mostoslavsky, R.; Maheswaran, S.; Lawrence, M.S.; Haber, D.A. 2021: NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer. Molecular Cell 81(19): 4041-4058.E15
Liu, Q.; Dong, Q. 2020: NR4A2 Exacerbates Cerebral Ischemic Brain Injury via Modulating microRNA-652/Mul1 Pathway. Neuropsychiatric Disease and Treatment 16: 2285-2296
Jesús, S.; Hinarejos, I.; Carrillo, F.át.; Martínez-Rubio, D.; Macías-García, D.; Sánchez-Monteagudo, A.; Adarmes, A.; Lupo, V.; Pérez-Dueñas, B.én.; Mir, P.; Espinós, C. 2021: NR4A2 Mutations can Cause Intellectual Disability and Language Impairment with Persistent Dystonia-Parkinsonism. NEUROLOGY. Genetics 7(1): E543
de Alwis, N.; Beard, S.; Binder, N.K.; Pritchard, N.; Kaitu'u-Lino, T'uhevaha.J.; Walker, S.P.; Stock, O.; Groom, K.M.; Petersen, S.; Henry, A.; Said, J.M.; Seeho, S.; Kane, S.C.; Tong, S.; Hannan, N.J. 2021: NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast. Scientific Reports 11(1): 20670
Liu, H.; Liu, P.; Shi, X.; Yin, D.; Zhao, J. 2018: NR4A2 protects cardiomyocytes against myocardial infarction injury by promoting autophagy. Cell Death Discovery 4: 27
Owosho, A.; Tyler, D.; Adesina, O.; Odujoko, O.; Summersgill, K. 2021: NR4A3 (NOR-1) Immunostaining Shows Better Performance than DOG1 Immunostaining in Acinic Cell Carcinoma of Salivary Gland: a Preliminary Study. Journal of Oral and Maxillofacial Research 12(1): E4
Wang, Y.-H.; Li, C.-X.; Stephenson, J.M.; Marrelli, S.P.; Kou, Y.-M.; Meng, D.-Z.; Wu, T. 2021: NR4A3 and CCL20 clusters dominate the genetic networks in CD146+ blood cells during acute myocardial infarction in humans. European Journal of Medical Research 26(1): 113
Wang, J.; Li, H.; Lv, Z.; Luo, X.; Deng, W.; Zou, T.; Zhang, Y.; Sang, W.; Wang, X. 2021: NR4A3 induces endothelial dysfunction through up-regulation of endothelial 1 expression in adipose tissue-derived stromal cells. Life Sciences 264: 118727
Baetens, D.; Stoop, H.; Peelman, F.; Todeschini, A-Laure.; Rosseel, T.; Coppieters, F.; Veitia, R.A.; Looijenga, L.H.J.; De Baere, E.; Cools, M. 2017: NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of sex development. Genetics in Medicine: Official Journal of the American College of Medical Genetics 19(4): 367-376
Zhang, K.; Xiao, M.; Jin, X.; Jiang, H. 2021: NR5A2 Is one of 12 Transcription Factors Predicting Prognosis in HNSCC and Regulates Cancer Cell Proliferation in a p53-Dependent Manner. Frontiers in Oncology 11: 691318
Yang, Q.; Deng, L.; Li, J.; Miao, P.; Liu, W.; Huang, Q. 2020: NR5A2 Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma. Oncotargets and Therapy 13: 10231-10244
Qiao, J.; Chen, Y.; Mi, Y.; Jin, H.; Huang, T.; Liu, L.; Gong, L.; Wang, L.; Wang, Q.; Zou, Z. 2020: NR5A2 synergizes with NCOA3 to induce breast cancer resistance to BET inhibitor by upregulating NRF2 to attenuate ferroptosis. Biochemical and Biophysical Research Communications 530(2): 402-409
Guo, F.; Zhou, Y.; Guo, H.; Ren, D.; Jin, X.; Wu, H. 2021: NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15. Cell Death Discovery 7(1): 78
Ijiri, M.; Lai, Y.-C.; Kawaguchi, H.; Fujimoto, Y.; Miura, N.; Matsuo, T.; Tanimoto, A. 2021: NR6A1 Allelic Frequencies as an Index for both Miniaturizing and Increasing Pig Body Size. In Vivo 35(1): 163-167
Wang, X.; Shao, Z.; Zetoune, F.S.; Zeidler, M.G.; Gowrishankar, K.; Vincenz, C. 2003: NRADD, a novel membrane protein with a death domain involved in mediating apoptosis in response to ER stress. Cell Death and Differentiation 10(5): 580-591
Yang, Q.; Pan, Q.; Li, C.; Xu, Y.; Wen, C.; Sun, F. 2016: NRAGE is involved in homologous recombination repair to resist the DNA-damaging chemotherapy and composes a ternary complex with RNF8-BARD1 to promote cell survival in squamous esophageal tumorigenesis. Cell Death and Differentiation 23(8): 1406-1416
Bertrand, M.J.M.; Kenchappa, R.S.; Andrieu, D.; Leclercq-Smekens, M.; Nguyen, H.N.T.; Carter, B.D.; Muscatelli, F.; Barker, P.A.; De Backer, O. 2008: NRAGE, a p75NTR adaptor protein, is required for developmental apoptosis in vivo. Cell Death and Differentiation 15(12): 1921-1929
Poon, A.H.; Laprise, C.; Lemire, M.; Hudson, T.J.; Schurr, E. 2005: NRAMP1 is not associated with asthma, atopy, and serum immunoglobulin E levels in the French Canadian population. Genes and Immunity 6(6): 519-527
Pinto, Iês.; Duque, M.; Gonçalves, J.; Akkapeddi, P.; Oliveira, M.L.; Cabrita, R.; Yunes, J.Andrés.; Durum, S.K.; Barata, Jão.T.; Fragoso, R. 2020: NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling. Oncogene 39(5): 975-986
Valencia-Sama, I.; Ladumor, Y.; Kee, L.; Adderley, T.; Christopher, G.; Robinson, C.M.; Kano, Y.; Ohh, M.; Irwin, M.S. 2020: NRAS Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS-MAPK Pathway in Neuroblastoma. Cancer Research 80(16): 3413-3423
Yu, R.Timothy.D.; Garcia, R.L. 2020: NRAS mutant E132K identified in young-onset sporadic colorectal cancer and the canonical mutants G12D and Q61K affect distinct oncogenic phenotypes. Scientific Reports 10(1): 11028
Bansal, N.; Das, M.; Chatterjee, U.; Mallick, M.G.; Arora, N.; Mishra, D.K. 2021: NRAS mutant melanoma arising in a giant congenital melanocytic nevus in an infant. Indian Journal of Pathology and Microbiology 64(2): 402-405
Randic, T.; Kozar, I.; Margue, C.; Utikal, J.; Kreis, S. 2021: NRAS mutant melanoma: Towards better therapies. Cancer Treatment Reviews 99: 102238
Fedorenko, I.V.; Gibney, G.T.; Smalley, K.S.M. 2013: NRAS mutant melanoma: biological behavior and future strategies for therapeutic management. Oncogene 32(25): 3009-3018
Charbel, C.; Fontaine, R.H.; Malouf, G.G.; Picard, A.; Kadlub, N.; El-Murr, N.; How-Kit, A.; Su, X.; Coulomb-L'Hermine, A.; Tost, J.; Mourah, S.; Aractingi, S.; Guégan, S. 2014: NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. Journal of Investigative Dermatology 134(4): 1067-1074
Murphy, D.M.; Bejar, R.; Stevenson, K.; Neuberg, D.; Shi, Y.; Cubrich, C.; Richardson, K.; Eastlake, P.; Garcia-Manero, G.; Kantarjian, H.; Ebert, B.L.; Mike Makrigiorgos, G. 2013: NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes. Leukemia 27(10): 2077-2081
Castilla, L.H. 2020: NRAS palmitoylation and oncogenic fitness. Blood 135(20): 1725-1726
Uguen, A.; Talagas, M.; Costa, S.; De Braekeleer, M.; Marcorelles, P. 2016: NRASQ61R immunohistochemistry: a new tool for mutational status screening in challenging melanoma samples. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 29(1): 91-92
Li, Z.; Liu, B.; Li, C.; Sun, S.; Zhang, H.; Sun, S.; Wang, Z.; Zhang, X. 2021: NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer. Frontiers in Oncology 11: 634026
Melton, L. 2014: NRC revisits GE crop risks. Nature Biotechnology 32(10): 969
Haigh, G.E.; Pearson, A.W.; Watkins, D.S.; Gibbons, M. 1971: NRDC and the environment for innovation. Nature 232(5312): 527-531
Zhang, C.; Wei, L.; Zeng, F.; Zhang, T.; Sun, Y.; Shen, Y.; Wang, G.; Ma, J.; Zhang, J. 2021: NREM Sleep EEG Characteristics Correlate to the Mild Cognitive Impairment in Patients with Parkinsonism. Biomed Research International 2021: 5561974
Scarpa, J.R.; Jiang, P.; Gao, V.D.; Vitaterna, M.H.; Turek, F.W.; Kasarskis, A. 2021: NREM delta power and AD-relevant tauopathy are associated with shared cortical gene networks. Scientific Reports 11(1): 7797
Rocha, A.L.; Arnulf, I. 2020: NREM parasomnia as a dream enacting behavior. Sleep Medicine 75: 103-105
Terzaghi, M.; Minafra, B.; Zangaglia, R.; Picascia, M.; Pozzi, N.ò; Cremascoli, R.; Arnaldi, D.; Versino, M.; Sinforiani, E.; Rustioni, V.; Pacchetti, C.; Manni, R. 2020: NREM sleep arousal-related disorders reflect cognitive impairment in Parkinson's disease. Sleep Medicine 75: 491-496
Levenstein, D.; Buzsáki, Görgy.; Rinzel, J. 2019: NREM sleep in the rodent neocortex and hippocampus reflects excitable dynamics. Nature Communications 10(1): 2478
Castelnovo, A.; Lopez, Régis.; Proserpio, P.; Nobili, L.; Dauvilliers, Y. 2018: NREM sleep parasomnias as disorders of sleep-state dissociation. Nature Reviews. Neurology 14(8): 470-481
Tarun, A.; Wainstein-Andriano, D.; Sterpenich, V.; Bayer, L.; Perogamvros, L.; Solms, M.; Axmacher, N.; Schwartz, S.; Van De Ville, D. 2021: NREM sleep stages specifically alter dynamical integration of large-scale brain networks. Iscience 24(1): 101923
Zhuang, W.; Dong, X.; Wang, B.; Liu, N.; Guo, H.; Zhang, C.; Gan, W. 2021: NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells. Oncology Letters 22(3): 679
Wei, D-Wei.; Gui, L-Sheng.; Raza, S.Haidar.Abbas.; Zhang, S.; Khan, R.; Wang, L.; Guo, H-Fang.; Zan, L-Sen. 2017: NRF1 and ZSCAN10 bind to the promoter region of the SIX1 gene and their effects body measurements in Qinchuan cattle. Scientific Reports 7(1): 7867
Wang, L.; Yang, B.; Xu, Z.; Song, X.; Gong, Z.; Xue, S.; Kong, L. 2021: NRF1-regulated CircNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1. Cell Cycle 2021: 1-10
Huang, J.; Hao, C.; Li, Z.; Wang, L.; Jiang, J.; Tang, W.; Wang, L.; Zhang, W.; Hu, J.; Yang, W. 2020: NRF2 -617 C/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens. Frontiers in Pharmacology 11: 563321
Singh, A.; Daemen, A.; Nickles, D.; Jeon, S.-M.; Foreman, O.; Sudini, K.; Gnad, F.; Lajoie, S.; Gour, N.; Mitzner, W.; Chatterjee, S.; Choi, E.-J.; Ravishankar, B.; Rappaport, A.; Patil, N.; McCleland, M.; Johnson, L.; Acquaah-Mensah, G.; Gabrielson, E.; Biswal, S.; Hatzivassiliou, G. 2021: NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 27(3): 877-888
Ogawa, T.; Ishitsuka, Y.; Nakamura, Y.; Kubota, N.; Saito, A.; Fujisawa, Y.; Watanabe, R.; Okiyama, N.; Suga, Y.; Roop, D.R.; Fujimoto, M. 2020: NRF2 Augments Epidermal Antioxidant Defenses and Promotes Atopy. Journal of Immunology 205(4): 907-914
Ziv, E.; Zhang, Y.; Kelly, L.; Nikolovski, I.; Boas, F.E.; Erinjeri, J.P.; Cai, L.; Petre, E.N.; Brody, L.A.; Covey, A.M.; Getrajdman, G.; Harding, J.J.; Sofocleous, C.; Abou-Alfa, G.K.; Solomon, S.B.; Brown, K.T.; Yarmohammadi, H. 2020: NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: a Cohort Study and Laboratory Investigation. Radiology 297(1): 225-234
Anandhan, A.; Nguyen, N.; Syal, A.; Dreher, L.A.; Dodson, M.; Zhang, D.D.; Madhavan, L. 2021: NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing Mice. Aging and Disease 12(4): 964-982
Mondal, G.; Debnath, J. 2021: NRF2 activates macropinocytosis upon autophagy inhibition. Cancer Cell 39(5): 596-598
Yu, X.; Mansouri, A.; Liu, Z.; Gao, R.; Li, K.; Chen, C.; Huang, Y.; Chen, Z.; Chen, S.; Lu, Y.; Li, Y.; Zeng, C.; Zeng, Y. 2021: NRF2 activation induced by PML-RARα promotes microRNA 125b-1 expression and confers resistance to chemotherapy in acute promyelocytic leukemia. Clinical and Translational Medicine 11(5): E418
Fox, D.B.; Garcia, N.Marie.G.; McKinney, B.J.; Lupo, R.; Noteware, L.C.; Newcomb, R.; Liu, J.; Locasale, J.W.; Hirschey, M.D.; Alvarez, J.V. 2020: NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism. Nature Metabolism 2(4): 318-334
Calabrese, E.J.; Kozumbo, W.J.; Kapoor, R.; Dhawan, G.; Lara, P.C.; Giordano, J. 2021: Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 160: 125-131
Goess, C.; Terrillon, S.; Mayo, M.; Bousquet, P.; Wallace, C.; Hart, M.; Mathieu, S.; Twomey, R.; Donnelly-Roberts, D.; Namovic, M.; Jung, P.; Hu, M.; Richardson, P.; Esbenshade, T.; Cuff, C.A. 2021: NRF2 activator A-1396076 ameliorates inflammation in autoimmune disease models by inhibiting antigen dependent T cell activation. Journal of Translational Autoimmunity 4: 100079
Sporn, M.B.; Liby, K.T. 2012: NRF2 and cancer: the good, the bad and the importance of context. Nature Reviews. Cancer 12(8): 564-571
Ahmed, O.; Xu, M.; Zhou, F.; Wein, A.N.; Upadhya, G.A.; Ye, L.; Wong, B.W.; Lin, Y.; O'Farrelly, C.; Chapman, W.C. 2022: NRF2 assessment in discarded liver allografts: a role in allograft function and salvage. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 22(1): 58-70
Sánchez-de-Diego, C.; Pedrazza, L.; Pimenta-Lopes, C.; Martinez-Martinez, A.; Dahdah, N.; Valer, J.é A.; Garcia-Roves, P.; Rosa, J.L.; Ventura, F. 2021: NRF2 function in osteocytes is required for bone homeostasis and drives osteocytic gene expression. Redox Biology 40: 101845
Liu, Y.; Lang, F.; Yang, C. 2021: NRF2 in human neoplasm: Cancer biology and potential therapeutic target. Pharmacology and Therapeutics 217: 107664
Zhang, X.; Ye, L.; Xu, H.; Zhou, Q.; Tan, B.; Yi, Q.; Yan, L.; Xie, M.; Zhang, Y.; Tian, J.; Zhu, J. 2021: NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes. Stem Cell Research and Therapy 12(1): 208
Ryu, D.; Lee, J.-H.; Kwak, M.-K. 2020: NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling. Archives of Pharmacal Research 43(12): 1297-1310
Murphy, P.J.; Guo, J.; Jenkins, T.G.; James, E.R.; Hoidal, J.R.; Huecksteadt, T.; Broberg, D.S.; Hotaling, J.M.; Alonso, D.F.; Carrell, D.T.; Cairns, B.R.; Aston, K.I. 2020: NRF2 loss recapitulates heritable impacts of paternal cigarette smoke exposure. Plos Genetics 16(6): E1008756
Zhu, X.; Xi, C.; Ward, A.; Takezaki, M.; Shi, H.; Peterson, K.R.; Pace, B.S. 2020: NRF2 mediates γ-globin gene regulation through epigenetic modifications in a β-YAC transgenic mouse model. Experimental Biology and Medicine 245(15): 1308-1318
O'Cathail, S.éa.M.; Wu, C.-H.; Lewis, A.; Holmes, C.; Hawkins, M.A.; Maughan, T. 2020: NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer. Cancer Genetics 248-249: 1-10
Wati, S.M.; Matsumaru, D.; Motohashi, H. 2020: NRF2 pathway activation by KEAP1 inhibition attenuates the manifestation of aging phenotypes in salivary glands. Redox Biology 36: 101603
Sun, X.; Wang, Y.; Ji, K.; Liu, Y.; Kong, Y.; Nie, S.; Li, N.; Hao, J.; Xie, Y.; Xu, C.; Du, L.; Liu, Q. 2020: NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest. Nucleic Acids Research 48(16): 9109-9123
Joshi, C.S.; Mora, A.; Felder, P.A.; Mysorekar, I.U. 2021: NRF2 promotes urothelial cell response to bacterial infection by regulating reactive oxygen species and RAB27B expression. Cell Reports 37(3): 109856
DeNicola, G.M.; Chen, P-Hsuan.; Mullarky, E.; Sudderth, J.A.; Hu, Z.; Wu, D.; Tang, H.; Xie, Y.; Asara, J.M.; Huffman, K.E.; Wistuba, I.I.; Minna, J.D.; DeBerardinis, R.J.; Cantley, L.C. 2015: NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nature Genetics 47(12): 1475-1481
Lister, A.; Bourgeois, S.; Imenez Silva, P.H.; Rubio-Aliaga, I.; Marbet, P.; Walsh, J.; Shelton, L.M.; Keller, B.; Verrey, F.; Devuyst, O.; Giesbertz, P.; Daniel, H.; Goldring, C.E.; Copple, I.M.; Wagner, C.A.; Odermatt, A. 2018: NRF2 regulates the glutamine transporter Slc38a3 (SNAT3) in kidney in response to metabolic acidosis. Scientific Reports 8(1): 5629
Liu, P.; Wu, D.; Duan, J.; Xiao, H.; Zhou, Y.; Zhao, L.; Feng, Y. 2020: NRF2 regulates the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via FOCAD-FAK signaling pathway. Redox Biology 37: 101702
Martín-Montalvo, A.; Villalba, J.M.; Navas, P.; de Cabo, R. 2011: NRF2, cancer and calorie restriction. Oncogene 30(5): 505-520
Tian, Y.; Liu, Q.; Yu, S.; Chu, Q.; Chen, Y.; Wu, K.; Wang, L. 2020: NRF2-Driven KEAP1 Transcription in Human Lung Cancer. Molecular Cancer Research: Mcr 18(10): 1465-1476
Wang, J.; Xiao, M.; Wang, J.; Wang, S.; Zhang, J.; Guo, Y.; Tang, Y.; Gu, J. 2021: NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus. Frontiers in Endocrinology 12: 598005
Martin-Hurtado, A.; Martin-Morales, R.; Robledinos-Antón, N.; Blanco, R.; Palacios-Blanco, I.; Lastres-Becker, I.; Cuadrado, A.; Garcia-Gonzalo, F.R. 2019: NRF2-dependent gene expression promotes ciliogenesis and Hedgehog signaling. Scientific Reports 9(1): 13896
Shah, N.M.; Zaitseva, L.; Bowles, K.M.; MacEwan, D.J.; Rushworth, S.A. 2015: NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival. Cell Death and Differentiation 22(4): 654-664
Odera, J.Otieno.; Xiong, Z.; Huang, C.; Gu, N.; Yang, W.; Githang'a, J.; Odera, E.; Paiboonrungruang, C.; Chen, X. 2020: NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma. Biochemical Journal 477(16): 3075-3089
Waku, T.; Hagiwara, T.; Tamura, N.; Atsumi, Y.; Urano, Y.; Suzuki, M.; Iwami, T.; Sato, K.; Yamamoto, M.; Noguchi, N.; Kobayashi, A. 2021: NRF3 upregulates gene expression in SREBP2-dependent mevalonate pathway with cholesterol uptake and lipogenesis inhibition. Iscience 24(10): 103180
Chetvertkov, M.; Monroe, J.I.; Boparai, J.; Solberg, T.D.; Pafundi, D.H.; Ruo, R.L.; Gladstone, D.J.; Yin, F.-F.; Chetty, I.J.; Benedict, S.; Followill, D.S.; Xiao, Y.; Sohn, J.W. 2020: NRG Oncology Survey on Practice and Technology use in SRT and SBRT Delivery. Frontiers in Oncology 10: 602607
Higgins, K.A.; Hu, C.; Stinchcombe, T.E.; Jabbour, S.K.; Kozono, D.E.; Owonikoko, T.K.; Movsas, B.; Ritter, T.A.; Xiao, C.; Williams, T.M.; Welsh, J.W.; Simko, J.; Wang, X.; Mohindra, N.A.; Hsu, C.C.; Bradley, J.D. 2021: NRG Oncology/Alliance LU005: A Phase II/III Randomized Study of Chemoradiation vs. Chemoradiation Plus Atezolizumab in Limited Stage Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics 111(3s): E470-E471
Ganz, P.A.; Cecchini, R.S.; Fehrenbacher, L.; Geyer, C.E.; Rastogi, P.; Crown, J.P.; Thirlwell, M.P.; Ellison, D.M.; Boileau, J-Francois.; Flynn, P.J.; Jeong, J-Hyeon.; Mamounas, E.P.; Wolmark, N. 2021: NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab. Npj Breast Cancer 7(1): 55
Levchenko, A.; Vyalova, N.M.; Nurgaliev, T.; Pozhidaev, I.V.; Simutkin, G.G.; Bokhan, N.A.; Ivanova, S.A. 2020: NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder. Frontiers in Genetics 11: 936
Kelsey, R. 2020: NRG1 can promote antiandrogen resistance. Nature Reviews. Urology 17(9): 486
Laskin, J.; Liu, S.V.; Tolba, K.; Heining, C.; Schlenk, R.F.; Cheema, P.; Cadranel, J.; Jones, M.R.; Drilon, A.; Cseh, A.; Gyorffy, S.; Solca, F.; Duruisseaux, M. 2020: NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. Annals of Oncology: Official Journal of the European Society for Medical Oncology 31(12): 1693-1703
Howarth, K.D.; Mirza, T.; Cooke, S.L.; Chin, S.-F.; Pole, J.C.; Turro, E.; Eldridge, M.D.; Garcia, R.M.; Rueda, O.M.; Boursnell, C.; Abraham, J.E.; Caldas, C.; Edwards, P.A.W. 2021: NRG1 fusions in breast cancer. Breast Cancer Research: Bcr 23(1): 3
Liu, S.V. 2021: NRG1 fusions: Biology to therapy. Lung Cancer 158: 25-28
Prentice, L.M.; Shadeo, A.; Lestou, V.S.; Miller, M.A.; deLeeuw, R.J.; Makretsov, N.; Turbin, D.; Brown, L.A.; Macpherson, N.; Yorida, E.; Cheang, M.C.U.; Bentley, J.; Chia, S.; Nielsen, T.O.; Gilks, C.Blake.; Lam, W.; Huntsman, D.G. 2005: NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene 24(49): 7281-7289
Fledrich, R.; Akkermann, D.; Schütza, V.; Abdelaal, T.A.; Hermes, D.; Schäffner, E.; Soto-Bernardini, M.Clara.; Götze, T.; Klink, A.; Kusch, K.; Krueger, M.; Kungl, T.; Frydrychowicz, C.; Möbius, W.; Brück, W.; Mueller, W.C.; Bechmann, I.; Sereda, M.W.; Schwab, M.H.; Nave, K-Armin.; Stassart, R.M. 2019: NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nature Communications 10(1): 1467
Miyake, T.M.; Pradeep, S.; Bayraktar, E.; Stur, E.; Handley, K.F.; Wu, S.Y.; Rodriguez-Aguayo, C.; Lee, J.-S.; Lopez-Berestein, G.; Coleman, R.L.; Sood, A.K. 2020: NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors. Molecular Cancer Therapeutics 19(8): 1727-1735
Shen, Y.H.; Abe, J.-I. 2021: Nrg1β as a Proangiogenesis Therapy: how Is Nrg1β Therapy Unique from other Angiogenesis Therapies?. Arteriosclerosis Thrombosis and Vascular Biology 41(8): 2315-2317
Yang, Y.; Zhang, N.; Zhang, G.; Sauve, A.A. 2020: NRH salvage and conversion to NAD + requires NRH kinase activity by adenosine kinase. Nature Metabolism 2(4): 364-379
Kim, T.; Hempstead, B.L. 2009: NRH2 is a trafficking switch to regulate sortilin localization and permit proneurotrophin-induced cell death. EMBO Journal 28(11): 1612-1623
Suo, D.; Wang, L.; Zeng, T.; Zhang, H.; Li, L.; Liu, J.; Yun, J.; Guan, X-Yuan.; Li, Y. 2020: NRIP3 upregulation confers resistance to chemoradiotherapy in ESCC via RTF2 removal by accelerating ubiquitination and degradation of RTF2. Oncogenesis 9(8): 75
Marjani, M.; Tabarsi, P.; Moniri, A.; Hashemian, S.M.; Nadji, S.A.; Abtahian, Z.; Malekmohammad, M.; Kiani, A.; Farzanegan, B.; Eslaminejad, A.; Fakharian, A.; Heshmatnia, J.; Abedini, A.; Seifi, S.; Yassari, F.; Mirenayat, M.S.; Rezaei, M.; Sheikhzade, H.; Ahmadi, Z.H.; Dastan, F.; Sadeghi, M.; Lookzadeh, S.; Porabdollah, M.; Askari, E.; Baghaei, P.; Mansourafshar, B.; Jahangirifard, A.; Vasheghani, M.; Mokhber Dezfuli, M.; Varahram, M.; Jamaati, H.; Mansouri, D.; Zali, A.; Velayati, A.A. 2020: NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals. Tanaffos 19(2): 91-99
Ratajczak, J.; Joffraud, M.; Trammell, S.A.J.; Ras, R.; Canela, Núria.; Boutant, M.; Kulkarni, S.S.; Rodrigues, M.; Redpath, P.; Migaud, M.E.; Auwerx, J.; Yanes, O.; Brenner, C.; Cantó, C. 2016: NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications 7: 13103
Bessant, D.A.; Payne, A.M.; Plant, C.; Bird, A.C.; Swaroop, A.; Bhattacharya, S.S. 2000: NRL S50T mutation and the importance of 'founder effects' in inherited retinal dystrophies. European Journal of Human Genetics: Ejhg 8(10): 783-787
Tooley, C.E.Schaner.; Petkowski, J.J.; Muratore-Schroeder, T.L.; Balsbaugh, J.L.; Shabanowitz, J.; Sabat, M.; Minor, W.; Hunt, D.F.; Macara, I.G. 2010: NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein. Nature 466(7310): 1125-1128
Liu, S.Y.; Song, W.Q.; Xin, J.R.; Li, Z.; Lei, S.; Chen, Y.Q.; Zhao, T.Y.; Wang, H.Y.; Xu, L.W.; Zhang, M.B.; Hong, Y.; Yang, L. 2021: NRN1 and CAT Gene Polymorphisms, Complex Noise, and Lifestyles interactively Affect the Risk of Noise-induced Hearing Loss. Biomedical and Environmental Sciences: Bes 34(9): 705-718
Grun, D.; Adhikary, G.; Eckert, R.L. 2018: NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival. Oncogene 37(34): 4711-4722
Seng, S.; Avraham, H.K.; Birrane, G.; Jiang, S.; Li, H.; Katz, G.; Bass, C.E.; Zagozdzon, R.; Avraham, S. 2009: NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors. Oncogene 28(3): 378-389
Acharya, N.; Anderson, A.C. 2020: NRP1 cripples immunological memory. Nature Immunology 21(9): 972-973
Wu, Y.-N.; He, L.-H.; Bai, Z.-T.; Li, X. 2020: NRP1 is a Prognostic Factor and Promotes the Growth and Migration of Cells in Intrahepatic Cholangiocarcinoma. Cancer Management and Research 12: 7021-7032
Chen, Z.; Gao, H.; Dong, Z.; Shen, Y.; Wang, Z.; Wei, W.; Yi, J.; Wang, R.; Wu, N.; Jin, S. 2020: NRP1 regulates radiation-induced EMT via TGF-β/Smad signaling in lung adenocarcinoma cells. International Journal of Radiation Biology 96(10): 1281-1295
Dutta, S.; Roy, S.; Polavaram, N.S.; Baretton, G.B.; Muders, M.H.; Batra, S.; Datta, K. 2016: NRP2 transcriptionally regulates its downstream effector WDFY1. Scientific Reports 6: 23588
Kang, Y.; Zhang, Y.; Zhang, Y.; Sun, Y. 2021: NRP2, a potential biomarker for oral squamous cell carcinoma. American Journal of Translational Research 13(8): 8938-8951
Noubade, R.; Wong, K.; Ota, N.; Rutz, S.; Eidenschenk, C.; Valdez, P.A.; Ding, J.; Peng, I.; Sebrell, A.; Caplazi, P.; DeVoss, J.; Soriano, R.H.; Sai, T.; Lu, R.; Modrusan, Z.; Hackney, J.; Ouyang, W. 2014: NRROS negatively regulates reactive oxygen species during host defence and autoimmunity. Nature 509(7499): 235-239
Chen, Z.F.; Paquette, A.J.; Anderson, D.J. 1998: NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nature Genetics 20(2): 136-142
Nour-Eldin, H.Hassan.; Andersen, T.Grube.; Burow, M.; Madsen, S.Roesen.; Jørgensen, M.Egevang.; Olsen, C.Erik.; Dreyer, I.; Hedrich, R.; Geiger, D.; Halkier, B.Ann. 2012: NRT/PTR transporters are essential for translocation of glucosinolate defence compounds to seeds. Nature 488(7412): 531-534
Fang, X.Z.; Fang, S.Q.; Ye, Z.Q.; Liu, D.; Zhao, K.L.; Jin, C.W. 2021: NRT1.1 Dual-Affinity Nitrate Transport/Signalling and its Roles in Plant Abiotic Stress Resistance. Frontiers in Plant Science 12: 715694
Chai, S.; Li, E.; Zhang, Y.; Li, S. 2020: NRT1.1-Mediated Nitrate Suppression of Root Coiling Relies on PIN2- and AUX1-Mediated Auxin Transport. Frontiers in Plant Science 11: 671
Maghiaoui, A.; Gojon, A.; Bach, L.ên. 2020: NRT1.1-centered nitrate signaling in plants. Journal of Experimental Botany 71(20): 6226-6237
Ledray, A.P.; Mittra, K.; Green, M.T. 2021: NRVS investigation of ascorbate peroxidase compound II: Observation of Iron(IV)oxo stretching. Journal of Inorganic Biochemistry 224: 111548
Yotsumoto, T.; Maemura, K.; Watanabe, K.; Amano, Y.; Matsumoto, Y.; Zokumasu, K.; Ando, T.; Kawakami, M.; Kage, H.; Nakajima, J.; Yatomi, Y.; Nagase, T.; Takai, D. 2020: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer. Oncotarget 11(39): 3590-3600
Alliey-Rodriguez, N.; Grey, T.A.; Shafee, R.; Asif, H.; Lutz, O.; Bolo, N.R.; Padmanabhan, J.; Tandon, N.; Klinger, M.; Reis, K.; Spring, J.; Coppes, L.; Zeng, V.; Hegde, R.R.; Hoang, D.T.; Bannai, D.; Nawaz, U.; Henson, P.; Liu, S.; Gage, D.; McCarroll, S.; Bishop, J.R.; Hill, S.; Reilly, J.L.; Lencer, R.; Clementz, B.A.; Buckley, P.; Glahn, D.C.; Meda, S.A.; Narayanan, B.; Pearlson, G.; Keshavan, M.S.; Ivleva, E.I.; Tamminga, C.; Sweeney, J.A.; Curtis, D.; Badner, J.A.; Keedy, S.; Rapoport, J.; Liu, C.; Gershon, E.S. 2019: NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Translational Psychiatry 9(1): 230
Avazzadeh, S.; Quinlan, L.R.; Reilly, J.; McDonagh, K.; Jalali, A.; Wang, Y.; McInerney, V.; Krawczyk, J.; Ding, Y.; Fitzgerald, J.; O'Sullivan, M.; Forman, E.B.; Lynch, S.A.; Ennis, S.; Feerick, N.; Reilly, R.; Li, W.; Shen, X.; Yang, G.; Lu, Y.; Peeters, H.; Dockery, P.; O'Brien, T.; Shen, S.; Gallagher, L. 2021: NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons. Bmc Neuroscience 22(1): 56
Kumar, R.; Kumari, B.; Srivastava, A.; Kumar, M. 2014: NRfamPred: a proteome-scale two level method for prediction of nuclear receptor proteins and their sub-families. Scientific Reports 4: 6810
Honda, A.; Kuramoto, K.; Niwa, T.; Naito, H. 2018: NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways. Blood Cancer Journal 8(7): 62
Zhan, Y.; Pang, Z.; Du, Y.; Wang, W.; Yang, Y.; Wang, W.; Gao, G.F.; Huang, B.; Deng, Y.; Tan, W. 2020: NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 85: 104521
Pereira, S.S.; Andreata-Santos, R.; Pereira, L.R.; Soares, C.P.; Félix, A.C.; de Andrade, P.íc.d.M.J.C.; Durigon, E.L.ís.; Romano, C.M.; Ferreira, L.ís.C.d.S. 2021: NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 112: 202-204
Ji, Z.-X.; Wang, X.-Q.; Liu, X.-F. 2021: NS1: a Key Protein in the "Game" Between Influenza a Virus and Host in Innate Immunity. Frontiers in Cellular and Infection Microbiology 11: 670177
Jeker, B.; Novak, U.; Mansouri Taleghani, B.; Baerlocher, G.M.; Seipel, K.; Mueller, B.U.; Bigler, M.; Betticher, D.; Luethi, J-M.; Farese, S.; Ruefer, A.; Pabst, T. 2018: NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma. Bone Marrow Transplantation 53(2): 175-179
Lind, K.E.; Raban, M.Z.; Georgiou, A.; Westbrook, J.I. 2019: NSAID use among residents in 68 residential aged care facilities 2014 to 2017: An analysis of duration, concomitant medication use, and high-risk conditions. Pharmacoepidemiology and drug safety 28(11): 1480-1488
Brakedal, B.; Tzoulis, C.; Tysnes, O.-B.ør.; Haugarvoll, K. 2021: NSAID use is not associated with Parkinson's disease incidence: a Norwegian Prescription Database study. Plos one 16(9): E0256602
Woo, S.-D.; Luu, Q.Q.; Park, H.-S. 2020: NSAID-Exacerbated Respiratory Disease (NERD): from Pathogenesis to Improved Care. Frontiers in Pharmacology 11: 1147
Maseda, D.; Ricciotti, E. 2020: NSAID-Gut Microbiota Interactions. Frontiers in Pharmacology 11: 1153
Kamboj, A.K.; Moreira, R.K.; Sweetser, S. 2021: NSAID-Induced Colopathy. Mayo Clinic Proceedings 96(10): 2724-2725
Paton, D.J.W.; Kumarasinghe, M.P. 2020: NSAID-associated submucosal fibrous nodules of the small intestine revisited. Pathology 52(6): 717-719
Zimmer, V.; Emrich, K. 2021: NSAID-induced colonic diaphragm disease. Clinics and Research in Hepatology and Gastroenterology 45(6): 101728
Gupta, H.O.; Mele, T.; Giannoudis, P.V.; Buckley, R. 2020: NSAIDs - Harmful or helpful for fracture healing in orthopedic trauma patients?. Injury 51(8): 1696-1697
Schmidt, J.; Klingler, F-Maria.; Proschak, E.; Steinhilber, D.; Schubert-Zsilavecz, M.; Merk, D. 2015: NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X Receptor. Scientific Reports 5: 14782
Zhao, X.; Xu, Z.; Li, H. 2017: NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis. Scientific Reports 7(1): 1875
Bell, S.; Marwick, C.A. 2014: NSAIDs and cardiovascular risk. Kidney International 85(1): 211
Doomra, R.; Goyal, A. 2020: NSAIDs and self-medication: a serious concern. Journal of Family Medicine and Primary Care 9(5): 2183-2185
García Rodríguez, L.A.; González-Pérez, A. 2007: NSAIDs and the risk of acute myocardial infarction. Nature Clinical Practice. Rheumatology 3(4): 202-203
Herrero-Villar, M.; Velarde, R.; Camarero, P.R.; Taggart, M.A.; Bandeira, V.; Fonseca, C.; Marco, I.; Mateo, R. 2020: NSAIDs detected in Iberian avian scavengers and carrion after diclofenac registration for veterinary use in Spain. Environmental Pollution 266(Part 2): 115157
Chamoun-Emanuelli, A.M.; Bryan, L.K.; Cohen, N.D.; Tetrault, T.L.; Szule, J.A.; Barhoumi, R.; Whitfield-Cargile, C.M. 2019: NSAIDs disrupt intestinal homeostasis by suppressing macroautophagy in intestinal epithelial cells. Scientific Reports 9(1): 14534
Herzberg, D.L.; Sukumaran, H.P.; Viscusi, E. 2020: NSAIDs for analgesia in the era of COVID-19. Regional Anesthesia and Pain Medicine 45(9): 677-678
Potter, J.; Sari, Z.; Lindblad, A.J. 2021: NSAIDs for heavy menstrual bleeding. Canadian Family Physician Medecin de Famille Canadien 67(8): 598
Baker, M.; Perazella, M.A. 2020: NSAIDs in CKD: Are they Safe?. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 76(4): 546-557
Dormond, O.; Foletti, A.; Paroz, C.; Rüegg, C. 2001: NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nature Medicine 7(9): 1041-1047
Yoshinaga, N.; Arimura, N.; Otsuka, H.; Kawahara, K-Ichi.; Hashiguchi, T.; Maruyama, I.; Sakamoto, T. 2011: NSAIDs inhibit neovascularization of choroid through HO-1-dependent pathway. Laboratory Investigation; a Journal of Technical Methods and Pathology 91(9): 1277-1290
Vane, J.R. 1995: NSAIDs, Cox-2 inhibitors, and the gut. Lancet 346(8982): 1105-1106
Brandolini, L.; Antonosante, A.; Giorgio, C.; Bagnasco, M.; d'Angelo, M.; Castelli, V.; Benedetti, E.; Cimini, A.; Allegretti, M. 2020: NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes. Scientific Reports 10(1): 18337
Doña, I.; Barrionuevo, E.; Salas, Mía.; Laguna, Jé.Julio.; Agúndez, Jé.; García-Martín, E.; Bogas, Gádor.; Perkins, J.Richard.; Cornejo-García, Jé.Antonio.; Torres, Mía.José. 2018: NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs. Scientific Reports 8(1): 16710
Shi, Y.; Ma, I.T.; Patel, R.H.; Shang, X.; Chen, Z.; Zhao, Y.; Cheng, J.; Fan, Y.; Rojas, Y.; Barbieri, E.; Chen, Z.; Yu, Y.; Jin, J.; Kim, E.S.; Shohet, J.M.; Vasudevan, S.A.; Yang, J. 2015: NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis. Cell Death and Disease 6: E1841
Šašinková, Méta.; Heřman, P.; Holoubek, Aš.; Strachotová, D.; Otevřelová, P.; Grebeňová, D.; Kuželová, Křina.; Brodská, B. 2021: NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization. Scientific Reports 11(1): 1084
Qi, W.; Shakalya, K.; Stejskal, A.; Goldman, A.; Beeck, S.; Cooke, L.; Mahadevan, D. 2008: NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene 27(30): 4210-4220
Krüger, M.; Ruschke, K.; Braun, T. 2004: NSCL-1 and NSCL-2 synergistically determine the fate of GnRH-1 neurons and control necdin gene expression. EMBO Journal 23(21): 4353-4364
Tao, Z.; Bingqiang, H.; Huiling, L.; Zaoli, Y.; Hongbin, S. 2020: NSCR-Based DenseNet for Lung Tumor Recognition Using Chest CT Image. Biomed Research International 2020: 6636321
Zhang, L.; Fan, C.; Hao, W.; Zhuang, Y.; Liu, X.; Zhao, Y.; Chen, B.; Xiao, Z.; Chen, Y.; Dai, J. 2021: NSCs Migration Promoted and Drug Delivered Exosomes-Collagen Scaffold via a Bio-Specific Peptide for One-Step Spinal Cord Injury Repair. Advanced Healthcare Materials 10(8): E2001896
Abraham, J-Andrea.; Blaschke, S.; Tarazi, S.; Dreissen, G.; Vay, S.U.; Schroeter, M.; Fink, G.R.; Merkel, R.; Rueger, M.A.; Hoffmann, B. 2021: NSCs Under Strain-Unraveling the Mechanoprotective Role of Differentiating Astrocytes in a Cyclically Stretched Coculture With Differentiating Neurons. Frontiers in Cellular Neuroscience 15: 706585
Cornejo, Y.; Li, M.; Dellinger, T.H.; Mooney, R.; Rahman, M.M.; McFadden, G.; Aboody, K.S.; Hammad, M. 2020: NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy. Oncotarget 11(51): 4693-4698
Pluchino, S.; Nicaise, A.M. 2021: NSCs: Sentinel Cells of the Brain. Cell Stem Cell 28(2): 177-179
Sun, J.; Xu, Z.; Liang, S. 2021: NSD-SSD: a Novel Real-Time Ship Detector Based on Convolutional Neural Network in Surveillance Video. Computational Intelligence and Neuroscience 2021: 7018035
Tauchmann, S.; Almosailleakh, M.; Schwaller, J. 2020: NSD1 in erythroid differentiation and leukemogenesis. Molecular and Cellular Oncology 7(6): 1809919
Brennan, K.; Shin, J.Ho.; Tay, J.K.; Prunello, M.; Gentles, A.J.; Sunwoo, J.B.; Gevaert, O. 2017: NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma. Scientific Reports 7(1): 17064
Choufani, S.; Cytrynbaum, C.; Chung, B.H.Y.; Turinsky, A.L.; Grafodatskaya, D.; Chen, Y.A.; Cohen, A.S.A.; Dupuis, L.; Butcher, D.T.; Siu, M.T.; Luk, H.M.; Lo, I.F.M.; Lam, S.T.S.; Caluseriu, O.; Stavropoulos, D.J.; Reardon, W.; Mendoza-Londono, R.; Brudno, M.; Gibson, W.T.; Chitayat, D.; Weksberg, R. 2015: NSD1 mutations generate a genome-wide DNA methylation signature. Nature Communications 6: 10207
Peri, S.; Izumchenko, E.; Schubert, A.D.; Slifker, M.J.; Ruth, K.; Serebriiskii, I.G.; Guo, T.; Burtness, B.A.; Mehra, R.; Ross, E.A.; Sidransky, D.; Golemis, E.A. 2017: NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis. Nature Communications 8(1): 1772
Shirane, K.; Miura, F.; Ito, T.; Lorincz, M.C. 2020: NSD1-deposited H3K36me2 directs de novo methylation in the mouse male germline and counteracts Polycomb-associated silencing. Nature Genetics 52(10): 1088-1098
Aytes, A.; Giacobbe, A.; Mitrofanova, A.; Ruggero, K.; Cyrta, J.; Arriaga, J.; Palomero, L.; Farran-Matas, S.; Rubin, M.A.; Shen, M.M.; Califano, A.; Abate-Shen, C. 2018: NSD2 is a conserved driver of metastatic prostate cancer progression. Nature Communications 9(1): 5201
Lhoumaud, P.; Badri, S.; Rodriguez-Hernaez, J.; Sakellaropoulos, T.; Sethia, G.; Kloetgen, A.; Cornwell, M.; Bhattacharyya, S.; Ay, F.; Bonneau, R.; Tsirigos, A.; Skok, J.A. 2019: NSD2 overexpression drives clustered chromatin and transcriptional changes in a subset of insulated domains. Nature Communications 10(1): 4843
Dalton, R. 2000: NSF aims to inject more maths into biology. Nature 407(6803): 435
Smaglik, P. 2000: NSF calls for funding boost in a bid to reverse decline in maths. Nature 407(6807): 931
Macilwain 2000: NSF celebrates half a century with big plans. Nature 405(6782): 8
Mervis, J. 1993: NSF does well, NIH does not in Clinton's 1994 budget. Nature 362(6419): 382-383
Viglione, G. 2020: NSF grant changes raise alarm about commitment to basic research. Nature 584(7820): 177-178
Schwarz, T.L. 1999: NSF is up to new tricks. Nature Cell Biology 1(6): E141-E143
Macilwain, C. 2000: NSF puts big money into complex ecology. Nature 407(6806): 823
Anderson, C. 1992: NSF unmoved by politics of relocation. Nature 358(6388): 612
Macilwain, C. 1997: NSF urged to increase plant genome sequencing effort. Nature 388(6640): 312
Reichhardt, T. 2003: NSF urged to take multidisciplinary tack on environment. Nature 421(6919): 102
Mervis, J. 1992: NSF will experiment with fixed budgets in an effort to simplify grants process. Nature 359(6391): 94-95
Macilwain, C. 1994: NSF wins approval for 'new' research strategy. Nature 368(6469): 280
Scopim-Ribeiro, R.; Lizardo, M.M.; Zhang, H.-F.; Dhez, A.-C.é; Hughes, C.S.; Sorensen, P.H. 2021: NSG Mice Facilitate ex vivo Characterization of Ewing Sarcoma Lung Metastasis Using the PuMA Model. Frontiers in Oncology 11: 645757
Maletzki, C.; Bock, S.; Fruh, P.; Macius, K.; Witt, A.; Prall, F.; Linnebacher, M. 2020: NSG mice as hosts for oncological precision medicine. Laboratory Investigation; a Journal of Technical Methods and Pathology 100(1): 27-37
Johe, K.K.; Kay, G.; Kumar, S.; Burdick, K.E.; McIntyre, R.S.; Papakostas, G.I.; Fava, M. 2020: NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: a post-hoc analysis of a phase 2 study of major depressive disorder. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 32(3): 182-196
Popova, V.V.; Workman, J.L. 2019: NSL complex acetylates Lamin A/C. Nature Cell Biology 21(10): 1177-1178
Singh, J.; Singh, A.K. 2021: NSLPCD: Topic based tweets clustering using Node significance based label propagation community detection algorithm. Annals of Mathematics and Artificial Intelligence 89(3-4): 371-407
Morgan, M.D. 1998: NSNA in the 1960's. Imprint 45(1): 53-54
Nayer, D. 1987: NSNA: how it grew. Imprint 34(6): 80-86
Mace, P.D.; Wallez, Y.; Dobaczewska, Młgorzata.K.; Lee, J.J.; Robinson, H.; Pasquale, E.B.; Riedl, S.J. 2011: NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling. Nature Structural and Molecular Biology 18(12): 1381-1387
Du, L.; Wang, H.; Liu, F.; Wei, Z.; Weng, C.; Tang, J.; Feng, W.-H. 2021: NSP2 Is Important for Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus to Trigger High Fever-Related COX-2-PGE2 Pathway in Pigs. Frontiers in Immunology 12: 657071
Rossini, L.; Hoffman, E.M.; Laurenzi, A.; Tsagarakis, N.G. 2021: NSPG: An Efficient Posture Generator Based on Null-Space Alteration and Kinetostatics Constraints. Frontiers in Robotics and Ai 8: 715325
Hu, P-S.; Xia, Q-S.; Wu, F.; Li, D-K.; Qi, Y-J.; Hu, Y.; Wei, Z-Z.; Li, S-S.; Tian, N-Y.; Wei, Q-F.; Shen, L-J.; Yin, B.; Jiang, T.; Yuan, J-G.; Qiang, B-Q.; Han, W.; Peng, X-Z. 2017: NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma. Oncogene 36(33): 4706-4718
Atwood, R.; Blair, S.; Fisk, M.; Bradley, M.; Coleman, C.; Rodriguez, C. 2021: NSQIP Based Predictors of False Negative and Indeterminate Ultrasounds in Adults with Appendicitis. Journal of Surgical Research 261: 326-333
Rocha, B.; Aguiar, C. 2021: NSTE-ACS at the Emergency: can you Guess what is Under the Umbrella?. Arquivos Brasileiros de Cardiologia 117(2): 288-289
Gill, G.S.; Kanmanthareddy, A. 2021: NSTEMi Versus STEMi and Cardiogenic Shock: Are Multivessel Interventions Better in one and not the Other?. JACC. Cardiovascular Interventions 14(16): 1850-1851
Hu, Y.; Chen, C.; Tong, X.; Chen, S.; Hu, X.; Pan, B.; Sun, X.; Chen, Z.; Shi, X.; Hu, Y.; Shen, X.; Xue, X.; Lu, M. 2021: NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death and Disease 12(9): 842
Nakano, S.; Suzuki, T.; Kawarada, L.; Iwata, H.; Asano, K.; Suzuki, T. 2016: NSUN3 methylase initiates 5-formylcytidine biogenesis in human mitochondrial tRNA(Met). Nature Chemical Biology 12(7): 546-551
Sun, B.; Zeng, H.; Liang, J.; Zhang, L.; Hu, H.; Wang, Q.; Meng, W.; Li, C.; Ye, F.; Wang, C.; Zhu, J. 2020: NSUN5 Facilitates Viral RNA Recognition by RIG-i Receptor. Journal of Immunology 205(12): 3408-3418
Tsitsikas, Y.; Papalexakis, E.E. 2020: NSVD: Normalized Singular Value Deviation Reveals Number of Latent Factors in Tensor Decomposition. Big Data 8(5): 412-430
Léger, P.; Nachman, E.; Richter, K.; Tamietti, C.; Koch, J.; Burk, R.; Kummer, S.; Xin, Q.; Stanifer, M.; Bouloy, Mèle.; Boulant, S.; Kräusslich, H-Georg.; Montagutelli, X.; Flamand, M.; Nussbaum-Krammer, C.; Lozach, P-Yves. 2020: NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice. Nature Communications 11(1): 3281
Du, J.; Song, X.-Y.; Shi, X.-B.; Tang, X.; Chen, J.-B.; Zhang, Z.-H.; Chen, G.; Zhang, Z.; Zhou, X.-G.; Liu, Y.; Zhang, D.-Y. 2020: NSs, the Silencing Suppressor of Tomato Spotted Wilt Orthotospovirus, Interferes with JA-Regulated Host Terpenoids Expression to Attract Frankliniella occidentalis. Frontiers in Microbiology 11: 590451
Xu, X.; Zhang, Y.; Zhang, J.; Zhang, X. 2020: NSun2 promotes cell migration through methylating autotaxin mRNA. Journal of Biological Chemistry 295(52): 18134-18147
Miao, Y.; Zhao, Y.; Han, L.; Ma, X.; Deng, J.; Yang, J.; Lü, S.; Shao, F.; Kong, W.; Wang, W.; Xu, Q.; Wang, X.; Feng, J. 2021: NSun2 regulates aneurysm formation by promoting autotaxin expression and T cell recruitment. Cellular and Molecular Life Sciences: Cmls 78(4): 1709-1727
Zhang, S.; Sun, S.; He, J.; Shen, L. 2020: NT-3 promotes osteogenic differentiation of mouse bone marrow mesenchymal stem cells by regulating the Akt pathway. Journal of Musculoskeletal and Neuronal Interactions 20(4): 591-599
Wang, T.; Zhang, J.; Li, P.; Ding, Y.; Tang, J.; Chen, G.; Zhang, J.H. 2020: NT-4 attenuates neuroinflammation via TrkB/PI3K/FoxO1 pathway after germinal matrix hemorrhage in neonatal rats. Journal of Neuroinflammation 17(1): 158
Riddle, D.R.; Lo, D.C.; Katz, L.C. 1995: NT-4-mediated rescue of lateral geniculate neurons from effects of monocular deprivation. Nature 378(6553): 189-191
Kim, J.; Moon, J.; Park, C-Hong.; Lee, J.; Cheng, H.; Floyd, Z.Elizabeth.; Chang, J.Suk. 2021: NT-PGC-1α deficiency attenuates high-fat diet-induced obesity by modulating food intake, fecal fat excretion and intestinal fat absorption. Scientific Reports 11(1): 1323
Rubio-Zapata, H.A.; Rembao-Bojorquez, J.D.; Arango-Rodriguez, M.L.; Dupouy, S.; Forgez, P.; Martinez-Fong, D. 2009: NT-polyplex: a new tool for therapeutic gene delivery to neuroblastoma tumors. Cancer Gene Therapy 16(7): 573-584
Ulusoy, B.ül.; Tunçez, A.; Gül, O.; Tezcan, H.üs.; Erdur, Öm.; Vatansev, H.üs.; Hataysal, E.P.ş; Körez, M.K.ım.; Çolpan, B. 2020: NT-pro BNP as a new marker in the investigation of nasal septum deviation impacts on cardiopulmonary functions. American Journal of Otolaryngology 41(6): 102671
Büttner, P.; Seewöster, T.; Obradovic, D.; Hindricks, G.; Thiele, H.; Kornej, J. 2022: NT-proANP levels in peripheral and cardiac circulation. Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing 63(2): 409-415
Yang, W.-L.; Hawley, C.; Cho, Y.; Johnson, D.W.; Pascoe, E.M.; Fahim, M. 2020: NT-proBNP Concentration and Early Cardiac Dysfunction in Patients Receiving Dialysis: a Prospective Cohort Study. Cardiorenal Medicine 10(5): 323-332
Cunningham, J.W.; Myhre, P.L. 2021: NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate. Journal of the American College of Cardiology 78(13): 1333-1336
Pascual-Figal, D.; Wachter, R.; Senni, M.; Bao, W.; Noè, A.; Schwende, H.; Butylin, D.; Prescott, M.F.; Gniot, J.; Mozheiko, M.; Lelonek, M.; Dominguez, A.R.; Horacek, T.; Garcia Del Rio, E.; Kobalava, Z.; Mueller, C.E.; Cavusoglu, Y.; Straburzynska-Migaj, E.; Slanina, M.; Vom Dahl, J.; Senni, M.; Ryding, A.; Moriarty, A.; Robles, M.B.; Villota, J.N.; Quintana, A.G.; Nitschke, T.; Garcia Pinilla, J.M.; Bonet, L.A.; Chaaban, S.; Filali Zaatari, S.; Spinar, J.; Musial, W.; Abdelbaki, K.; Belohlavek, J.; Fehske, W.; Bott, M.C.; Hoegalmen, G.; Leiro, M.C.; Ozcan, I.T.; Mullens, W.; Kryza, R.; Al-Ani, R.; Loboz-Grudzien, K.; Ermoshkina, L.; Hojerova, S.; Fernandez, A.A.; Spinarova, L.; Lapp, H.; Bulut, E.; Almeida, F.; Vishnevsky, A.; Belicova, 2020: NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients with Reduced Ejection Fraction: TRANSITION Study. JACC. Heart Failure 8(10): 822-833
Blancas, I.; Martín-Pérez, F.J.; Garrido, J.é M.; Rodríguez-Serrano, F. 2020: NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patients. Breast 54: 106-113
Tanaka, A.; Node, K. 2020: NT-proBNP in Heart Failure with Preserved Ejection Fraction: Quest for a Marker Reflecting the Truth. JACC. Heart Failure 8(7): 596-597
Şimşek, M.A.; Değertekin, M.; Türer Cabbar, A.ça.; Hünük, B.; Aktürk, S.; Erdoğmuş, S.; Mutlu, B.ül.; Kozan, Öm. 2020: NT-proBNP level in stage 3-4 chronic kidney disease and mortality in long-term follow-up: HAPPY study subgroup analysis. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir 48(5): 454-460
Roubinian, N.H.; Chowdhury, D.; Hendrickson, J.E.; Triulzi, D.J.; Gottschall, J.L.; Looney, M.R.; Matthay, M.A.; Kor, D.J.; Brambilla, D.; Kleinman, S.H.; Murphy, E.L. 2020: NT-proBNP levels in the identification and classification of pulmonary transfusion reactions. Transfusion 60(11): 2548-2556
Cavender, M.A.; Scirica, B.M. 2020: NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?. Diabetes Care 43(12): 2904-2905
Yu, S.; Wang, Y.; Lv, K.; Hou, J.; Li, W.; Wang, X.; Guo, H.; Wang, W. 2021: NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway. Technology in Cancer Research and Treatment 20: 15330338211027916
Fenerich, B.Alves.; Fernandes, J.Cristina.; Rodrigues Alves, A.Paula.Nunes.; Coelho-Silva, J.Luiz.; Scopim-Ribeiro, R.; Scheucher, P.Santos.; Eide, C.A.; Tognon, C.E.; Druker, B.J.; Rego, E.Magalhães.; Machado-Neto, Jão.Agostinho.; Traina, F. 2020: NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2 V617F -positive myeloproliferative neoplasm cells. Signal Transduction and Targeted Therapy 5: 5
Fenerich, B.Alves.; Fernandes, J.Cristina.; Rodrigues Alves, A.Paula.Nunes.; Coelho-Silva, J.Luiz.; Scopim-Ribeiro, R.; Scheucher, P.Santos.; Eide, C.A.; Tognon, C.E.; Druker, B.J.; Rego, E.Magalhães.; Machado-Neto, Jão.Agostinho.; Traina, F. 2020: NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2 V617F -positive myeloproliferative neoplasm cells. Signal Transduction and Targeted Therapy 5(1): 5
Bové, M.ía.; Monto, F.; Guillem-Llobat, P.; Ivorra, M.D.; Noguera, M.A.; Zambrano, A.; Sirerol-Piquer, M.S.; Requena, A.C.; García-Alonso, M.; Tejerina, T.; Real, J.é T.; Fariñas, I.; D'Ocon, P. 2021: NT3/TrkC Pathway Modulates the Expression of UCP-1 and Adipocyte Size in Human and Rodent Adipose Tissue. Frontiers in Endocrinology 12: 630097
Chen, X.; Zhang, Z.; Wang, X.; Chen, Y.; Wang, C. 2020: NT5C2 Gene Polymorphisms and the Risk of Coronary Heart Disease. Public Health Genomics 23(3-4): 90-99
Tulstrup, M.; Grosjean, M.; Nielsen, S.Nygaard.; Grell, K.; Wolthers, B.Ole.; Wegener, P.Skov.; Jonsson, O.Gisli.; Lund, B.; Harila-Saari, A.; Abrahamsson, J.; Vaitkeviciene, G.; Pruunsild, K.; Toft, N.; Holm, M.; Hulegårdh, E.; Liestøl, S.; Griskevicius, L.; Punab, M.; Wang, J.; Carroll, W.L.; Zhang, Z.; Dalgaard, M.D.; Gupta, R.; Nersting, J.; Schmiegelow, K. 2018: NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia. Leukemia 32(12): 2527-2535
Chen, Y-Tay.; Lin, W-De.; Liao, W-Ling.; Tsai, Y-Ching.; Liao, J-Wang.; Tsai, F-Jen. 2020: NT5C2 methylation regulatory interplay between DNMT1 and insulin receptor in type 2 diabetes. Scientific Reports 10(1): 16087
Nakashima, A.; Yamaguchi, H.; Kondo, M.; Furumura, T.; Kodani, Y.; Kaneko, Y.S.; Kawata, M.; Nagasaki, H.; Nagatsu, T.; Ota, A. 2020: NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity. Journal of Neural Transmission 127(12): 1631-1640
Chen, J.; Cao, J.; Wang, P.; He, X. 2020: NT5DC2 is a novel prognostic marker in human hepatocellular carcinoma. Oncology Letters 20(4): 70
Zhu, Z.; Hou, Q.; Guo, H. 2020: NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: a mechanism involving VEGF signaling. Experimental Cell Research 397(1): 112311
Li, K-Shuai.; Zhu, X-Dong.; Liu, H-Da.; Zhang, S-Zhe.; Li, X-Long.; Xiao, N.; Liu, X-Feng.; Xu, B.; Lei, M.; Zhang, Y-Yuan.; Shi, W-Kai.; Cao, M-Qing.; Xu, Y-Fei.; Tang, Z-You.; Sun, H-Chuan. 2020: NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma. Cell Death and Disease 11(5): 335
Jin, X.; Liu, X.; Zhang, Z.; Xu, L. 2020: NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling. Biochemical and Biophysical Research Communications 533(3): 354-361
Wang, H.; Lee, S.; Nigro, C.Lo.; Lattanzio, L.; Merlano, M.; Monteverde, M.; Matin, R.; Purdie, K.; Mladkova, N.; Bergamaschi, D.; Harwood, C.; Syed, N.; Szlosarek, P.; Briasoulis, E.; McHugh, A.; Thompson, A.; Evans, A.; Leigh, I.; Fleming, C.; Inman, G.J.; Hatzimichael, E.; Proby, C.; Crook, T. 2012: NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity. British Journal of Cancer 106(8): 1446-1452
Lo Nigro, C.; Monteverde, M.; Lee, S.; Lattanzio, L.; Vivenza, D.; Comino, A.; Syed, N.; McHugh, A.; Wang, H.; Proby, C.; Garrone, O.; Merlano, M.; Hatzimichael, E.; Briasoulis, E.; Gojis, O.; Palmieri, C.; Jordan, L.; Quinlan, P.; Thompson, A.; Crook, T. 2012: NT5E CpG island methylation is a favourable breast cancer biomarker. British Journal of Cancer 107(1): 75-83
Azuma, N.; Uchida, T.; Kikuchi, S.; Sadahiro, M.; Shintani, T.; Yanagi, K.; Higashita, R.; Yamashita, A.; Makita, Y.; Kaname, T. 2020: NT5E Genetic Mutation Is a Rare but Important Cause of Intermittent Claudication and Chronic Limb-Threatening Ischemia. Circulation Journal: Official Journal of the Japanese Circulation Society 84(7): 1183-1188
Zylka, M.J.; Sowa, N.A. 2011: NT5E mutations and arterial calcifications. New England Journal of Medicine 364(16): 1579; Author Reply 1579-1580
Hofbauer, L.C.; Hamann, C.; Schoppet, M. 2011: NT5E mutations and arterial calcifications. New England Journal of Medicine 364(16): 1578; Author Reply 1579-1580
Eltzschig, H.K.; Robson, S.C. 2011: NT5E mutations and arterial calcifications. New England Journal of Medicine 364(16): 1577-1578; Author Reply 1579-1580
Thomé, C.Hassibe.; Ferreira, G.Aguiar.; Pereira-Martins, D.Antonio.; Dos Santos, G.Augusto.; Ortiz, César.Alexander.; de Souza, L.Eduardo.Botelho.; Sobral, L.Martins.; Silva, C.Lúcia.Araújo.; Scheucher, P.Santos.; Gil, C.Damas.; Leopoldino, Aéia.Machado.; Silveira, D.R.A.; Coelho-Silva, J.L.; Traina, Fíola.; Koury, L.C.; Melo, R.A.M.; Bittencourt, R.; Pagnano, K.; Pasquini, R.; Nunes, E.C.; Fagundes, E.M.; Gloria, A.Beatriz.F.; Kerbauy, Fábio.Rodrigues.; Chauffaille, M.de.Lourdes.; Keating, A.; Tallman, M.S.; Ribeiro, R.C.; Dillon, R.; Ganser, A.; Löwenberg, B.; Valk, P.; Lo-Coco, F.; Sanz, 2020: NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports 10(1): 10315
Stieb, S.; Lee, A.; van Dijk, L.V.; Frank, S.; Fuller, C.D.; Blanchard, P. 2021: NTCP Modeling of Late Effects for Head and Neck Cancer: a Systematic Review. International Journal of Particle Therapy 8(1): 95-107
Schroeder, C.; Köthe, A.; De Angelis, C.; Basler, L.; Leiser, D.; Lomax, A.; Weber, D.C. 2021: NTCP Modelling for High Grade Temporal Radio-Necrosis in a Large Cohort of Patients Receiving PBS Proton Therapy for Skull Base and Head and Neck Tumors. International Journal of Radiation Oncology Biology Physics 111(3s): E586-E587
Nyarko, E.; Obirikorang, C.; Owiredu, W.K.B.A.; Adu, E.A.; Acheampong, E.; Aidoo, F.; Ofori, E.; Addy, B.S.; Asare-Anane, H. 2020: NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population. Virology Journal 17(1): 91
Huang, H.; Roberson, J.; Hou, W.; Mani, K.; Valentine, E.; Ryu, S.; Stessin, A. 2021: NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 154: 87-92
Mavroidis, P.; Pearlstein, K.A.; Moon, D.H.; Xu, V.; Royce, T.J.; Weiner, A.A.; Shen, C.J.; Marks, L.B.; Chera, B.S.; Das, S.K.; Wang, K. 2021: NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation. Radiation Oncology 16(1): 56
Fukano, K.; Oshima, M.; Tsukuda, S.; Aizaki, H.; Ohki, M.; Park, S.-Y.; Wakita, T.; Wakae, K.; Watashi, K.; Muramatsu, M. 2021: NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization. Journal of Virology 95(24): E0093821
Sabouri, P.; Yam, M.; Yu, J.; Khan, F.; Gutierrez, A.; Kaiser, A.; Chuong, M.D. 2021: NTCP-Driven Comparison of Proton Versus VMAT Approaches for Reducing Hematologic and Gastrointestinal Toxicities in Anal Cancer Patients Receiving Definitive Chemoradiation. International Journal of Radiation Oncology Biology Physics 111(3s): E527-E528
Hotez, P.J. 2020: NTDs in the 2020s: An epic struggle of effective control tools versus the Anthropocene. Plos Neglected Tropical Diseases 14(9): E0007872
Fazal, O.; Hotez, P.J. 2020: NTDs in the age of urbanization, climate change, and conflict: Karachi, Pakistan as a case study. Plos Neglected Tropical Diseases 14(11): E0008791
Adepoju, P. 2020: NTDs in the time of COVID-19. LANCET. Microbe 1(6): E244
Jin, J.; Wang, L.; Liu, X.; Long, Z.; Zhou, Y.; Huang, H.; Wang, Y. 2021: NTF4 stimulates the progression of gastric cancer via regulating FOXL1. Journal of Buon: Official Journal of the Balkan Union of Oncology 26(2): 499-505
Matta, A.; Karim, M.Zia.; Gerami, H.; Jun, P.; Funabashi, M.; Kawchuk, G.; Goldstein, A.; Foltz, W.; Sussman, M.; Eek, B.C.; Erwin, W.Mark. 2018: NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease. Scientific Reports 8(1): 16809
Das, L.; Quintana, V.G.; Sweasy, J.B. 2020: NTHL1 in genomic integrity, aging and cancer. Dna Repair 93: 102920
Fang, S.; Luo, Y.; Zhang, Y.; Wang, H.; Liu, Q.; Li, X.; Yu, T. 2021: NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway. Frontiers in Cell and Developmental Biology 9: 652325
Skulberg, A.K.; Tylleskär, I.; Braarud, A.-C.; Dale, J.; Heyerdahl, F.; Mellesmo, S.; Valberg, M.; Dale, O. 2020: NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use. Bmj Open 10(11): E041556
Hou, L-Yu.; Ehrlich, M.; Thormählen, I.; Lehmann, M.; Krahnert, I.; Obata, T.; Cejudo, F.J.; Fernie, A.R.; Geigenberger, P. 2019: NTRC Plays a Crucial Role in Starch Metabolism, Redox Balance, and Tomato Fruit Growth1  [OPEN. Plant Physiology 181(3): 976-992
Annunziata, M.Grazia. 2019: NTRC: A Key Regulatory Hub in Carbon Metabolism and Redox Balance in Developing Tomato Fruits. Plant Physiology 181(3): 851-852
Wang, Y.; Long, P.; Wang, Y.; Ma, W. 2020: NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma. Frontiers in Oncology 10: 593578
Leal, J.L.; Peters, G.; Szaumkessel, M.; Leong, T.; Asadi, K.; Rivalland, G.; Do, H.; Senko, C.; Mitchell, P.L.; Quing, C.Z.; Dobrovic, A.; Thapa, B.; John, T. 2020: NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer. Lung Cancer 146: 154-159
Solomon, J.P.; Linkov, I.; Rosado, A.; Mullaney, K.; Rosen, E.Y.; Frosina, D.; Jungbluth, A.A.; Zehir, A.; Benayed, R.; Drilon, A.; Hyman, D.M.; Ladanyi, M.; Sireci, A.N.; Hechtman, J.F. 2020: NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 33(1): 38-46
Yue, J.Q.; Cai, L.; Li, J.L.; Guan, W.B.; Wang, R.F.; Yu, W.W.; Wang, L.F. 2020: NTRK fusion gene expression in solid tumors and research progress of Trk small molecule inhibitors. Zhonghua Bing Li Xue Za Zhi 49(9): 972-976
Yamashiro, Y.; Kurihara, T.; Hayashi, T.; Suehara, Y.; Yao, T.; Kato, S.; Saito, T. 2021: NTRK fusion in Japanese colorectal adenocarcinomas. Scientific Reports 11(1): 5635
Cocco, E.; Scaltriti, M.; Drilon, A. 2018: NTRK fusion-positive cancers and TRK inhibitor therapy. Nature Reviews. Clinical Oncology 15(12): 731-747
Harada, G.; Santini, F.C.; Wilhelm, C.; Drilon, A. 2021: NTRK fusions in lung cancer: from biology to therapy. Lung Cancer 161: 108-113
Chou, A.; Fraser, T.; Ahadi, M.; Fuchs, T.; Sioson, L.; Clarkson, A.; Sheen, A.; Singh, N.; Corless, C.L.; Gill, A.J. 2020: NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 33(5): 924-932
Hechtman, J.F. 2021: NTRK insights: best practices for pathologists. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 2021
Somwar, R.; Hofmann, N.E.; Smith, B.; Odintsov, I.; Vojnic, M.; Linkov, I.; Tam, A.; Khodos, I.; Mattar, M.S.; de Stanchina, E.; Flynn, D.; Ladanyi, M.; Drilon, A.; Shinde, U.; Davare, M.A. 2020: NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors. Communications Biology 3(1): 776
Yang, X.; Shen, H.; Buckley, B.; Chen, Y.; Yang, N.; Mussell, A.L.; Chernov, M.; Kobzik, L.; Frangou, C.; Han, S-Xia.; Zhang, J. 2019: NTRK1 is a positive regulator of YAP oncogenic function. Oncogene 38(15): 2778-2787
Britton, H.M.; Levine, A.B.; Shen, Y.; Mungall, K.; Serrano, J.; Snuderl, M.; Pleasance, E.; Jones, S.J.M.; Laskin, J.; Marra, M.A.; Rassekh, S.R.; Deyell, R.; Yip, S.; Cheng, S.; Dunham, C. 2021: NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling. Clinical Case Reports 9(3): 1472-1477
Yuzugullu, H.; Von, T.; Thorpe, L.M.; Walker, S.R.; Roberts, T.M.; Frank, D.A.; Zhao, J.J. 2016: NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K-AKT and JAK-STAT3 pathways. Cell Discovery 2: 16030
Vukojevic, V.; Coynel, D.; Ghaffari, N.R.; Freytag, V.; Elbert, T.; Kolassa, I.-T.; Wilker, S.; McGaugh, J.L.; Papassotiropoulos, A.; de Quervain, D.J.-F. 2020: NTRK2 methylation is related to reduced PTSD risk in two African cohorts of trauma survivors. Proceedings of the National Academy of Sciences of the United States of America 117(35): 21667-21672
Kao, Y-Chien.; Sung, Y-Shao.; Argani, P.; Swanson, D.; Alaggio, R.; Tap, W.; Wexler, L.; Dickson, B.C.; Antonescu, C.R. 2020: NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 33(7): 1341-1349
Cheng, W.; Ndoka, E.; Maung, J.N.; Pan, W.; Rupp, A.C.; Rhodes, C.J.; Olson, D.P.; Myers, M.G. 2021: NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity. Nature Communications 12(1): 5175
Carlson, D.A.; Kou, W.; Masihi, M.; Acharya, S.; Baumann, A.J.; Donnan, E.N.; Kahrilas, P.J.; Pandolfino, J.E. 2020: Repetitive Antegrade Contractions: A novel response to sustained esophageal distension is modulated by cholinergic influence. American Journal of Physiology. Gastrointestinal and Liver Physiology 26(11): 1086-1087
Wald, H.S.; Chandra, A.; Kalluri, A.; Ong, Z.Y.; Hayes, M.R.; Grill, H.J. 2020: NTS and VTA oxytocin reduces food motivation and food seeking. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 319(6): R673-R683
Barykina, N.V.; Doronin, D.A.; Subach, O.M.; Sotskov, V.P.; Plusnin, V.V.; Ivleva, O.A.; Gruzdeva, A.M.; Kunitsyna, T.A.; Ivashkina, O.I.; Lazutkin, A.A.; Malyshev, A.Y.; Smirnov, I.V.; Varizhuk, A.M.; Pozmogova, G.E.; Piatkevich, K.D.; Anokhin, K.V.; Enikolopov, G.; Subach, F.V. 2018: NTnC-like genetically encoded calcium indicator with a positive and enhanced response and fast kinetics. Scientific Reports 8(1): 15233
Dasgupta, S.; Aly, A.M.; Malloy, M.H.; Okorodudu, A.O.; Jain, S.K. 2018: NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Journal of Perinatology: Official Journal of the California Perinatal Association 38(9): 1252-1257
Mammarella, E.; Zampieri, C.; Panatta, E.; Melino, G.; Amelio, I. 2021: NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network. Biology Direct 16(1): 11
Yuan, W-Chien.; Pepe-Mooney, B.; Galli, G.G.; Dill, M.T.; Huang, H-Tsang.; Hao, M.; Wang, Y.; Liang, H.; Calogero, R.A.; Camargo, F.D. 2018: NUAK2 is a critical YAP target in liver cancer. Nature Communications 9(1): 4834
Liu, G.; Xirodimas, D.P. 2010: NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways. Oncogene 29(15): 2252-2261
Aron, R.; Tsvetkov, A.; Finkbeiner, S. 2013: NUB1 snubs huntingtin toxicity. Nature Neuroscience 16(5): 523-525
Hosono, T.; Tanaka, T.; Tanji, K.; Nakatani, T.; Kamitani, T. 2010: NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation. British Journal of Cancer 102(5): 873-882
Boyd, L.N.C.; Peters, G.J.; Kazemier, G.; Giovannetti, E. 2020: NUC-1031 in biliary tract cancer: from bench to bedside and back?. Cancer ChemoTherapy and Pharmacology 85(6): 1011-1014
Kapacee, Z.A.; Knox, J.J.; Palmer, D.; Blagden, S.P.; Lamarca, A.; Valle, J.W.; McNamara, M.éa.G. 2020: NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials. Medical Oncology 37(7): 61
Hu, C.; Zha, Q.; Hua, P.; Xiao, L.; Pan, D. 2021: NUCKS Promotes the Proliferation, Migration and Invasion of Lung Cancer Cells Through Pi3k/Akt Signalling Pathway. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 44(2): E55-E61
Zhao, E.; Feng, L.; Bai, L.; Cui, H. 2020: NUCKS promotes cell proliferation and suppresses autophagy through the mTOR-Beclin1 pathway in gastric cancer. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 194
Vanrossum, R. 1963: Nuclear Bombs and their effects on the Human Body. Le Scalpel 116: 1001-1013 Contd
Vanrossum, R. 1963: Nuclear Bombs and their effects on the Human Body. Le Scalpel 116: 1028-1038 Contd
Vanrossum, R. 1963: Nuclear Bombs and their effects on the Human Body. Le Scalpel 116: 1045-1067 Concl
Hod, N.; Levin, D.; Tiktinsky, K.; Ezroh Katzap, D.; Lantsberg, S. 2021: Nuclear Medicine and Molecular Imaging: from Basic Science to the Front in Innovative Imaging and Treatment. Harefuah 160(7): 448-454
Keidar, Z. 2021: Nuclear Medicine in Israel: Past, Present and Especially the Future. Harefuah 160(7): 412-414
Tozetto-Mendoza, T.R.; Kanunfre, K.A.; Vilas-Boas, L.S.; Sanchez Espinoza, E.P.; Paião, H.G.O.; Rocha, M.C.; de Paula, A.V.; de Oliveira, M.S.; Zampelli, D.B.; Vieira, J.é M.; Buss, L.; Costa, S.F.; Sabino, E.C.; Witkin, S.S.; Okay, T.S.; Mendes-Correa, M.C. 2021: Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: could an old assay be suitable for serodiagnosis of the new coronavirus?. Journal of Virological Methods 290: 114064
Geng, Z.; She, Z.; Zhou, Q.; Dong, Z.; Zhan, F.; Zhang, H.; Xu, J.; Gao, Z.; Dong, Y. 2021: NUDIM: a non-uniform fast Fourier transform based dual-space constraint iterative reconstruction method in biological electron tomography. Journal of Structural Biology 213(3): 107770
Banerjee, R.; Ravikanth, V.V.; Pal, P.; Bale, G.; Avanthi, U.S.; Goren, I.; Girish, B.G.; Mitnala, S.; Reddy, D.N. 2020: NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India. Alimentary Pharmacology and Therapeutics 52(11-12): 1683-1694
Kakuta, Y.; Naito, T.; Onodera, M.; Kuroha, M.; Kimura, T.; Shiga, H.; Endo, K.; Negoro, K.; Kinouchi, Y.; Shimosegawa, T. 2016: NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. Pharmacogenomics Journal 16(3): 280-285
Pai, A.A.; Mohan, A.; Benjamin, E.S.B.; Illangeswaran, R.S.S.; Xavier Raj, I.; Janet, N.B.; Arunachalam, A.K.; Kavitha, M.L.; Kulkarni, U.; Devasia, A.J.; Fouzia, N.A.; Abraham, A.; Srivastava, A.; George, B.; Mathews, V.; Korula, A.; Balasubramanian, P. 2021: NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy. Pharmacogenomics and Personalized Medicine 14: 1303-1313
Liang, D-C.; Yang, C-P.; Liu, H-C.; Jaing, T-H.; Chen, S-H.; Hung, I-J.; Yeh, T-C.; Lin, T-H.; Lai, C-L.; Lai, C-Y.; Shih, L-Y. 2016: NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharmacogenomics Journal 16(6): 536-539
Matsuoka, K. 2020: NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease. Intestinal Research 18(3): 275-281
Xu, Y.; Qiao, Y.-Q.; Li, H.-Y.; Zhou, M.; Cai, C.-W.; Shen, J.; Ran, Z.-H. 2020: NUDT15 genotyping during azathioprine treatment in patients with inflammatory bowel disease: implications for a dose-optimization strategy. Gastroenterology Report 8(6): 437-444
Nishii, R.; Mizuno, T.; Rehling, D.; Smith, C.; Clark, B.L.; Zhao, X.; Brown, S.A.; Smart, B.; Moriyama, T.; Yamada, Y.; Ichinohe, T.; Onizuka, M.; Atsuta, Y.; Yang, L.; Yang, W.; Thomas, P.G.; Stenmark, Pål.; Kato, M.; Yang, J.J. 2021: NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir. Nature Communications 12(1): 4181
Moriyama, T.; Nishii, R.; Perez-Andreu, V.; Yang, W.; Klussmann, F.Antillon.; Zhao, X.; Lin, T-Nien.; Hoshitsuki, K.; Nersting, J.; Kihira, K.; Hofmann, U.; Komada, Y.; Kato, M.; McCorkle, R.; Li, L.; Koh, K.; Najera, C.Rolando.; Kham, S.Kow-Yin.; Isobe, T.; Chen, Z.; Chiew, E.Kean-Hui.; Bhojwani, D.; Jeffries, C.; Lu, Y.; Schwab, M.; Inaba, H.; Pui, C-Hon.; Relling, M.V.; Manabe, A.; Hori, H.; Schmiegelow, K.; Yeoh, A.E.J.; Evans, W.E.; Yang, J.J. 2016: NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nature Genetics 48(4): 367-373
Kato, M. 2021: NUDT15: a major determinant of thiopurine sensitivity in Asians. Pediatrics International: Official Journal of the Japan Pediatric Society 63(7): 748-749
Zhu, Y.; Zhang, R.; Zhang, Y.; Cheng, X.; Li, L.; Wu, Z.; Ding, K. 2021: NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer. Frontiers in Oncology 11: 670353
Wang, B.-J.; Liu, D.-C.; Guo, Q.-Y.; Han, X.-W.; Bi, X.-M.; Wang, H.; Wu, Z.-S.; Wu, W.-Y. 2020: NUDT21 Suppresses Breast Cancer Tumorigenesis Through Regulating CPSF6 Expression. Cancer Management and Research 12: 3069-3078
Zheng, Y.-S.; Chen, M.-L.; Lei, W.-d.; Zhu, S.-L.; You, X.-Q.; Liu, Y. 2020: NUDT21 knockdown inhibits proliferation and promotes apoptosis of pancreatic ductal adenocarcinoma through EIF2 signaling. Experimental Cell Research 395(2): 112182
Li, X.; Ding, J.; Wang, X.; Cheng, Z.; Zhu, Q. 2020: NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma. Oncogene 39(4): 891-904
Lv, S.; Xu, W.; Zhang, Y.; Zhang, J.; Dong, X. 2020: NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer. International Journal of Oncology 57(6): 1358-1367
Colaluca, I.N.; Tosoni, D.; Nuciforo, P.; Senic-Matuglia, F.; Galimberti, V.; Viale, G.; Pece, S.; Di Fiore, P.Paolo. 2008: NUMB controls p53 tumour suppressor activity. Nature 451(7174): 76-80
Flores, A.N.; McDermott, N.; Meunier, A.; Marignol, L. 2014: NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer. Nature Reviews. Urology 11(9): 499-507
Ye, L.; Lou, F.; Yu, F.; Zhang, D.; Wang, C.; Wu, F.; Li, X.; Ping, Y.; Yang, X.; Yang, J.; Chen, D.; Gao, B.; Huang, D.; Liu, P. 2018: NUMB maintains bone mass by promoting degradation of PTEN and GLI1 via ubiquitination in osteoblasts. Bone Research 6: 32
Wang, X.; Cai, J.; Zhao, L.; Zhang, D.; Xu, G.; Hu, J.; Zhang, T.; Jin, M. 2021: NUMB suppression by miR-9-5P enhances CD44 + prostate cancer stem cell growth and metastasis. Scientific Reports 11(1): 11210
Swarnkar, G.; Chen, T.Hung-Po.; Arra, M.; Nasir, A.M.; Mbalaviele, G.; Abu-Amer, Y. 2017: NUMBL Interacts with TAK1, TRAF6 and NEMO to Negatively Regulate NF-κB Signaling During Osteoclastogenesis. Scientific Reports 7(1): 12600
Linderman, G.C.; Steinerberger, S. 2020: Numerical Integration on Graphs: Where to Sample and how to Weigh. Mathematics of Computation 89(324): 1933-1952
Chien, M.-L.; Lai, J.-H.; Lin, T.-F.; Yang, W.-S.; Juang, Y.-L. 2020: NUP62 is required for the maintenance of the spindle assembly checkpoint and chromosomal stability. International Journal of Biochemistry and Cell Biology 128: 105843
Fagnan, A.; Mercher, T. 2020: NUP98 and KMT2A: usually the bride rather than the bridesmaid. Haematologica 105(7): 1757-1760
Lam, D.H.; Aplan, P.D. 2001: NUP98 gene fusions in hematologic malignancies. Leukemia 15(11): 1689-1695
Struski, S.; Lagarde, S.; Bories, P.; Puiseux, C.; Prade, N.; Cuccuini, W.; Pages, M-P.; Bidet, A.; Gervais, C.; Lafage-Pochitaloff, M.; Roche-Lestienne, C.; Barin, C.; Penther, D.; Nadal, N.; Radford-Weiss, I.; Collonge-Rame, M-A.; Gaillard, B.; Mugneret, F.; Lefebvre, C.; Bart-Delabesse, E.; Petit, A.; Leverger, G.; Broccardo, C.; Luquet, I.; Pasquet, M.; Delabesse, E. 2017: NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Leukemia 31(3): 565-572
Liu, H. 2020: NUP98 rearrangement in B lymphoblastic leukemia with hyperdiploidy. Blood 136(8): 1011
Romana, S.P.; Radford-Weiss, I.; Ben Abdelali, R.; Schluth, C.; Petit, A.; Dastugue, N.; Talmant, P.; Bilhou-Nabera, C.; Mugneret, F.; Lafage-Pochitaloff, M.; Mozziconacci, M-J.; Andrieu, J.; Lai, J-L.; Terre, C.; Rack, K.; Cornillet-Lefebvre, P.; Luquet, I.; Nadal, N.; Nguyen-Khac, F.; Perot, C.; Van den Akker, J.; Fert-Ferrer, S.; Cabrol, C.; Charrin, C.; Tigaud, I.; Poirel, H.; Vekemans, M.; Bernard, O.A.; Berger, R. 2006: NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique. Leukemia 20(4): 696-706
Petit, A.; Ragu, C.; Della-Valle, V.; Mozziconacci, M.J.; Lafage-Pochitaloff, M.; Soler, G.; Schluth, C.; Radford, I.; Ottolenghi, C.; Bernard, O.A.; Penard-Lacronique, V.; Romana, S.P. 2010: NUP98-HMGB3: a novel oncogenic fusion. Leukemia 24(3): 654-658
Dong, Y.; Wang, K.; Weng, Q.; Wang, T.; Zhou, P.; Liu, X.; Geng, Y.; Liu, L.; Wu, H.; Wang, J.; Du, J. 2020: NUP98-HOXA10hd fusion protein sustains multi-lineage haematopoiesis of lineage-committed progenitors in transplant setting. Cell proliferation 53(9): e12885
Wang, G.G.; Cai, L.; Pasillas, M.P.; Kamps, M.P. 2007: NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nature Cell Biology 9(7): 804-812
de Rooij, J.D.E.; Hollink, I.H.I.M.; Arentsen-Peters, S.T.C.J.M.; van Galen, J.F.; Berna Beverloo, H.; Baruchel, A.; Trka, J.; Reinhardt, D.; Sonneveld, E.; Zimmermann, M.; Alonzo, T.A.; Pieters, R.; Meshinchi, S.; van den Heuvel-Eibrink, M.M.; Zwaan, C.Michel. 2013: NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia 27(12): 2280-2288
Huang, C.; Santofimia-Castaño, P.; Liu, X.; Xia, Y.; Peng, L.; Gotorbe, Célia.; Neira, J.Luis.; Tang, D.; Pouyssegur, J.; Iovanna, J. 2021: NUPR1 inhibitor ZZW-115 induces ferroptosis in a mitochondria-dependent manner. Cell Death Discovery 7(1): 269
Liu, J.; Song, X.; Kuang, F.; Zhang, Q.; Xie, Y.; Kang, R.; Kroemer, G.; Tang, D. 2021: NUPR1 is a critical repressor of ferroptosis. Nature Communications 12(1): 647
Päth, G.ün.; Mehana, A.E.; Pilz, I.H.; Alt, M.; Baumann, J.; Sommerer, I.; Hoffmeister, A.; Seufert, J. 2020: NUPR1 preserves insulin secretion of pancreatic β-cells during inflammatory stress by multiple low-dose streptozotocin and high-fat diet. American Journal of Physiology. Endocrinology and Metabolism 319(2): E338-E344
Emma, M.R.; Iovanna, J.L.; Bachvarov, D.; Puleio, R.; Loria, G.R.; Augello, G.; Candido, S.; Libra, M.; Gulino, A.; Cancila, V.; McCubrey, J.A.; Montalto, G.; Cervello, M. 2016: NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance. Cell Death and Disease 7(6): E2269
Tabatabaei Mirakabad, F.S.; Khoramgah, M.S.; Abdollahifar, M.-A.; Tehrani, A.S.; Rezaei-Tavirani, M.; Niknazar, S.; Tahmasebinia, F.; Mahmoudiasl, G.-R.; Khoshsirat, S.; Abbaszadeh, H.A. 2021: NUPR1- CHOP experssion, autophagosome formation and apoptosis in the postmortem striatum of chronic methamphetamine user. Journal of Chemical Neuroanatomy 114: 101942
Cain, D.W.; Gunn, M.D. 2011: NUR who? An orphan transcription factor holds promise for monomaniacs. Nature Immunology 12(8): 727-729
Valsecchi, C.; Grisoni, F.; Motta, S.; Bonati, L.; Ballabio, D. 2020: NURA: A curated dataset of nuclear receptor modulators. Toxicology and Applied Pharmacology 407: 115244
Meshorer, E.; Gruenbaum, Y. 2009: NURD keeps chromatin young. Nature Cell Biology 11(10): 1176-1177
Fazzio, T.G.; Rando, O.J. 2012: NURDs are required for diversity. EMBO Journal 31(14): 3036-3037
Montarolo, F.; Martire, S.; Perga, S.; Spadaro, M.; Brescia, I.; Allegra, S.; De Francia, S.; Bertolotto, A. 2019: NURR1 deficiency is associated to ADHD-like phenotypes in mice. Translational Psychiatry 9(1): 207
Decressac, M.; Volakakis, N.; Björklund, A.; Perlmann, T. 2013: NURR1 in Parkinson disease--from pathogenesis to therapeutic potential. Nature Reviews. Neurology 9(11): 629-636
Wieske, L.H.E.; Erdélyi, M.át.é 2021: Non-uniform sampling for NOESY? a case study on spiramycin. Magnetic Resonance in Chemistry: Mrc 59(7): 723-737
Araki, K.; Nakamura, R.; Ito, D.; Kato, K.; Iguchi, Y.; Sahashi, K.; Toyama, M.; Hamada, K.; Okamoto, N.; Wada, Y.; Nakamura, T.; Ogi, T.; Katsuno, M. 2020: NUS1 mutation in a family with epilepsy, cerebellar ataxia, and tremor. Epilepsy Research 164: 106371
Wang, H.; Liu, Z.; Wu, P.; Wang, H.; Ren, W. 2021: NUSAP1 Accelerates Osteosarcoma Cell Proliferation and Cell Cycle Progression via Upregulating CDC20 and Cyclin A2. Oncotargets and Therapy 14: 3443-3454
Zhao, Y.; He, J.; Li, Y.; Lv, S.; Cui, H. 2020: NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR. Signal Transduction and Targeted Therapy 5(1): 44
Yu, Z.; Li, X.M.; Huai, M.; Cao, S.S.; Han, H.Y.; Bi, Y.H. 2020: NUSAP1 promotes lung cancer progression by activating AKT/mTOR signaling pathway. Zhonghua Zhong Liu Za Zhi 42(7): 551-555
Jung, M.; Kim, S.I.; Kim, J.-W.; Jeon, Y.K.; Lee, C. 2022: NUT Carcinoma in the Pelvic Cavity with Unusual Pathologic Features. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 41(3): 292-297
Gökmen-Polar, Y.; Cano, O.D.; Kesler, K.A.; Loehrer, P.J.; Badve, S. 2014: NUT midline carcinomas in the thymic region. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 27(12): 1649-1656
Van Treeck, B.J.; Thangaiah, J.Jebastin.; Torres-Mora, J.; Stevens, T.M.; Rothermundt, C.; Fassan, M.; Loupakis, F.; Diebold, J.; Hornick, J.L.; Halling, K.C.; Folpe, A.L. 2021: NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 2021
Wang, X.; Sun, H.; Hu, Z.; Mei, P.; Wu, Y.; Zhu, M. 2021: NUTM2A-AS1 silencing alleviates LPS-induced apoptosis and inflammation in dental pulp cells through targeting let-7c-5p/HMGB1 axis. International Immunopharmacology 96: 107497
Hinkley, L.B.N.; Dale, C.L.; Cai, C.; Zumer, J.; Dalal, S.; Findlay, A.; Sekihara, K.; Nagarajan, S.S. 2020: NUTMEG: Open Source Software for M/EEG Source Reconstruction. Frontiers in Neuroscience 14: 710
Nedoklan, S.đa.; Knezovic, Z.; Knezovic, N.; Sutlovic, D. 2021: Nutrition and Mineral Content in Human Teeth through the Centuries. Archives of Oral Biology 124: 105075
Mulder, T. 1964: Nutrition in the Netherlands. Voeding 25: 604-608
Strashok, L.A.; Buznytska, O.V.; Meshkova, O.M. 2021: Nutrition Peculiarities of Ukrainian Adolescents with Metabolic Syndrome. Wiadomosci Lekarskie 74(3 Cz 1): 492-497
Behling, E.B.; Camelo Júnior, J.é S.; Ferriolli, E.; Pfrimer, K.; Monteiro, J.P. 2021: Nutritional Status in Children with Cancer: Comparison of Deuterium Oxide Dilution with Bioelectric Impedance Analysis and Anthropometry. Revista Paulista de Pediatria: Orgao Oficial da Sociedade de Pediatria de Sao Paulo 39: E2019209
Victo, E.Rossato.de.; Ferrari, G.; Matsudo, V.Keihan.Rodrigues.; Pires, C.André.Miranda.; Araújo, Tóteo.Leandro.; Katzmarzyk, P.Todd.; Solé, D. 2020: Nutritional Status, Physical Activity, Sedentary Behavior, Diet, and Lifestyle in Childhood: An Analysis of Respiratory Diseases in Adolescence. Revista Paulista de Pediatria: Orgao Oficial da Sociedade de Pediatria de Sao Paulo 39: E2020007
MendonÇa, A.P.M.d.; Yamashita, L.M.; Silva, E.D.; Solar, I.; Santos, L.A.O.; Vasques, A.C.J. 2020: Nutritional Status, Quality of Life and Life Habits of Women with Irritable Bowel Syndrome: a Case-Control Study. Arquivos de Gastroenterologia 57(2): 114-120
Barbera, D.S.; Huckvale, M.; Fleming, V.; Upton, E.; Coley-Fisher, H.; Doogan, C.; Shaw, I.; Latham, W.; Leff, A.P.; Crinion, J. 2021: NUVA: a Naming Utterance Verifier for Aphasia Treatment. Computer Speech and Language 69: None
Biacchesi, Séphane.; Mérour, E.; Chevret, D.; Lamoureux, A.; Bernard, J.; Brémont, M. 2017: NV Proteins of Fish Novirhabdovirus Recruit Cellular PPM1Bb Protein Phosphatase and Antagonize RIG-I-Mediated IFN Induction. Scientific Reports 7: 44025
Aharon, N.; Rotem, A.; McGuinness, L.P.; Jelezko, F.; Retzker, A.; Ringel, Z. 2019: NV center based nano-NMR enhanced by deep learning. Scientific Reports 9(1): 17802
Liu, J.; Cao, L.; Qu, J.-Z.; Chen, T.-T.; Su, Z.-J.; Hu, Y.-L.; Wang, Y.; Yao, M.-D.; Xiao, W.-H.; Li, C.; Li, B.; Yuan, Y.-J. 2020: NVD-BM-mediated genetic biosensor triggers accumulation of 7-dehydrocholesterol and inhibits melanoma via Akt1/NF-ĸB signaling. Aging 12(14): 15021-15036
Vazquez, N.; Lopez, A.; Cuello, V.; Persans, M.; Schuenzel, E.; Innis-Whitehouse, W.; Keniry, M. 2021: NVP-BEZ235 or JAKi Treatment leads to decreased survival of examined GBM and BBC cells. Cancer Treatment and Research Communications 27: 100340
Hsu, C-Ming.; Lin, P-Mei.; Tsai, Y-Te.; Tsai, M-Shao.; Tseng, C-Han.; Lin, S-Fung.; Yang, M-Yu. 2018: NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin. Cell Death Discovery 4: 57
Wang, W-juan.; Long, L-mei.; Yang, N.; Zhang, Q-qing.; Ji, W-jun.; Zhao, J-hu.; Qin, Z-hong.; Wang, Z.; Chen, G.; Liang, Z-qin. 2013: NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro. Acta Pharmacologica Sinica 34(5): 681-690
Nanta, R.; Kumar, D.; Meeker, D.; Rodova, M.; Van Veldhuizen, P.J.; Shankar, S.; Srivastava, R.K. 2013: NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128. Oncogenesis 2: E42
Sackett, I. 2001: NVQ in oral health care for dental nurses. British Dental Journal 191(1): 2
Guebre-Xabier, M.; Patel, N.; Tian, J.-H.; Zhou, B.; Maciejewski, S.; Lam, K.; Portnoff, A.D.; Massare, M.J.; Frieman, M.B.; Piedra, P.A.; Ellingsworth, L.; Glenn, G.; Smith, G. 2020: NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. Vaccine 38(50): 7892-7896
Ježek, P.; Teeters, J.L.; Sommer, F.T. 2020: NWB Query Engines: Tools to Search Data Stored in Neurodata Without Borders Format. Frontiers in Neuroinformatics 14: 27
Aprà, E.; Bylaska, E.J.; de Jong, W.A.; Govind, N.; Kowalski, K.; Straatsma, T.P.; Valiev, M.; van Dam, H.J.J.; Alexeev, Y.; Anchell, J.; Anisimov, V.; Aquino, F.W.; Atta-Fynn, R.; Autschbach, J.; Bauman, N.P.; Becca, J.C.; Bernholdt, D.E.; Bhaskaran-Nair, K.; Bogatko, S.; Borowski, P.; Boschen, J.; Brabec, J.; Bruner, A.; Cauët, E.; Chen, Y.; Chuev, G.N.; Cramer, C.J.; Daily, J.; Deegan, M.J.O.; Dunning, T.H.; Dupuis, M.; Dyall, K.G.; Fann, G.I.; Fischer, S.A.; Fonari, A.; Früchtl, H.; Gagliardi, L.; Garza, J.; Gawande, N.; Ghosh, S.; Glaesemann, K.; Götz, A.W.; Hammond, J.; Helms, V.; Hermes, E.D.; Hirao, K.; Hirata, S.; Jacquelin, M.; Jensen, L.; Johnson, B.G.; Jónsson, H.; Kendall, R.A.; Klemm, M.; Kobayashi, R.; Konkov, V.; Krishn 2020: NWChem: Past, present, and future. Journal of Chemical Physics 152(18): 184102
Lu, Z.; Chen, Y.; Xue, J.; Liu, L. 2021: NXP2-positive dermatomyositis complicated with refractory skin edema: Successful treatment with tocilizumab. Dermatologic Therapy 34(1): E14712
Koska, M.T. 1989: NY hospitals gamble with quality incentive pool. Trustee: the Journal for Hospital Governing Boards 42(12): 11
Endo, M.; de Graaff, M.A.; Ingram, D.R.; Lim, S.; Lev, D.C.; Briaire-de Bruijn, I.H.; Somaiah, N.; Bovée, J.V.M.G.; Lazar, A.J.; Nielsen, T.O. 2015: NY-ESO-1 (CTAG1B) expression in mesenchymal tumors. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 28(4): 587-595
Wang, H.; Huang, W.; Gao, H.; Liu, T.T. 2020: NY-ESO-1 Protein Vaccine Combining Alum, CpG ODN, and HH2 Complex Adjuvant Induces Protective and Therapeutic Anti-Tumor Responses in Murine Multiple Myeloma. Oncotargets and Therapy 13: 8069-8077
Fujiwara, S.; Wada, H.; Kawada, J.; Kawabata, R.; Takahashi, T.; Fujita, J.; Hirao, T.; Shibata, K.; Makari, Y.; Iijima, S.; Nishikawa, H.; Jungbluth, A.A.; Nakamura, Y.; Kurokawa, Y.; Yamasaki, M.; Miyata, H.; Nakajima, K.; Takiguchi, S.; Nakayama, E.; Mori, M.; Doki, Y. 2013: NY-ESO-1 antibody as a novel tumour marker of gastric cancer. British Journal of Cancer 108(5): 1119-1125
Lai, J-Ping.; Robbins, P.F.; Raffeld, M.; Aung, P.Phyu.; Tsokos, M.; Rosenberg, S.A.; Miettinen, M.M.; Lee, C-Chia.Richard. 2012: NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 25(6): 854-858
Hemminger, J.A.; Iwenofu, O.Hans. 2013: NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 26(9): 1204-1210
Rapoport, A.P.; Stadtmauer, E.A.; Binder-Scholl, G.K.; Goloubeva, O.; Vogl, D.T.; Lacey, S.F.; Badros, A.Z.; Garfall, A.; Weiss, B.; Finklestein, J.; Kulikovskaya, I.; Sinha, S.K.; Kronsberg, S.; Gupta, M.; Bond, S.; Melchiori, L.; Brewer, J.E.; Bennett, A.D.; Gerry, A.B.; Pumphrey, N.J.; Williams, D.; Tayton-Martin, H.K.; Ribeiro, L.; Holdich, T.; Yanovich, S.; Hardy, N.; Yared, J.; Kerr, N.; Philip, S.; Westphal, S.; Siegel, D.L.; Levine, B.L.; Jakobsen, B.K.; Kalos, M.; June, C.H. 2015: NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nature Medicine 21(8): 914-921
Yokoyama, K.; Tezuka, T.; Kotani, M.; Nakazawa, T.; Hoshina, N.; Shimoda, Y.; Kakuta, S.; Sudo, K.; Watanabe, K.; Iwakura, Y.; Yamamoto, T. 2011: NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. EMBO Journal 30(23): 4739-4754
Wilk, J.B.; Laramie, J.M.; Latourelle, J.C.; Williamson, S.; Nagle, M.W.; Tobin, J.E.; Foster, C.L.; Eckfeldt, J.H.; Province, M.A.; Borecki, I.B.; Myers, R.H. 2008: NYD-SP18 is associated with obesity in the NHLBI Family Heart Study. International Journal of Obesity 32(6): 930-935
Iung, B. 2020: NYHA Functional Class in Secondary Mitral Regurgitation: An Old Classification to Evaluate an Innovative Technique. JACC. Cardiovascular Interventions 13(20): 2329-2330
Giustino, G.; Lindenfeld, J.; Abraham, W.T.; Kar, S.; Lim, D.S.; Grayburn, P.A.; Kapadia, S.R.; Cohen, D.J.; Kotinkaduwa, L.N.; Weissman, N.J.; Mack, M.J.; Stone, G.W. 2020: NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: the COAPT Trial. JACC. Cardiovascular Interventions 13(20): 2317-2328
Nagai, T.; Anzai, T. 2016: NYHA functional classification and AHA/ACC Stages for heart failure management. Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl. 6: 340-344
Grybauskas, A.; Koga, T.; Kuprys, P.V.; Nolan, M.; McCarty, R.; Walker, L.; Green, K.A.; Norkett, W.M.; Yue, B.Y.J.T.; Knepper, P.A. 2015: ABCB1 transporter and Toll-like receptor 4 in trabecular meshwork cells. Molecular Vision 21: 201-212
Scanga, H.L.; Liasis, A.; Pihlblad, M.S.; Nischal, K.K. 2021: NYX- related Congenital Stationary Night Blindness in Two Siblings due to Probable Maternal Germline Mosaicism. Ophthalmic Genetics 2021: 1-5
Aubrey, K.R.; Vandenberg, R.J. 2001: N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport. British Journal of Pharmacology 134(7): 1429-1436
Yang, W.; Sukhanov, A.A.; Lim, J.H.; Li, X.; Meng, Y.; Zhao, J.; Sun, H.; Lee, J.Y.; Gurzadyan, G.G.; Voronkova, V.K. 2020: N^N Pt(II) Bisacetylide Complexes with Oxoverdazyl Radical Ligands: Preparation, Photophysical Properties, and Magnetic Exchange Interaction between the two Radical Ligands. Inorganic Chemistry 59(17): 12471-12485
Lee, S.; Axelsen, T.V.; Jessen, N.; Pedersen, S.F.; Vahl, P.; Boedtkjer, E. 2018: Na + ,HCO 3 - -cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice. Oncogene 37(41): 5569-5584
Liu, C-Lin.; Zhang, X.; Liu, J.; Wang, Y.; Sukhova, G.K.; Wojtkiewicz, G.R.; Liu, T.; Tang, R.; Achilefu, S.; Nahrendorf, M.; Libby, P.; Guo, J.; Zhang, J-Ying.; Shi, G-Ping. 2019: Na + -H + exchanger 1 determines atherosclerotic lesion acidification and promotes atherogenesis. Nature Communications 10(1): 3978
Zheng, L.-F.; Ji, T.; Guo, Z.-H.; Wang, T.; Xiu, X.-L.; Liu, X.-Y.; Li, S.-C.; Sun, L.; Xue, H.; Zhang, Y.; Zhu, J.-X. 2020: Na+-K+-2Cl- cotransporter 2 located in the human and murine gastric mucosa is involved in secretagogue-induced gastric acid secretion and is downregulated in lipopolysaccharide-treated mice. European Journal of Pharmacology 880: 173162
Ishida, H.; Yamaguchi, M.; Saito, S.-Y.; Furukawa, T.; Shannonhouse, J.L.; Kim, Y.S.; Ishikawa, T. 2021: Na+-dependent inactivation of vascular Na+/Ca2+ exchanger responsible for reduced peripheral blood flow in neuropathic pain model. European Journal of Pharmacology 910: 174448
Tao, Y.; Lin, J.; Wang, D.; Wang, Y. 2021: Na+-functionalized carbon dots with aggregation-induced and enhanced cyan emission. Journal of Colloid and Interface Science 588: 469-475
Hori, T.; Okuno, T.; Hirata, K.; Yamashita, K.; Kawano, Y.; Yamamoto, M.; Hato, M.; Nakamura, M.; Shimizu, T.; Yokomizo, T.; Miyano, M.; Yokoyama, S. 2018: Na + -mimicking ligands stabilize the inactive state of leukotriene B 4 receptor BLT1. Nature Chemical Biology 14(3): 262-269
Secondo, A.; Esposito, A.; Petrozziello, T.; Boscia, F.; Molinaro, P.; Tedeschi, V.; Pannaccione, A.; Ciccone, R.; Guida, N.; Di Renzo, G.; Annunziato, L. 2018: Na + /Ca 2+ exchanger 1 on nuclear envelope controls PTEN/Akt pathway via nucleoplasmic Ca 2+ regulation during neuronal differentiation. Cell Death Discovery 4: 12
Farhat, E.; Devereaux, M.E.M.; Cheng, H.; Weber, J.-M.; Pamenter, M.E. 2021: Na+/K+-ATPase activity is regionally regulated by acute hypoxia in naked mole-rat brain. Neuroscience Letters 764: 136244
Souza E Souza, K.ê F.C.êa.; Moraes, B.P.T.; Paixão, I.C.N.d.P.; Burth, P.íc.; Silva, A.R.; Gonçalves-de-Albuquerque, C.F. 2021: Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection. Frontiers in Pharmacology 12: 624704
Takei, G.L.; Hayashi, K. 2020: Na+/K+-ATPase α4 regulates sperm hyperactivation while Na+/K+-ATPase α1 regulates basal motility in hamster spermatozoa. Theriogenology 157: 48-60
Zhu, M.; Cao, L.; Xiong, S.; Sun, H.; Wu, Z.; Bian, J-Song. 2020: Na + /K + -ATPase-dependent autophagy protects brain against ischemic injury. Signal Transduction and Targeted Therapy 5(1): 55
Hernansanz-Agustín, P.; Choya-Foces, C.; Carregal-Romero, S.; Ramos, E.; Oliva, T.; Villa-Piña, T.; Moreno, L.; Izquierdo-Álvarez, A.; Cabrera-García, J.Daniel.; Cortés, A.; Lechuga-Vieco, A.Victoria.; Jadiya, P.; Navarro, E.; Parada, E.; Palomino-Antolín, A.; Tello, D.; Acín-Pérez, R.; Rodríguez-Aguilera, J.Carlos.; Navas, Pácido.; Cogolludo, Ángel.; López-Montero, Ián.; Martínez-Del-Pozo, Álvaro.; Egea, J.; López, M.G.; Elrod, J.W.; Ruíz-Cabello, Jús.; Bogdanova, A.; Enríquez, Jé.Antonio.; Martínez-Ruiz, A. 2020: Na + controls hypoxic signalling by the mitochondrial respiratory chain. Nature 586(7828): 287-291
Muraki, K.; Ohnishi, K.; Takezawa, A.; Suzuki, H.; Hatano, N.; Muraki, Y.; Hamzah, N.; Foster, R.; Waldmann, H.; Nussbaumer, P.; Christmann, M.; Bon, R.S.; Beech, D.J. 2017: Na + entry through heteromeric TRPC4/C1 channels mediates (-)Englerin A-induced cytotoxicity in synovial sarcoma cells. Scientific Reports 7(1): 16988
Kurlov, A.; Kierzkowska, A.M.; Huthwelker, T.; Abdala, P.M.; Müller, C.R. 2020: Na2CO3-modified CaO-based CO2 sorbents: the effects of structure and morphology on CO2 uptake. Physical Chemistry Chemical Physics: Pccp 22(42): 24697-24703
Reginato, M.; Cenzano, A.M.; Arslan, I.; Furlán, A.; Varela, C.; Cavallin, V.; Papenbrock, J.; Luna, V. 2021: Na2SO4 and NaCl salts differentially modulate the antioxidant systems in the highly stress tolerant halophyte Prosopis strombulifera. Plant Physiology and Biochemistry: Ppb 167: 748-762
Xing, S.; Cheng, Y.; Yu, F.; Ma, J. 2021: Na3(VO)2(PO4)2F nanocuboids/graphene hybrid materials as faradic electrode for extra-high desalination capacity. Journal of Colloid and Interface Science 598: 511-518
Xiong, S.; Liu, Z.; Rong, H.; Wang, H.; McDaniel, M.; Chen, H. 2018: Na 3 SbSe 4-x S x as Sodium Superionic Conductors. Scientific Reports 8(1): 9146
Cong, X.; Wang, T.; Shen, J.; Chen, P.; Yao, H.; Wang, Z. 2020: Na3V2(PO4)3/Porous Carbon Skeleton Embellished with ZIF-67 for Sodium-Ion Storage. Inorganic Chemistry 59(13): 9252-9260
Zhang, S.; Liang, F.; Gong, P.; Yang, Y.; Lin, Z. 2020: Na4CdGe2S7: a Sodium-Rich Quaternary Wide-Band-Gap Chalcogenide with Two-Dimensional [Ge2CdS7]∞ Layers. Inorganic Chemistry 59(22): 16132-16136
Ding, M.; Yu, H.; Hu, Z.; Wang, J.; Wu, Y. 2021: Na7(IO3)(SO4)3: the first noncentrosymmetric alkaline-metal iodate-sulfate with isolated [IO3] and [SO4] units. Chemical Communications 57(75): 9598-9601
Jood, P.; Male, J.P.; Anand, S.; Matsushita, Y.; Takagiwa, Y.; Kanatzidis, M.G.; Snyder, G.J.; Ohta, M. 2020: Na Doping in PbTe: Solubility, Band Convergence, Phase Boundary Mapping, and Thermoelectric Properties. Journal of the American Chemical Society 142(36): 15464-15475
Léna, I.; Mantegazza, M. 2019: Na V 1.2 haploinsufficiency in Scn2a knock-out mice causes an autistic-like phenotype attenuated with age. Scientific Reports 9(1): 12886
Bayless-Edwards, L.; Winston, V.; Lehmann-Horn, F.; Arinze, P.; Groome, J.R.; Jurkat-Rott, K. 2018: Na V 1.4 DI-S4 periodic paralysis mutation R222W enhances inactivation and promotes leak current to attenuate action potentials and depolarize muscle fibers. Scientific Reports 8(1): 10372
Cortada, E.; Verges, M. 2020: NaV 1.5 in embryonic heart development. Acta Physiologica 230(2): E13542
Pierre, M.; Djemai, M.; Poulin, H.; Chahine, M. 2021: Na V 1.5 knockout in iPSCs: a novel approach to study Na V 1.5 variants in a human cardiomyocyte environment. Scientific Reports 11(1): 17168
Beam, K.G.; Caldwell, J.H.; Campbell, D.T. 1985: Na channels in skeletal muscle concentrated near the neuromuscular junction. Nature 313(6003): 588-590
Barreto, R.F.; Prado, R.d.M.; Bodelão, N.ál.C.; Teixeira, G.C.M. 2022: Na improves the growth of K-deficient but not K-sufficient kale. Food Chemistry 370: 131017
Nathan, S.; Gabelli, S.B. 2021: Navigating the intricacies of cellular machinery. Journal of Biological Chemistry 296: 100832
Zhang, X-Feng.; Long, Z-Da.; Liu, X-Min.; Ma, F.; Li, Q.; Lv, Y. 2016: Na(+) Micro-Current Value Detection as a New Modality for Identification of Benign and Malignant Disease in Surgery. Scientific Reports 6: 24937
Liu, L.; Fissel, J.A.; Tasnim, A.; Borzan, J.; Gocke, A.; Calabresi, P.A.; Farah, M.H. 2016: Increased TNFR1 expression and signaling in injured peripheral nerves of mice with reduced BACE1 activity. Neurobiology of Disease 93(9): 21-27
Chen, C.; Wen, Y.; Hu, X.; Ji, X.; Yan, M.; Mai, L.; Hu, P.; Shan, B.; Huang, Y. 2015: Na(+) intercalation pseudocapacitance in graphene-coupled titanium oxide enabling ultra-fast sodium storage and long-term cycling. Nature Communications 6: 6929
Matsuoka, S.; Noma, A. 1998: Na(+)-Ca2+ exchange. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 43(12 Suppl): 1555-1560
Chen, H.; Luo, J.; Kintner, D.B.; Shull, G.E.; Sun, D. 2005: Na(+)-dependent chloride transporter (NKCC1)-null mice exhibit less gray and white matter damage after focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 25(1): 54-66
Farkas, A.S.; Acsai, K.; Nagy, N.; Tóth, A.; Fülöp, F.; Seprényi, G.; Birinyi, P.; Nánási, P.P.; Forster, T.; Csanády, M.; Papp, J.G.; Varró, A.; Farkas, A. 2008: Na(+)/Ca(2+) exchanger inhibition exerts a positive inotropic effect in the rat heart, but fails to influence the contractility of the rabbit heart. British Journal of Pharmacology 154(1): 93-104
Mahon, M.J.; Donowitz, M.; Yun, C.Chris.; Segre, G.V. 2002: Na(+)/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417(6891): 858-861
Brisson, L.; Gillet, L.; Calaghan, S.; Besson, P.; Le Guennec, J-Y.; Roger, S.; Gore, J. 2011: Na(V)1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H(+) efflux in caveolae. Oncogene 30(17): 2070-2076
Hiyama, T.Y.; Watanabe, E.; Ono, K.; Inenaga, K.; Tamkun, M.M.; Yoshida, S.; Noda, M. 2002: Na(x) channel involved in CNS sodium-level sensing. Nature Neuroscience 5(6): 511-512
Palacios, J.; Espinoza, F.; Munita, C.; Cifuentes, F.; Michea, L. 2006: Na+ -K+ -2Cl- cotransporter is implicated in gender differences in the response of the rat aorta to phenylephrine. British Journal of Pharmacology 148(7): 964-972
Isom, L.L.; Catterall, W.A. 1996: Na+ channel subunits and Ig domains. Nature 383(6598): 307-308
Fleidervish, I.A.; Lasser-Ross, N.; Gutnick, M.J.; Ross, W.N. 2010: Na+ imaging reveals little difference in action potential-evoked Na+ influx between axon and soma. Nature Neuroscience 13(7): 852-860
Palmer, L.G. 1982: Na+ transport and flux ratio through apical Na+ channels in toad bladder. Nature 297(5868): 688-690
Wilcox, C.S.; Guzman, N.J.; Mitch, W.E.; Kelly, R.A.; Maroni, B.J.; Souney, P.F.; Rayment, C.M.; Braun, L.; Colucci, R.; Loon, N.R. 1987: Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril. Kidney International 31(1): 135-141
Jung, S.Yong.; Park, Y.Joo.; Park, Y.Jun.; Cha, S.Ho.; Lee, M.Za.; Suh, C.Kook. 2007: Na+-Ca2+ exchanger modulates Ca2+ content in intracellular Ca2+ stores in rat osteoblasts. Experimental and Molecular Medicine 39(4): 458-468
Bondarenko, A.; Sagach, V. 2006: Na+-K+-ATPase is involved in the sustained ACh-induced hyperpolarization of endothelial cells from rat aorta. British Journal of Pharmacology 149(7): 958-965
Budelli, G.; Hage, T.A.; Wei, A.; Rojas, P.; Jong, Y-Jiin.Ivy.; O'Malley, K.; Salkoff, L. 2009: Na+-activated K+ channels express a large delayed outward current in neurons during normal physiology. Nature Neuroscience 12(6): 745-750
LaPointe, M.S.; Ye, M.; Moe, O.W.; Alpern, R.J.; Batlle, D.C. 1995: Na+/H+ antiporter (NHE-1 isoform) in cultured vascular smooth muscle from the spontaneously hypertensive rat. Kidney International 47(1): 78-87
Moolenaar, W.H.; Tsien, R.Y.; van der Saag, P.T.; de Laat, S.W. 1983: Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts. Nature 304(5927): 645-648
Feng, Z.; Tang, L.; Wu, L.; Cui, S.; Hong, Q.; Cai, G.; Wu, D.; Fu, B.; Wei, R.; Chen, X. 2014: Na+/H+ exchanger-1 reduces podocyte injury caused by endoplasmic reticulum stress via autophagy activation. Laboratory Investigation; a Journal of Technical Methods and Pathology 94(4): 439-454
Miyai, A.; Yamauchi, A.; Nakanishi, T.; Sugita, M.; Takamitsu, Y.; Yokoyama, K.; Itoh, T.; Andou, A.; Kamada, T.; Ueda, N. 1995: Na+/myo-inositol cotransport is regulated by tonicity in cultured rat mesangial cells. Kidney International 47(2): 473-480
Molony, D.A.; Reeves, W.B.; Andreoli, T.E. 1989: Na+:K+:2Cl- cotransport and the thick ascending limb. Kidney International 36(3): 418-426
Yordy, M.R.; Bowen, J.W. 1993: Na,K-ATPase expression and cell volume during hypertonic stress in human renal cells. Kidney International 43(4): 940-948
Chen, W.; Zhang, J.-M.; Xia, Q.-L.; Nie, Y.-Z.; Guo, G.-H. 2020: Na-Based monolayer photocatalysts with an extremely high intrinsic electric-field for water splitting. Physical Chemistry Chemical Physics: Pccp 22(28): 16007-16012
Kimura, J.; Noma, A.; Irisawa, H. 1986: Na-Ca exchange current in mammalian heart cells. Nature 319(6054): 596-597
Kiefer, W.; Löw, R.; Wrachtrup, Jörg.; Gerhardt, I. 2014: Na-Faraday rotation filtering: the optimal point. Scientific Reports 4: 6552
Bumajdad, A.; Nahar, S.; Zaki, M.I. 2021: Na-Influenced Bulk and Surface Properties of the So-Called Iota(ι)-Alumina: Spectroscopy and Microscopy Studies. Frontiers in Chemistry 9: 633877
Henriksen, C.; Karlsen, M.A.; Jakobsen, C.L.; Ravnsbæk, D.B. 2020: Na-Ion storage in iron hydroxide phosphate hydrate through a reversible crystalline-to-amorphous phase transition. Nanoscale 12(24): 12824-12830
Retuerto, Mía.; Pascual, L.; Calle-Vallejo, F.; Ferrer, P.; Gianolio, D.; Pereira, A.González.; García, Álvaro.; Torrero, J.; Fernández-Díaz, Mía.Teresa.; Bencok, P.; Peña, M.A.; Fierro, Jé.Luis.G.; Rojas, S. 2019: Na-doped ruthenium perovskite electrocatalysts with improved oxygen evolution activity and durability in acidic media. Nature Communications 10(1): 2041
Ma, L.A.; Palm, R.; Nocerino, E.; Forslund, O.K.; Matsubara, N.; Cottrell, S.; Yokoyama, K.; Koda, A.; Sugiyama, J.; Sassa, Y.; Månsson, M.; Younesi, R. 2021: Na-ion mobility in P2-type Na0.5MgxNi0.17-xMn0.83O2 (0 ≤ x ≤ 0.07) from electrochemical and muon spin relaxation studies. Physical Chemistry Chemical Physics: Pccp 23(42): 24478-24486
Song, S.; Kotobuki, M.; Chen, Y.; Manzhos, S.; Xu, C.; Hu, N.; Lu, L. 2017: Na-rich layered Na 2 Ti 1-x Cr x O 3-x/2 (x = 0, 0.06): Na-ion battery cathode materials with high capacity and long cycle life. Scientific Reports 7(1): 373
Singh, A.N.; Kim, M.-H.; Meena, A.; Wi, T.-U.; Lee, H.-W.; Kim, K.S. 2021: Na/Al Codoped Layered Cathode with Defects as Bifunctional Electrocatalyst for High-Performance Li-Ion Battery and Oxygen Evolution Reaction. Small 17(18): E2005605
Banerjee, M.; Cui, X.; Li, Z.; Yu, H.; Cai, L.; Jia, X.; He, D.; Wang, C.; Gao, T.; Xie, Z. 2018: Na/K-ATPase Y260 Phosphorylation-mediated Src Regulation in Control of Aerobic Glycolysis and Tumor Growth. Scientific Reports 8(1): 12322
Zhao, Q.; Suo, J.; Chen, S.; Jin, Y.; Ma, X.; Yin, Z.; Zhang, Y.; Wang, T.; Luo, J.; Jin, W.; Zhang, X.; Zhou, Z.; Dai, S. 2016: Na2CO3-responsive mechanisms in halophyte Puccinellia tenuiflora roots revealed by physiological and proteomic analyses. Scientific Reports 6: 32717
Ma, X.; An, K.; Bai, J.; Chen, H. 2017: NaAlTi 3 O 8 , A Novel Anode Material for Sodium Ion Battery. Scientific Reports 7(1): 162
Kumar, A.; Cordes, T.; Thalacker-Mercer, A.E.; Pajor, A.M.; Murphy, A.N.; Metallo, C.M. 2021: NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions. Cell Reports 36(11): 109701
Hazra, S.; Tiwari, V.; Verma, A.; Dolui, P.; Elias, A.J. 2020: NaCl as Catalyst and Water as Solvent: Highly E-Selective Olefination of Methyl Substituted N-Heteroarenes with Benzyl Amines and Alcohols. Organic Letters 22(14): 5496-5501
Maeoka, Y.; McCormick, J.A. 2020: NaCl cotransporter activity and Mg2+ handling by the distal convoluted tubule. American Journal of Physiology. Renal Physiology 319(6): F1043-F1053
Yoshioka, T.; Itagaki, Y.; Abe, Y.; Kawahara, N.; Goda, Y.; Ozeki, Y.; Yamada, A. 2021: NaCl dependent production of coniferin in Alluaudiopsis marnieriana suspension cultured cells. Plant Biotechnology 38(1): 183-186
Guo, J.; Du, M.; Lu, C.; Wang, B. 2020: NaCl improves reproduction by enhancing starch accumulation in the ovules of the euhalophyte Suaeda salsa. Bmc Plant Biology 20(1): 262
Madhu, M.; Tseng, W.-L. 2021: NaCl nanocrystal-encapsulated carbon dots as a solution-based sensor for phosphorescent sensing of trace amounts of water in organic solvents. Analytical Methods: Advancing Methods and Applications 13(41): 4949-4954
Waldner, L.; Rääf, C.; Bernhardsson, C. 2020: NaCl pellets for prospective dosimetry using optically stimulated luminescence: Signal integrity and long-term versus short-term exposure. Radiation and Environmental Biophysics 59(4): 693-702
Rubinigg, M.; Wenisch, J.; Elzenga, J.T.M.; Stulen, I. 2004: NaCl salinity affects lateral root development in Plantago maritima. Functional Plant Biology: Fpb 31(8): 775-780
Graham, C.; Frances, M.Marchena.Martin.; Maniyara, R.Abraham.; Wen, Y.; Mazumder, P.; Pruneri, V. 2020: NaCl substrates for high temperature processing and transfer of ultrathin materials. Scientific Reports 10(1): 7253
Liu, R.; Yan, Q.; Tang, Y.; Liu, R.; Huang, L.; Shuai, Q. 2022: NaCl template-assisted synthesis of self-floating COFs foams for the efficient removal of sulfamerazine. Journal of Hazardous Materials 421: 126702
Li, A.; Xu, D.; Lin, H.; Yang, S.; Shao, Y.; Zhang, Y. 2016: NaGd(MoO4)2 nanocrystals with diverse morphologies: controlled synthesis, growth mechanism, photoluminescence and thermometric properties. Scientific Reports 6: 31366
Duan, W.-D.; Zhang, Y.-F.; Hu, Y. 2020: NaH Promoted One-Pot Tandem Reactions of 3-(1-Alkynyl) Chromones to Form 2-Nitrogen-Substituted Xanthones. Acs Omega 5(22): 13454-13461
Nozawa-Kumada, K.; Iwakawa, Y.; Onuma, S.; Shigeno, M.; Kondo, Y. 2020: NaH-mediated direct C-H arylation in the presence of 1,10-phenanthroline. Chemical Communications 56(56): 7773-7776
Park, S.H.; Jung, B.Y.; Lee, S.Y.; Yu, D.S.; Woo, S.-Y.; Yun, S.-T.; Lee, J.T.; Kim, J.-W.; Lee, Y.B. 2021: NaHCO3- and NaCl-Type Hot Springs Enhance the Secretion of Inflammatory Cytokine Induced by Polyinosinic-Polycytidylic Acid in HaCaT Cells. Annals of Dermatology 33(5): 440-447
Zhao, G.; Yang, L.; Li, L.; Fan, Z. 2021: NaHS Alleviated Cell Apoptosis and Mitochondrial Dysfunction in Remote Lung Tissue after Renal Ischemia and Reperfusion via Nrf2 Activation-Mediated NLRP3 Pathway Inhibition. Biomed Research International 2021: 5598869
Karthick, M.; Konikkara Abi, E.; Someshwar, N.; Anthony, S.P.; Ramanathan, C.R. 2020: NaHSO4/SiO2 catalyzed generation of o-quinone/ o-thioquinone methides: synthesis of arylxanthenes/ arylthioxanthenes via oxa-6π-electrocyclization. Organic and Biomolecular Chemistry 18(42): 8653-8667
Zhu, Y.; Liu, L.; Shen, L.; Yu, H. 2016: NaKR1 regulates long-distance movement of FLOWERING LOCUS T in Arabidopsis. Nature Plants 2(6): 16075
Wang, M.; Han, Z.; Huang, J.; Liao, J.; Sun, Y.; Huang, H.; Wen, H.-R. 2021: NaLaMgWO6:Mn4+/Pr3+/Bi3+ bifunctional phosphors for optical thermometer and plant growth illumination matching phytochrome PR and PFR. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 259: 119915
Portugal, G.R.; Barbosa, G.G.; Arantes, J.T. 2021: NaNbO3/NaTaO3 Superlattices: Cation-Ordering Improved Band-Edge Alignment for Water Splitting and CO2 Photocatalysis. Langmuir: the Acs Journal of Surfaces and Colloids 37(15): 4493-4503
Mekonnen, K.D.; Sendekie, Z.B. 2021: NaOH-Catalyzed Methanolysis Optimization of Biodiesel Synthesis from Desert Date Seed Kernel Oil. Acs Omega 6(37): 24082-24091
Shami, Z.; Amininasab, S.M.; Katoorani, S.A.; Gharloghi, A.; Delbina, S. 2021: NaOH-Induced Fabrication of a Superhydrophilic and Underwater Superoleophobic Styrene-Acrylate Copolymer Filtration Membrane for Effective Separation of Emulsified Light Oil-Polluted Water Mixtures. Langmuir: the Acs Journal of Surfaces and Colloids 37(42): 12304-12312
Maruyama, S.; Marbury, T.C.; Connaire, J.; Ries, D.; Maxwell, W.; Rambaran, C. 2021: NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients. Kidney International Reports 6(3): 675-684
Li, J.; Li, M.; Wang, C.; Zhang, S.; Gao, Q.; Wang, L.; Ma, L. 2020: NaSH increases SIRT1 activity and autophagy flux through sulfhydration to protect SH-SY5Y cells induced by MPP~. Cell Cycle 19(17): 2216-2225
Dib-Hajj, S.D.; Black, J.A.; Waxman, S.G. 2015: NaV1.9: a sodium channel linked to human pain. Nature Reviews. Neuroscience 16(9): 511-519
Peng, G.; Lin, C.; Ye, N. 2020: NaZnCO3(OH): a High-Performance Carbonate Ultraviolet Nonlinear Optical Crystal Derived from KBe2BO3F2. Journal of the American Chemical Society 142(49): 20542-20546
Wang, Q.; Kajimura, S. 2019: Naa10P puts a brake on PGC1α and fat browning. Nature Structural and Molecular Biology 26(10): 849-851
Sun, L.; Wang, K.; Peng, L.; Zhang, J.; Yang, J.; Zhao, J.; Xu, J.; Zheng, J.; Zeng, Y. 2021: Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells. Cancer Management and Research 13: 1843-1851
Ribeiro, A.Luisa.; Silva, R.D.; Foyn, Håvard.; Tiago, M.N.; Rathore, O.Singh.; Arnesen, T.; Martinho, R.Gonçalo. 2016: Naa50/San-dependent N-terminal acetylation of Scc1 is potentially important for sister chromatid cohesion. Scientific Reports 6: 39118
Le, N.; Nagarajan, R.; Wang, J.Y.T.; Svaren, J.; LaPash, C.; Araki, T.; Schmidt, R.E.; Milbrandt, J. 2005: Nab proteins are essential for peripheral nervous system myelination. Nature Neuroscience 8(7): 932-940
Kin, T.; Ohtani, S.; Maeda, R.; Ueno, A.; Fujihara, M.; Takamatsu, Y.; Kajiwara, Y.; Ito, M.; Kawasaki, K.; Abe, K.; Sakata, Y.; Hiraki, K. 2020: Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: a Phase Ii Trial. World Journal of Oncology 11(5): 197-203
Chen, Y.; Li, J.; Chen, S.; Zhang, Y.; Hu, Y.; Zhang, G.; Yan, X.; Jiao, S. 2017: Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer. Scientific Reports 7(1): 10760
Patel, A.; Sirohi, B. 2020: Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer. Indian Journal of Medical Research 152(5): 442-443
Hao, X.; Zhu, Y.; Mu, Y.; Wang, S.; Li, J.; Xing, P. 2020: Nab-paclitaxel in combination with Bevacizumab in patients with non-squamous non-small cell lung cancer after failure of at least one prior systemic regimen. Journal of Cancer 11(21): 6421-6428
Portal, A.; Pernot, S.; Tougeron, D.; Arbaud, C.; Bidault, A.Thirot.; de la Fouchardière, C.; Hammel, P.; Lecomte, T.; Dréanic, J.; Coriat, R.; Bachet, J-Baptiste.; Dubreuil, O.; Marthey, L.; Dahan, L.; Tchoundjeu, B.; Locher, C.; Lepère, Céline.; Bonnetain, F.; Taieb, J. 2015: Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort. British Journal of Cancer 113(7): 989-995
Chen, Y.; Liu, R.; Li, C.; Song, Y.; Liu, G.; Huang, Q.; Yu, L.; Zhu, D.; Lu, C.; Lu, A.; Li, L.; Liu, Y. 2021: Nab-paclitaxel promotes the cancer-immunity cycle as a potential immunomodulator. American Journal of Cancer Research 11(7): 3445-3460
Cascinu, S.; Berardi, R.; Bianco, R.; Bilancia, D.; Zaniboni, A.; Ferrari, D.; Mosconi, S.; Spallanzani, A.; Cavanna, L.; Leo, S.; Negri, F.; Beretta, G.D.; Sobrero, A.; Banzi, M.; Morabito, A.; Bittoni, A.; Marciano, R.; Ferrara, D.; Noventa, S.; Piccirillo, M.C.; Labianca, R.; Mosconi, C.; Casadei Gardini, A.; Gallo, C.; Perrone, F. 2021: Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - a GISCAD phase Ii randomized trial. European Journal of Cancer 148: 422-429
Talwar, V.; Raina, S.; Goel, V.; Dash, P.; Doval, D.C. 2020: Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer. Indian Journal of Medical Research 152(5): 475-481
Bretschneider, J. 2000: Nabada: the buried city. Scientific American 283(4): 74-81
Liu, J.; Liu, S.; Liu, C.; Zhang, Y.; Pan, Y.; Wang, Z.; Wang, J.; Wen, T.; Deng, L. 2021: Nabe: an energetic database of amino acid mutations in protein-nucleic acid binding interfaces. Database: the Journal of Biological Databases and Curation 2021
Baumann, T. 1949: Nabesepsis. Annales Paediatrici. International Review of Pediatrics 172(1): 69
Bagcchi, S. 2021: Nabil Aziz Awad Alla. LANCET. Infectious Diseases 21(8): 1081
Haney, M.; Cooper, Z.D.; Bedi, G.; Vosburg, S.K.; Comer, S.D.; Foltin, R.W. 2013: Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 38(8): 1557-1565
Sartori, A.; Dinoto, A.; Stragapede, L.; Mazzon, G.; Morelli, M.E.; Pasquin, F.; Bratina, A.; Bosco, A.; Manganotti, P. 2021: Nabiximols and botulinum toxin injections for patients with multiple sclerosis: efficacy on spasticity and spasms in a single-centre experience. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 42(12): 5037-5043
Chisari, C.G.; Solaro, C.; Annunziata, P.; Bergamaschi, R.; Bianco, A.; Bonavita, S.; Brescia Morra, V.; Bruno Bossio, R.; Capello, E.; Castelli, L.; Cavalla, P.; Costantino, G.; Centonze, D.; Cottone, S.; Danni, M.C.; Esposito, F.; Gajofatto, A.; Gasperini, C.; Guareschi, A.; Lanzillo, R.; Lus, G.; Maniscalco, G.T.; Matta, M.; Paolicelli, D.; Petrucci, L.; Pontecorvo, S.; Righini, I.; Rovaris, M.; Sessa, E.; Spinicci, G.; Spitaleri, D.; Valentino, P.; Zaffaroni, M.; Zappia, M.; Patti, F. 2020: Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. Journal of Neurology Neurosurgery and Psychiatry 91(9): 914-920
Calabrò, R.S.; Russo, M.; Naro, A.; Ciurleo, R.; D'Aleo, G.; Rifici, C.; Balletta, T.; La Via, C.; Destro, M.; Bramanti, P.; Sessa, E. 2020: Nabiximols plus robotic assisted gait training in improving motor performances in people with Multiple Sclerosis. Multiple Sclerosis and Related Disorders 43: 102177
Turan, B.; Akinci, M.A.; Esin, I.S.; Dursun, O.B. 2020: Nablus Mask-Like Facial Syndrome with Moderate Developmental Delay. Eurasian Journal of Medicine 52(2): 229-230
Qureshi, S.; Chandra, S.; Chopra, D.; Dubey, D.; Jain, V.; Roy, S.Kumar.; Ray, R.Singh. 2021: Nabumetone induced photogenotoxicity mechanism mediated by ROS generation under environmental UV radiation in human keratinocytes (HaCaT) cell line. Toxicology and Applied Pharmacology 420: 115516
Schrems, B.M. 2021: Nach der Krise ist vor der Krise oder: Nothing changes if nothing changes. Pflege 34(1): 1-2
Ludwig, I.; Panfil, E-Maria. 2021: Nachruf auf Liliane Juchli. Pflege 34(1): 64-65
Cartwright, J.H.E.; Checa, A.G.; Sainz-Díaz, C.I. 2020: Nacre Is a Liquid-Crystal Thermometer of the Oceans. Acs Nano 14(8): 9277-9281
Santana, P.; Aldana Aranda, D. 2021: Nacre morphology and chemical composition in Atlantic winged oyster Pteria colymbus (Röding, 1798). Peerj 9: E11527
Qiu, S.; Ren, X.; Zhou, X.; Zhang, T.; Song, L.; Hu, Y. 2020: Nacre-Inspired Black Phosphorus/Nanofibrillar Cellulose Composite Film with Enhanced Mechanical Properties and Superior Fire Resistance. Acs Applied Materials and Interfaces 12(32): 36639-36651
Zeng, B.; Yang, L.; Qin, J.; Zheng, Y.; Guo, S. 2020: Nacre-Inspired Polymeric Materials with Body Heat-Responsive Shape-Memory Effect, High Optical Transparence, and Balanced Mechanical Properties. Acs Applied Materials and Interfaces 12(46): 52008-52017
Das, P.; Malho, J-Markus.; Rahimi, K.; Schacher, F.H.; Wang, B.; Demco, D.Eugen.; Walther, A. 2015: Nacre-mimetics with synthetic nanoclays up to ultrahigh aspect ratios. Nature Communications 6: 5967
Pan, X.-F.; Gao, H.-L.; Wu, K.-J.; Chen, S.-M.; He, T.; Lu, Y.; Ni, Y.; Yu, S.-H. 2021: Nacreous aramid-mica bulk materials with excellent mechanical properties and environmental stability. Iscience 24(1): 101971
Kushwah, R.; Oliver, J.R.; Cao, H.; Hu, J. 2007: Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways. Gene Therapy 14(16): 1243-1248
Barnes, C.A.; Ryan, L.; Peterson, M.A. 2020: Nadel special issue introduction. Hippocampus 30(8): 773-775
Nader, R. 1971: Nader's en garde to Handler. Nature 231(5299): 144
Piatek, S.; Panek, G.; Lewandowski, Z.; Piatek, D.; Kosinski, P.; Bidzinski, M. 2021: Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer. Scientific Reports 11(1): 18190
Nakamura, K.; Kitahara, Y.; Nishimura, T.; Yamashita, S.; Kigure, K.; Ito, I.; Kanuma, T. 2020: Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer. World Journal of Surgical Oncology 18(1): 200
Baron, A.T.; Maihle, N. 2005: Nadir CA125 concentration as a prognostic indicator in ovarian cancer. Nature Clinical Practice. Oncology 2(6): 288-289
Sasaki, T.; Onishi, T.; Hoshina, A. 2011: Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis. Prostate Cancer and Prostatic Diseases 14(3): 248-252
Freitag, F.G.; Diamond, S. 1984: Nadolol and placebo comparison study in the prophylactic treatment of migraine. Journal of the American Osteopathic Association 84(4): 343-347
Mitenko, P.A.; McKenzie, J.K.; Sitar, D.S.; Penner, S.B.; Aoki, F.Y. 1989: Nadolol antihypertensive effect and disposition in young and elderly adults with mild to moderate essential hypertension. Clinical Pharmacology and Therapeutics 46(1): 56-62
Reeves, R.A.; From, G.L.; Paul, W.; Leenen, F.H. 1985: Nadolol, propranolol, and thyroid hormones: evidence for a membrane-stabilizing action of propranolol. Clinical Pharmacology and Therapeutics 37(2): 157-161
Guzmán-Téllez, P.; Martínez-Valencia, D.; Silva-Olivares, A.él.; Del Ángel, R.M.; Serrano-Luna, J.ús.; Shibayama, M. 2020: Naegleria fowleri and Naegleria gruberi 20S proteasome: identification and characterization. European Journal of Cell Biology 99(5): 151085
Leonard, P. 1946: Naevi adenatantes symmetrics of the large lips (type Hallopeau-Leredde-Darier) rare localization. Annales de Dermatologie et de Syphiligraphie 6(9): 501
Woringer, F.; Renard, R. 1949: Naevic epitheliomatosis with melanin pigmentation. Annales de Dermatologie et de Syphiligraphie 9(1): 38-44
Siddappa, K.; Mahipal, O.A.; Chandrasekhar, H.R. 1982: Naevus Lipomatosus Cutaneous Superficialis. Indian Journal of Dermatology Venereology and Leprology 48(5): 282-286
Blodi, F. 1949: Naevus flammeus faciei and glaucoma without enlarging the globe. OPHTHALMOLOGICA. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 117(2): 82-89
Torchia, D. 2021: Naevus vascularis mixtus and mixed vascular naevus syndrome. Clinical and Experimental Dermatology 46(1): 34-41
Hofbauer 1946: Naevus verrucosus systematicus zosteriformis. Wiener Klinische Wochenschrift 58(19): 314
Fuwa, M.; Kageyama, M.; Ohashi, K.; Sasaoka, M.; Sato, R.; Tanaka, M.; Tashiro, K. 2019: Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model. Scientific Reports 9(1): 20409
Chen, T.; Wang, J.; Li, C.; Zhang, W.; Zhang, L.; An, L.; Pang, T.; Shi, X.; Liao, H. 2014: Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition. Scientific Reports 4: 5531
Kuriyama, N.; Matsumoto, K.; Morita, K.; Shimomura, Y.; Hara, Y.; Hasegawa, D.; Nakamura, T.; Yamashita, C.; Kato, Y.; Komura, H.; Nishida, O. 2020: Nafamostat mesilate inhibits linezolid metabolism via its antioxidant effects. Therapeutic Apheresis and Dialysis: Official Peer-Reviewed Journal of the International Society for Apheresis the Japanese Society for Apheresis the Japanese Society for Dialysis Therapy 24(5): 499-502
Takada, N.; Sugano, H.; Shirai, Y.; Saito, N.; Hamura, R.; Taniai, T.; Uwagawa, T.; Yanaga, K.; Ikegami, T.; Ohashi, T.; Eto, K. 2021: Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. Plos one 16(9): E0257019
Ghali, G.Z.; Ghali, M.G.Z. 2020: Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia. Neural Regeneration Research 15(12): 2217-2234
Peng, L.; Zhang, H.; Hu, Z.; Zhao, Y.; Liu, S.; Chen, J. 2020: Nafamostat mesylate inhibits chlamydial intracellular growth in cell culture and reduces chlamydial infection in the mouse genital tract. Microbial Pathogenesis 147: 104413
Doi, K.; Ikeda, M.; Hayase, N.; Moriya, K.; Morimura, N.; Maehara, H.; Tagami, S.; Fukushima, K.; Misawa, N.; Inoue, Y.; Nakamura, H.; Takai, D.; Kurimoto, M.; Tokunaga, K.; Yamamoto, M.; Hirayama, I.; Horie, R.; Endo, Y.; Hiwatashi, K.; Shikama, M.; Jubishi, D.; Kanno, Y.; Okamoto, K.; Harada, S.; Okugawa, S.; Miyazono, K.; Seto, Y.; Inoue, J.-I. 2020: Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series. Critical Care 24(1): 392
Penzias, A.S.; Shamma, F.N.; Gutmann, J.N.; Jones, E.E.; DeCherney, A.H.; Lavy, G. 1992: Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial. Obstetrics and Gynecology 79(5): 739-742
Szczęch, M.; Łopuszyńska, N.; Tomal, W.; Jasiński, K.; Węglarz, W.ła.ła.P.; Warszyński, P.; Szczepanowicz, K. 2020: Nafion-Based Nanocarriers for Fluorine Magnetic Resonance Imaging. Langmuir: the Acs Journal of Surfaces and Colloids 36(32): 9534-9539
Morales, D.M.; Villalobos, J.; Kazakova, M.A.; Xiao, J.; Risch, M. 2021: Nafion-Induced Reduction of Manganese and its Impact on the Electrocatalytic Properties of a Highly Active MnFeNi Oxide for Bifunctional Oxygen Conversion. Chemelectrochem 8(15): 2979-2983
Zou, J.; Yu, J.-G. 2020: Nafion-stabilized black phosphorus nanosheets-maltosyl-β-cyclodextrin as a chiral sensor for tryptophan enantiomers. Materials Science and Engineering. C Materials for Biological Applications 112: 110910
Zhou, Y.; Jia, B.-S.; Zhou, Y.-G.; Li, A.-H.; Xue, L. 2020: Naganishia floricola sp. nov., a novel basidiomycetous yeast species isolated from flowers of Sorbaria sorbifolia. International Journal of Systematic and Evolutionary Microbiology 70(8): 4496-4501
Dehollain, J.P.; Mukhopadhyay, U.; Michal, V.P.; Wang, Y.; Wunsch, B.; Reichl, C.; Wegscheider, W.; Rudner, M.S.; Demler, E.; Vandersypen, L.M.K. 2020: Nagaoka ferromagnetism observed in a quantum dot plaquette. Nature 579(7800): 528-533
Mettenleiter, A. 2000: Nagasaki Medical School. Japan's medicine has European roots. MMW Fortschritte der Medizin 142(46): 69
Songsantiphap, C.; Suwanwatana, J.; Ittiwut, C.; Asawanonda, P.; Rerknimitr, P.; Shotelersuk, V. 2020: Nagashima-Type Palmoplantar Keratosis with Compound Heterozygous Mutations in SERPINB7. Case Reports in Dermatology 12(3): 241-248
Huang, C.; Yang, Y.; Huang, X.; Zhou, Z. 2021: Nagashima-Type Palmoplantar Keratosis: Clinical Characteristics, Genetic Characterization, and Clinical Management. Biomed Research International 2021: 8841994
Hayakawa, M.; Tahara, U.; Ono, N.; Aoki, S.; Kawai, T.; Nakabayashi, K.; Hata, K.; Amagai, M.; Kubo, A. 2020: Nagashima-type palmoplantar keratosis caused by biallelic maternal mutation of SERPINB7 with segmental uniparental disomy of chromosome 18q. Journal of Dermatology 47(12): E453-E454
Kubo, A. 2014: Nagashima-type palmoplantar keratosis: a common Asian type caused by SERPINB7 protease inhibitor deficiency. Journal of Investigative Dermatology 134(8): 2076-2079
Chen, Y.-C.; Huang, M.-Y.; Zhang, L.-L.; Feng, Z.-L.; Jiang, X.-M.; Yuan, L.-W.; Huang, R.-Y.; Liu, B.; Yu, H.; Wang, Y.-T.; Chen, X.-P.; Lin, L.-G.; Lu, J.-J. 2020: Nagilactone e increases PD-L1 expression through activation of c-Jun in lung cancer cells. Chinese Journal of Natural Medicines 18(7): 517-525
Lajaunie, C.; Morand, S. 2020: Nagoya Protocol and Infectious Diseases: Hindrance or Opportunity?. Frontiers in Public Health 8: 238
Yildirim, N.; Nahabed Roussignan 1995: Nahabed Roussignan, the first professor of deontology at the Royal School of Medicine. Yeni Tip Tarihi Arastirmalari 1: 148-161
Vompi, C.; Vernucci, R.; Costantini, A.M.; Mazzoli, V.; Galluccio, G.; Silvestri, A. 2020: Nahoum Index in Brachyfacial Patients: a Pilot Study. Turkish Journal of Orthodontics 33(2): 98-102
Linares-Rosas, M.I.; Gómez, B.; Aldasoro-Maya, E.M.; Casas, A. 2021: Nahua biocultural richness: an ethnoherpetological perspective. Journal of Ethnobiology and Ethnomedicine 17(1): 33
Kaur, I.; Jakhar, D.; Singal, A.; Grover, C. 2020: Nail Care for Healthcare Workers during COVID-19 Pandemic. Indian Dermatology Online Journal 11(3): 449-450
Shrimal, A.; Gupte, A.A. 2020: Nail Changes in Cirrhosis and Reversal After Adult and Pediatric Liver Transplantation. Journal of Clinical and Experimental Hepatology 10(5): 531-532
Verma, S.; Singal, A. 2021: Nail Changes in Hand-Foot-and-Mouth Disease (HFMD). Indian Dermatology Online Journal 12(4): 656-657
Rajput, C.D.; Nikam, B.P.; Gore, S.B.; Malani, S.S. 2020: Nail Changes in Leprosy: An Observational Study of 125 Patients. Indian Dermatology Online Journal 11(2): 195-201
Theunuo, R.; Sasidharanpillai, S.; Ajithkumar, K.; George, B.; Salim, R.S. 2020: Nail Changes in Leprosy: Onychoscopy Evaluation. Indian Dermatology Online Journal 11(6): 970-974
Żychowska, M.; Żychowska, M.łg. 2021: Nail Changes in Lichen Planus: a Single-Center Study. Journal of Cutaneous Medicine and Surgery 25(3): 281-285
Draelos, Z.D. 2021: Nail Cosmetics and Adornment. Dermatologic Clinics 39(2): 351-359
Monteiro, A.F.; Pinheiro, R.R.; Galhardas, C.él.; Lencastre, A.é 2021: Nail Disease: Clinical Decisions among Portuguese Dermatologists and Family Physicians. Skin Appendage Disorders 7(1): 13-17
Lipner, S.R. 2021: Nail Disorders: Diagnosis and Management. Dermatologic Clinics 39(2): Xi
Djuardi, I.; Ilyas, F.; Djawad, K.; Helina, I.; Wibisono, O. 2020: Nail Fold Dermatoscopic Findings in Scleroderma Patients. Skinmed 18(5): 308-310
Preda-Naumescu, A.; Penney, K.; Pearlman, R.L.; Brodell, R.T.; Daniel, C.R.; Nahar, V.K. 2021: Nail Manifestations in COVID-19: Insight into a Systemic Viral Disease. Skin Appendage Disorders 183: 1-6
Chiheb, S.; Benslimane Kamal, I.; Elfiboumi, A.; Hali, F. 2021: Nail Peeling with Glycolic Acid 50%: a Prospective Study of 20 Cases. Skin Appendage Disorders 7(5): 363-365
Ryo, T.; Ishiguro, F.; Takenaka, H.; Ashida, S.; Yokoyama, Y.; Shigemitsu, K. 2021: Nail Penetrating Injury of the Sternum. Kyobu Geka. Japanese Journal of Thoracic Surgery 74(3): 206-208
Rich, P.; Goldblum, O.; Disch, D.; Lin, C.-Y.; Merola, J.F.; Elewski, B. 2020: Nail Psoriasis Does not Affect Skin Response to Ixekizumab in Patients with Moderate-To-Severe Psoriasis. Journal of Drugs in Dermatology: Jdd 19(8): 741-746
Nirbhavane, P.; Sharma, G.; Verma, S.; Jadon, R.S.; Singh, B.; Katare, O.P. 2020: Nail Psoriasis Treatment: Insights into Current Progress and Future Trends. Critical Reviews in Therapeutic Drug Carrier Systems 37(2): 135-159
Ricardo, J.W.; Lipner, S.R. 2021: Nail Psoriasis in Older Adults: Epidemiology, Diagnosis, and Topical Therapy. Dermatologic Clinics 39(2): 183-193
Ricardo, J.W.; Lipner, S.R. 2021: Nail Psoriasis in Older Adults: Intralesional, Systemic, and Biological Therapy. Dermatologic Clinics 39(2): 195-210
Ricardo, J.W.; Lipner, S.R. 2020: Nail Surgery Myths and Truths. Journal of Drugs in Dermatology: Jdd 19(3): 230-234
Baltz, J.O.; Jellinek, N.J. 2021: Nail Surgery: Six Essential Techniques. Dermatologic Clinics 39(2): 305-318
Matsumoto, A.; Strickland, N.; Nijhawan, R.I.; Srivastava, D. 2021: Nail Unit Melanoma in Situ Treated with Mohs Micrographic Surgery. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 47(1): 98-103
Dany, M.; Fischer, A.S.; Pei, S.; Ogunleye, T.; Elenitsas, R.; Rubin, A.I. 2020: Nail Unit Schwannoma: An Important Consideration in the Differential Diagnosis of Soft Tissue Tumors Affecting the Nail Apparatus. Skin Appendage Disorders 6(6): 370-373
Ozaki, A.; Kanemoto, Y.; Morita, T.; Nishikawa, Y.; Sawano, T.; Fujioka, S.; Shimada, Y.; Higuchi, A.; Tsubokura, M.; Kanzaki, N. 2021: Nail Wound and Cellulitis Following Typhoon Hagibis in Fukushima, Japan. Disaster Medicine and Public Health Preparedness 15(5): 540-542
Goldberg, L.H.; Farshchian, M.; Tarantino, I.S.; Beroukhim, K.; Kimyai-Asadi, A. 2021: Nail bed staining as a guide for taking Mohs layers of the residual tumors. Dermatologic Therapy 34(6): E15149
Ocampo-Garza, S.S.; Ocampo-Candiani, J.; Camela, E.; Vastarella, M.; Fabbrocini, G.; Scalvenzi, M.; Villani, A. 2021: Nail changes as manifestation of systemic disease in COVID-19 infection. Journal of the European Academy of Dermatology and Venereology: Jeadv 35(8): E474-E475
Litaiem, N.; Chabchoub, I.; Gara, S.; Slouma, M.; Hamdi, M.S.; Zeglaoui, F. 2021: Nail changes in systemic amyloidosis. Clinical Case Reports 9(8): E04685
Trevisan, Fávia.; Werner, B.; Pinheiro, R.Lameira. 2019: Nail clipping in onychomycosis and comparison with normal nails and ungual psoriasis. Anais Brasileiros de Dermatologia 94(3): 344-347
Castro, L.Án.; Álvarez, M.ía.I.és. 2021: Nail dermatophytoma in HIV-infected patients in Cali, Colombia. Journal de Mycologie Medicale 31(3): 101172
Arievich, A.M.; Kukoleva, L.I. 1973: Nail diseases in lichen ruber planus. Vestnik Dermatologii i Venerologii 47(10): 9-15
Mathews, J.; Jacob, S.Elizabeth.; Chandrashekar, L. 2021: Nail dystrophy, conjunctival papules, and scalp lesions in a 1-year-old girl. References 38(2): E14-E15
Huang, J.T.; Duncan, C.N.; Boyer, D.; Khosravi, H.; Lehmann, L.E.; Saavedra, A. 2014: Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children. Bone Marrow Transplantation 49(12): 1521-1527
McGuinness, M.J.; Thompson, G.; Haysom, S.; Civil, I. 2021: Nail gun injuries: not just an occupational hazard. New Zealand Medical Journal 134(1540): 56-63
Starr, M.R.; Cohen, M.N. 2021: Nail gun injury with intraocular foreign body. Journal of the American College of Emergency Physicians Open 2(4): E12527
Ortiz Álvarez, J.; Ortiz Prieto, A.; Jiménez Thomas, G.J.; Ruiz Román, A.; García-Morillo, J.é S. 2021: Nail involvement as a solitary manifestation of pemphigus vulgaris at the time of diagnosis. Medicina 81(2): 305
Dehavay, F.; Richert, B. 2021: Nail is Systemic Disorders: Main Signs and Clues. Dermatologic Clinics 39(2): 153-173
Capatas, S.; Erraji, H.; Al Fatoiki, F.; Dahbi Skali, H.; Hali, F.; Marnissi, F.; Chiheb, S. 2020: Nail lichen planus: a descriptive and comparative study of 51 cases. Annales de Dermatologie et de Venereologie 147(12): 876-878
Dupond, A.S.; Magy, N.; Humbert, P.; Dupond, J.L. 2000: Nail manifestations of systemic diseases. La Revue du Praticien 50(20): 2236-2240
Chen, J.; Wang, X.; Zhu, Y.; He, J.; Rao, Y.; Liu, K. 2022: Nail matrix scars that result in nail dystrophy resemble cutaneous scars: a new nail trauma model. Burns: Journal of the International Society for Burn Injuries 48(2): 396-403
Duba, H.C.; Erdel, M.; Löffler, J.; Wirth, J.; Utermann, B.; Utermann, G. 1998: Nail patella syndrome in a cytogenetically balanced t(9;17)(q34.1;q25) carrier. European Journal of Human Genetics: Ejhg 6(1): 75-79
Daniel, C.R.; Osment, L.S. 1980: Nail pigmentation abnormalities. their importance and proper examination. Cutis 25(6): 595-607
Ganta, A.; Wang, C.; Konda, S.R.; Egol, K.A. 2022: Nail plate combination in the upper extremity: surgical technique and clinical application. European Journal of Orthopaedic Surgery and Traumatology: Orthopedie Traumatologie 32(3): 443-448
Duarte, A.Antônio.; Carneiro, Gúlio.Pisa.; Murari, C.Malavassi.; de Jesus, L.Costa.Beber. 2019: Nail psoriasis treated with intralesional methotrexate infiltration. Anais Brasileiros de Dermatologia 94(4): 491-492
Ghoumid, J.; Petit, F.; Holder-Espinasse, M.; Jourdain, A-Sophie.; Guerra, Jé.; Dieux-Coeslier, A.; Figeac, M.; Porchet, N.; Manouvrier-Hanu, S.; Escande, F. 2016: Nail-Patella Syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity. European Journal of Human Genetics: Ejhg 24(1): 44-50
Mirick Mueller, G.E. 2019: Nail-Plate Constructs for Periprosthetic Distal Femur Fractures. Journal of Knee Surgery 32(5): 403-406
Mann, A.J.D.; Van Voorhees, E.E.; Patel, T.A.; Wilson, S.M.; Gratz, K.L.; Calhoun, P.S.; Beckham, J.C.; Kimbrel, N.A. 2020: Nail-biting, scab-picking, and tattooing as nonsuicidal self-injury (NSSI): a deviant case series analysis of the proposed NSSi disorder diagnostic criteria. Journal of Clinical Psychology 76(12): 2296-2313
Rogner, B.; Rose, W.; Hornak, H.; Heinrich, H.G. 1989: Nail-patella syndrome. Zeitschrift für Urologie und Nephrologie 82(12): 661-665
Marfil, R.G.; Luna, S.; Hafiz, A.; Cohen, S. 1969: Nail-patella syndrome. Canadian Medical Association Journal 101(12): 44-47
Vesa, L.; Similä, S. 1968: Nail-patella syndrome. Duodecim; Laaketieteellinen Aikakauskirja 84(5): 319-323
Díaz-Pérez, J.L.; Esquerdeiro, P.; Moreno, J.; Goicoechea, A. 1981: Nail-patella syndrome. Medicina Cutanea Ibero-Latino-Americana 9(2): 143-148
Neuhold, A.; Seidl, G.; Stummvoll, H.; Syre, G.; Brandstätter, G. 1982: Nail-patella syndrome. Der Radiologe 22(12): 568-571
Sabnis, S.G.; Antonovych, T.T.; Argy, W.P.; Rakowski, T.A.; Gandy, D.R.; Salcedo, J.R. 1980: Nail-patella syndrome. Clinical Nephrology 14(3): 148-153
Lo Sicco, K.; Sadeghpour, M.; Ferris, L. 2015: Nail-patella syndrome. Journal of Drugs in Dermatology: Jdd 14(1): 85-86
Norton, L.A.; Mescon, H. 1968: Nail-patella-elbow syndrome. Archives of Dermatology 98(4): 372-374
Robson, W.L.; Leung, A.K. 1993: Nailbiting. Journal of the Royal Society of Medicine 86(2): 120
Arslan, N.G.; Pancar, G.S. 2021: Nailfold capillaroscopic changes of sleep apnea patients. Microvascular Research 137: 104177
Johnson, D.; van Eeden, C.; Moazab, N.; Redmond, D.; Phan, C.; Keeling, S.; Gniadecki, R.; Cohen Tervaert, J.W.; Osman, M. 2021: Nailfold Capillaroscopy Abnormalities Correlate with Disease Activity in Adult Dermatomyositis. Frontiers in Medicine 8: 708432
Chanprapaph, K.; Fakprapai, W.; Limtong, P.; Suchonwanit, P. 2021: Nailfold Capillaroscopy with USB Digital Microscopy in Connective Tissue Diseases: a Comparative Study of 245 Patients and Healthy Controls. Frontiers in Medicine 8: 683900
Pfahler, N.M.; Barry, J.L.; Bielskus, I.E.; Kakouri, A.; Giovingo, M.C.; Volpe, N.J.; Knepper, P.A. 2020: Nailfold Capillary Hemorrhages: Microvascular Risk Factors for Primary Open-Angle Glaucoma. Journal of Ophthalmology 2020: 8324319
Tsuzuki, S.; Komai, T.; Terada, K.; Tsuchida, Y.; Tanaka, M.; Tateishi, Y.; Shinozaki-Ushiku, A.; Shoda, H.; Fujio, K. 2021: Nailfold capillaroscopic abnormalities in angioedema with eosinophilia. Allergology International: Official Journal of the Japanese Society of Allergology 70(4): 501-503
Mansueto, N.; Rotondo, C.; Corrado, A.; Cantatore, F.P. 2021: Nailfold capillaroscopy : a comprehensive review on common findings and clinical usefulness in non-rheumatic disease. Journal of Medical Investigation: Jmi 68(1.2): 6-14
Sakamoto, T.; Kaburaki, M.; Shimizu, T. 2022: Nailfold capillaroscopy findings and systemic sclerosis. Qjm: Monthly Journal of the Association of Physicians 115(4): 266
Monfort, J.-B.ît.; Chasset, F.ço.; Barbaud, A.; Frances, C.; Senet, P. 2021: Nailfold capillaroscopy findings in cutaneous lupus erythematosus patients with or without digital lesions and comparison with dermatomyositis patients: a prospective study. Lupus 30(8): 1207-1213
Natalello, G.; De Luca, G.; Gigante, L.; Campochiaro, C.; De Lorenzis, E.; Verardi, L.; Paglionico, A.; Petricca, L.; Martone, A.M.; Calvisi, S.; Ripa, M.; Cavalli, G.; Della-Torre, E.; Tresoldi, M.; Landi, F.; Bosello, S.L.; Gremese, E.; Dagna, L. 2021: Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvascular Research 133: 104071
Piotto, D.G.P.; Len, C.áu.A.; Hilário, M.O.E.; Terreri, M.T.R.A.ão. 2012: Nailfold capillaroscopy in children and adolescents with rheumatic diseases. Revista Brasileira de Reumatologia 52(5): 722-732
Ciaffi, J.; Ajasllari, N.; Mancarella, L.; Brusi, V.; Meliconi, R.; Ursini, F. 2020: Nailfold capillaroscopy in common non-rheumatic conditions: a systematic review and applications for clinical practice. Microvascular Research 131: 104036
Sivasankari, M.; Arora, S.; Vasdev, V.; Mary, E.M. 2021: Nailfold capillaroscopy in psoriasis. Medical Journal Armed Forces India 77(1): 75-81
Çakmak, F.; Demirbuga, A.; Demirkol, D.; Gümüş, S.üh.; Torun, S.H.; Kayaalp, G.ül.şa.K.; Ömeroglu, R.E.; Somer, A.; Uysalol, M.; Yıldız, R.; Ayaz, N.A. 2021: Nailfold capillaroscopy: a sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvascular Research 138: 104196
Sirufo, M.M.; Bassino, E.M.; De Pietro, F.; Ginaldi, L.; De Martinis, M. 2021: Nailfold capillaroscopy: Clinical practice in non-rheumatic conditions. Microvascular Research 134: 104122
Hofstee, H.M.A.; de Waal, T.T.; Zweegman, S.; Voskuyl, A.E.; Smulders, Y.M.; Schoordijk, M.C.E.; Janssen, J.J.W.M.; Serné, E.H. 2013: Nailfold capillary abnormalities in sclerodermatous chronic GVHD. Bone Marrow Transplantation 48(12): 1574-1577
Mishra, A.; Grover, C.; Singal, A.; Narang, S.; Das, G.K. 2021: Nailfold capillary changes in newly diagnosed hypertensive patients: An observational analytical study. Microvascular Research 136: 104173
Cousins, C.C.; Kang, J.H.; Bovee, C.; Wang, J.; Greenstein, S.H.; Turalba, A.; Shen, L.Q.; Brauner, S.; Boumenna, T.; Blum, S.; Levkovitch-Verbin, H.; Ritch, R.; Wiggs, J.L.; Knepper, P.A.; Pasquale, L.R. 2017: Nailfold capillary morphology in exfoliation syndrome. Eye 31(5): 698-707
Houtman, N. 2000: Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. Journal of Rheumatology 27(11): 2722-2723
Arvanitaki, A.; Giannakoulas, G.; Triantafyllidou, E.; Karvounis, H.; Garyfallos, A.; Kitas, G.; Dimitroulas, T. 2020: Nailfold videocapillaroscopy: a novel possible surrogate marker for the evaluation of peripheral microangiopathy in pulmonary arterial hypertension. Scandinavian Journal of Rheumatology 2020: 1-10
Henley, M.J.; Doyle, S.K.; Koehler, A.N. 2021: Nailing down a Notoriously Elusive Cancer Target: Direct Inhibition of MYC by a Covalent Small Molecule. Cell Chemical Biology 28(1): 1-3
Garzia, L.; Taylor, M.D. 2020: Nailing a Fe-rocious form of cancer. Science 369(6501): 250-251
Salem, G. 1949: Nailing and late results of childhood femoral neck fractures and epiphyseal solutions. Wiener Klinische Wochenschrift 61(10): 152-154
Richman, D.D. 1998: Nailing down another HIV target. Nature Medicine 4(11): 1232-1233
Aprato, A.; Secco, D.C.; D'Amelio, A.; Grosso, E.; Massè, A. 2021: Nailing femoral shaft fracture with postless distraction technique: a new technique enabled by shape-conforming pad. Journal of Orthopaedics and Traumatology: Official Journal of the Italian Society of Orthopaedics and Traumatology 22(1): 14
Prat 1949: Nailing fractures of the femoral neck by the ball collimator. Marseille Chirurgical 1(4): 479-484
Massart, R. 1946: Nailing long bone fractures. Clinique 41: 41
Girard, P.; Zihindula, M.ïs.C.; Delinois, D.; Kolontchang, L.; Zirkle, L.; Djebara, A.-E.; Mathieu, L. 2021: Nailing of long bone fractures in precarious situations: focus on the Surgical Implant Generation Network (SIGN) nail. Pan African Medical Journal 39: 130
Moser, H. 1955: Nailing of pertrochanteric fractures. Wiener Medizinische Wochenschrift 105(13): 269-270
MAJNONI d'INTIGNANO, J.M. 1946: Nailing of the femoral neck with improved dead reckoning. Revued'OrthopedieetdeChirurgiedel'AppareilMoteur 33(1-2): 139
Hertz, C.; Kisselnok 1949: Nailing of the neck of the femur without an aiming device. Journal des Praticiens; Revue Generale de Clinique et de Therapeutique 63(13): 158
Sechehaye, L. 1948: Nailing of the wrist scaphoid in nonunions. Praxis 37(20): 353
Masmonteil, F.; Leuret, J. 1948: Nailing technique for the neck of the febrile wall under radiological control. Bulletin et Memoires de la Societe des Chirurgiens de Paris 38(2-3): 73-77
Yow, K.S.; Tan, C.L.; Nashi, N.B. 2020: Nailing the Diagnosis-Antisynthetase Syndrome as a Cause for Pyrexia of Unknown Origin. American Journal of Medicine 133(12): E737-E739
Hopf, J.C.; Nowak, T.E.; Mehler, D.; Arand, C.; Gruszka, D.; Westphal, R.; Rommens, P.M. 2020: Nailing vs. plating in comminuted proximal ulna fractures - a biomechanical analysis. Bmc Musculoskeletal Disorders 21(1): 616
Wollina, U.; Kanitakis, J.; Baran, R. 2021: Nails and COVID-19 - a comprehensive review of clinical findings and treatment. Dermatologic Therapy 34(5): E15100
Gollins, C.E.; de Berker, D. 2021: Nails in systemic disease. Clinical Medicine 21(3): 166-169
Gregoriou, S.; Platsidaki, E.; Sidiropoulou, P.; Rigopoulos, D. 2021: Nails with bloodstained discoloration. Bmj 375: N1951
Hughes, R.C.; Kitsao-Wekulo, P.; Bhopal, S.; Kimani-Murage, E.W.; Hill, Z.; Kirkwood, B.R. 2020: Nairobi Early Childcare in Slums (NECS) Study Protocol: a mixed-methods exploration of paid early childcare in Mukuru slum, Nairobi. Bmj Paediatrics Open 4(1): E000822
Janssen, M.; Bruijstens, A.L.; van Langelaar, J.; Wong, Y.; Wierenga-Wolf, A.F.; Melief, M.-J.é; Rijvers, L.; van Pelt, E.D.ël.; Smolders, J.; Wokke, B.H.; van Luijn, M.M. 2020: Naive B cells in neuromyelitis optica spectrum disorders: impact of steroid use and relapses. Brain Communications 2(2): Fcaa 197
Padgett, L.E.; Dinh, H.Q.; Wu, R.; Gaddis, D.E.; Araujo, D.J.; Winkels, H.; Nguyen, A.; McNamara, C.A.; Hedrick, C.C. 2020: Naive CD8+ T Cells Expressing CD95 Increase Human Cardiovascular Disease Severity. Arteriosclerosis Thrombosis and Vascular Biology 40(12): 2845-2859
Cinkornpumin, J.K.; Kwon, S.Y.; Guo, Y.; Hossain, I.; Sirois, J.; Russett, C.S.; Tseng, H.-W.; Okae, H.; Arima, T.; Duchaine, T.F.; Liu, W.; Pastor, W.A. 2020: Naive Human Embryonic Stem Cells can give Rise to Cells with a Trophoblast-like Transcriptome and Methylome. Stem Cell Reports 15(1): 198-213
Takada, K.; Jameson, S.C. 2009: Naive T cell homeostasis: from awareness of space to a sense of place. Nature Reviews. Immunology 9(12): 823-832
Flemming, A. 2019: Naive T cells can be primed for tissue residency. Nature Reviews. Immunology 19(12): 718-719
Bleakley, M. 2020: Naive T-cell depletion in stem cell transplantation. Blood Advances 4(19): 4980
Yang, L.; Mailloux, A.; Rollison, D.E.; Painter, J.S.; Maciejewski, J.; Paquette, R.L.; Loughran, T.P.; McGraw, K.; Makishima, H.; Radhakrishnan, R.; Wei, S.; Ren, X.; Komrokji, R.; List, A.F.; Epling-Burnette, P.K. 2013: Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency. Leukemia 27(4): 897-906
Zelianskaia, N.L.; Belousov, K.I.; Galinskaia, T.N.; Ichkineeva, D.A. 2020: Naive geography: geoconceptology and topology of geomental maps. Heliyon 6(12): E05644
Zhang, F.; Zong, X.; Zhou, X.; Sun, S.; Xiao, X.; Sun, J. 2021: Naive haemophilia mice displayed different pattern of cytokine profiles of cytokine profiles changes might be associated with subclinical bleeding. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 32(8): 584-590
Feldman, J.; Bals, J.; Altomare, C.G.; St Denis, K.; Lam, E.C.; Hauser, B.M.; Ronsard, L.; Sangesland, M.; Moreno, T.B.; Okonkwo, V.; Hartojo, N.; Balazs, A.B.; Bajic, G.; Lingwood, D.; Schmidt, A.G. 2021: Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. Biorxiv: the Preprint Server for Biology 2021
Feldman, J.; Bals, J.; Altomare, C.G.; St Denis, K.; Lam, E.C.; Hauser, B.M.; Ronsard, L.; Sangesland, M.; Moreno, T.B.; Okonkwo, V.; Hartojo, N.; Balazs, A.B.; Bajic, G.; Lingwood, D.; Schmidt, A.G. 2021: Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses. Science Immunology 6(66): Eabl 5842
Leitch, H.G.; McEwen, K.R.; Turp, A.; Encheva, V.; Carroll, T.; Grabole, N.; Mansfield, W.; Nashun, B.; Knezovich, J.G.; Smith, A.; Surani, M.Azim.; Hajkova, P. 2013: Naive pluripotency is associated with global DNA hypomethylation. Nature Structural and Molecular Biology 20(3): 311-316
Keehner, M.; Fischer, M.H. 2011: Naive realism in public perceptions of neuroimages. Nature Reviews. Neuroscience 12(2): 118; Author Reply 118
Vanam, H.P.; Mohanram, K.; Reddy, K.S.R.; Rengasamy, M.; Rudramurthy, S.M. 2019: Naive tinea corporis et cruris in an Immunocompetent adult caused by a geophile Nannizzia gypsea susceptible to Terbinafine-Rarity in the current scenario of Dermatophytosis in India. Access Microbiology 1(6): E000022
Freudenhammer, M.; Voll, R.E.; Binder, S.C.; Keller, B.; Warnatz, K. 2020: Naive- and Memory-like CD21low B Cell Subsets Share Core Phenotypic and Signaling Characteristics in Systemic Autoimmune Disorders. Journal of Immunology 205(8): 2016-2025
Mascetti, V.L.; Pedersen, R.A. 2014: Naiveté of the human pluripotent stem cell. Nature Biotechnology 32(1): 68-70
Deka, A.; Sharma, M.; Mukhopadhyay, R.; Devi, A.; Doley, R. 2020: Naja kaouthia venom protein, Nk-CRISP, upregulates inflammatory gene expression in human macrophages. International Journal of Biological Macromolecules 160: 602-611
Suryamohan, K.; Seshagiri, S. 2020: Naja naja (Indian Cobra). Trends in Genetics: Tig 36(10): 804-806
Wang, Y.; Sherchan, P.; Huang, L.; Akyol, O.; McBride, D.W.; Zhang, J.H. 2017: Naja sputatrix Venom Preconditioning Attenuates Neuroinflammation in a Rat Model of Surgical Brain Injury via PLA2/5-LOX/LTB4 Cascade Activation. Scientific Reports 7(1): 5466
Alpar, O. 2020: Nakagami imaging with related distributions for advanced thermogram pseudocolorization. Journal of Thermal Biology 93: 102704
Martínez-García, E.; Fraile, S.ía.; Rodríguez Espeso, D.; Vecchietti, D.; Bertoni, G.; de Lorenzo, V.íc. 2020: Naked Bacterium: Emerging Properties of a Surfome-Streamlined Pseudomonas putida Strain. Acs Synthetic Biology 9(9): 2477-2492
Bermudes, D. 1998: Naked DNA dons new clothes. Nature Biotechnology 16(9): 818-819
Pyun, W-B.; Hahn, W.; Kim, D-S.; Yoo, W-S.; Lee, S-D.; Won, J-H.; Rho, B-S.; Park, Z-Y.; Kim, J-M.; Kim, S. 2010: Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia. Gene Therapy 17(12): 1442-1452
Brower, V. 1998: Naked DNA vaccines come of age. Nature Biotechnology 16(13): 1304-1305
Moelling, K. 1998: Naked DNA--the poor man's gene therapy?. Gene Therapy 5(5): 573-574
Moffatt, M.; Cookson, W. 1996: Naked DNA: new shots for allergy?. Nature Medicine 2(5): 515-516
Mandal, A.; Adhikary, A.; Sarkar, A.; Das, D. 2020: Naked Eye Cd2+ Ion Detection and Reversible Iodine Uptake by a Three-Dimensional Pillared-Layered Zn-MOF. Inorganic Chemistry 59(23): 17758-17765
Hadi, F.; Smith, E.S.J.; Khaled, W.T. 2021: Naked Mole-Rats: Resistant to Developing Cancer or Good at Avoiding It?. Advances in Experimental Medicine and Biology 1319: 341-352
Davoust, J.; Banchereau, J. 2000: Naked antigen-presenting molecules on dendritic cells. Nature Cell Biology 2(3): E46-E48
Horridge, G.A.; Chapman, D.M.; Mackay, B. 1962: Naked axons and symmetrical synapses in an elementary nervous system. Nature 193: 899-900
Sulmasy, D.P. 2015: Naked bodies, naked genomes: the special (but not exceptional) nature of genomic information. Genetics in Medicine: Official Journal of the American College of Medical Genetics 17(5): 331-336
Wang, R.; Xie, H.; Yang, L.; Wang, P.; Chen, M.-M.; Wu, H.-Y.; Liao, Y.-L.; Wang, M.-Y.; Wang, Q.; Gong, X.-X.; Cheng, Q.; Cheng, L.; Xie, F.-Y.; Bi, C.-L.; Fang, M. 2021: Naked cuticle inhibits wingless signaling in Drosophila wing development. Biochemical and Biophysical Research Communications 576: 1-6
Sohtome, Y.; Nakamura, G.; Muranaka, A.; Hashizume, D.; Lectard, S.; Tsuchimoto, T.; Uchiyama, M.; Sodeoka, M. 2017: Naked d-orbital in a centrochiral Ni(II) complex as a catalyst for asymmetric [3+2] cycloaddition. Nature Communications 8: 14875
Singh, N.; Kumari, S.; Khan, S. 2021: Naked eye colorimetric detection of fluoride through TiO2 NPs/CQDs based detector. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 254: 119637
Kumar, P.; Jose, D.A. 2020: Naked eye detection of moisture in organic solvents and development of alginate polymer beads and test cassettes as a portable kit. Analytica Chimica Acta 1136: 178-186
Zimmer, V. 2021: Naked fat sign signifying terminal ileum lipoma. Clinics and Research in Hepatology and Gastroenterology 45(1): 101449
Cheng, H.; Munro, D.; Huynh, K.; Pamenter, M.E. 2021: Naked mole-rat skeletal muscle mitochondria exhibit minimal functional plasticity in acute or chronic hypoxia. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 255: 110596